<pdfxml CreationDate="D:20220804181442+05'30'" Creator="Adobe InDesign CS6 (Windows)" ModDate="D:20220804181450+05'30'" Producer="Adobe PDF Library 10.0.1" Trapped="/False" jobID="indesignAutoPage">
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="1" rotate="0" page_index="0" page_label="">
    <LTTextBoxHorizontal y0="605.451" y1="745.701" x0="145.672" x1="548.212" width="402.54" height="140.25" bbox="[145.672, 605.451, 548.212, 745.701]" index="1"><LTTextLineHorizontal y0="725.701" y1="745.701" x0="145.673" x1="548.212" width="402.54" height="20.0" bbox="[145.673, 725.701, 548.212, 745.701]" word_margin="0.1">Haemophagocytic lymphohistiocytosis as a complication </LTTextLineHorizontal><LTTextLineHorizontal y0="701.701" y1="721.701" x0="145.673" x1="529.612" width="383.94" height="20.0" bbox="[145.673, 701.701, 529.612, 721.701]" word_margin="0.1">of combination anti- PD- 1 and anti- CTLA- 4 checkpoint </LTTextLineHorizontal><LTTextLineHorizontal y0="677.701" y1="697.701" x0="145.672" x1="543.173" width="397.5" height="20.0" bbox="[145.672, 677.701, 543.173, 697.701]" word_margin="0.1">inhibitor immunotherapy for metastatic melanoma, and </LTTextLineHorizontal><LTTextLineHorizontal y0="653.701" y1="673.701" x0="145.672" x1="508.312" width="362.64" height="20.0" bbox="[145.672, 653.701, 508.312, 673.701]" word_margin="0.1">the outcome of rechallenge with single- agent anti- </LTTextLineHorizontal><LTTextLineHorizontal y0="629.701" y1="649.701" x0="145.672" x1="298.612" width="152.94" height="20.0" bbox="[145.672, 629.701, 298.612, 649.701]" word_margin="0.1">PD- 1 immunotherapy </LTTextLineHorizontal><LTTextLineHorizontal y0="605.451" y1="621.015" x0="145.673" x1="387.543" width="241.871" height="15.564" bbox="[145.673, 605.451, 387.543, 621.015]" word_margin="0.1">Zachary Holmes,1 Ashling Courtney,2 Alison Hiong3 <LTRect y0="605.451" y1="620.451" x0="352.336" x1="380.286" width="27.95" height="15.0" bbox="[352.336, 605.451, 380.286, 620.451]" linewidth="0" pts="[[352.336, 605.451], [380.286, 605.451], [380.286, 620.451], [352.336, 620.451]]"/><LTRect y0="605.451" y1="620.451" x0="267.77" x1="310.396" width="42.626" height="15.0" bbox="[267.77, 605.451, 310.396, 620.451]" linewidth="0" pts="[[267.77, 605.451], [310.396, 605.451], [310.396, 620.451], [267.77, 620.451]]"/><LTRect y0="605.451" y1="620.451" x0="185.361" x1="219.824" width="34.463" height="15.0" bbox="[185.361, 605.451, 219.824, 620.451]" linewidth="0" pts="[[185.361, 605.451], [219.824, 605.451], [219.824, 620.451], [185.361, 620.451]]"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="346.426" y1="576.326" x0="145.673" x1="344.83" width="199.157" height="229.9" bbox="[145.673, 346.426, 344.83, 576.326]" index="2"><LTTextLineHorizontal y0="566.826" y1="576.326" x0="145.673" x1="188.983" width="43.311" height="9.5" bbox="[145.673, 566.826, 188.983, 576.326]" word_margin="0.1">Summary </LTTextLineHorizontal><LTTextLineHorizontal y0="555.806" y1="565.306" x0="145.673" x1="317.908" width="172.235" height="9.5" bbox="[145.673, 555.806, 317.908, 565.306]" word_margin="0.1">A woman with metastatic melanoma was treated </LTTextLineHorizontal><LTTextLineHorizontal y0="544.786" y1="554.286" x0="145.673" x1="326.733" width="181.06" height="9.5" bbox="[145.673, 544.786, 326.733, 554.286]" word_margin="0.1">with immunotherapy induction with ipilimumab and </LTTextLineHorizontal><LTTextLineHorizontal y0="533.766" y1="543.266" x0="145.673" x1="326.562" width="180.889" height="9.5" bbox="[145.673, 533.766, 326.562, 543.266]" word_margin="0.1">nivolumab and radiotherapy to liver metastases. The </LTTextLineHorizontal><LTTextLineHorizontal y0="522.746" y1="532.246" x0="145.673" x1="338.352" width="192.679" height="9.5" bbox="[145.673, 522.746, 338.352, 532.246]" word_margin="0.1">patient deteriorated shortly thereafter, becoming febrile </LTTextLineHorizontal><LTTextLineHorizontal y0="511.726" y1="521.226" x0="145.673" x1="340.973" width="195.301" height="9.5" bbox="[145.673, 511.726, 340.973, 521.226]" word_margin="0.1">and hypotensive and requiring admission to the intensie </LTTextLineHorizontal><LTTextLineHorizontal y0="500.706" y1="510.206" x0="145.673" x1="344.83" width="199.157" height="9.5" bbox="[145.673, 500.706, 344.83, 510.206]" word_margin="0.1">care unit (ICU) for inotrope support. Failure to respond to </LTTextLineHorizontal><LTTextLineHorizontal y0="489.686" y1="499.186" x0="145.673" x1="344.469" width="198.797" height="9.5" bbox="[145.673, 489.686, 344.469, 499.186]" word_margin="0.1">antibiotics and a negative septic screen prompted further </LTTextLineHorizontal><LTTextLineHorizontal y0="478.666" y1="488.166" x0="145.673" x1="324.957" width="179.284" height="9.5" bbox="[145.673, 478.666, 324.957, 488.166]" word_margin="0.1">investigation, which ultimately led to a diagnosis of </LTTextLineHorizontal><LTTextLineHorizontal y0="467.646" y1="477.146" x0="145.673" x1="341.163" width="195.491" height="9.5" bbox="[145.673, 467.646, 341.163, 477.146]" word_margin="0.1">haemophagocytic lymphohistiocytosis (HLH). The patient </LTTextLineHorizontal><LTTextLineHorizontal y0="456.626" y1="466.126" x0="145.673" x1="326.724" width="181.051" height="9.5" bbox="[145.673, 456.626, 326.724, 466.126]" word_margin="0.1">improved on high dose steroids and was discharged </LTTextLineHorizontal><LTTextLineHorizontal y0="445.606" y1="455.106" x0="145.673" x1="316.178" width="170.506" height="9.5" bbox="[145.673, 445.606, 316.178, 455.106]" word_margin="0.1">home. Months later, in the context of progressive </LTTextLineHorizontal><LTTextLineHorizontal y0="434.586" y1="444.086" x0="145.673" x1="308.389" width="162.716" height="9.5" bbox="[145.673, 434.586, 308.389, 444.086]" word_margin="0.1">melanoma, the patient was re- challenged with </LTTextLineHorizontal><LTTextLineHorizontal y0="423.566" y1="433.066" x0="145.673" x1="337.468" width="191.795" height="9.5" bbox="[145.673, 423.566, 337.468, 433.066]" word_margin="0.1">nivolumab monotherapy and subsequently experienced </LTTextLineHorizontal><LTTextLineHorizontal y0="412.546" y1="422.046" x0="145.673" x1="328.814" width="183.141" height="9.5" bbox="[145.673, 412.546, 328.814, 422.046]" word_margin="0.1">recurrence of HLH, confirming the aetiology as being </LTTextLineHorizontal><LTTextLineHorizontal y0="401.526" y1="411.026" x0="145.673" x1="335.151" width="189.478" height="9.5" bbox="[145.673, 401.526, 335.151, 411.026]" word_margin="0.1">immunotherapy related. This case serves as a reminder </LTTextLineHorizontal><LTTextLineHorizontal y0="390.506" y1="400.006" x0="145.673" x1="325.479" width="179.807" height="9.5" bbox="[145.673, 390.506, 325.479, 400.006]" word_margin="0.1">to consider HLH where there are fevers of unknown </LTTextLineHorizontal><LTTextLineHorizontal y0="379.486" y1="388.986" x0="145.673" x1="341.496" width="195.823" height="9.5" bbox="[145.673, 379.486, 341.496, 388.986]" word_margin="0.1">origin in an unwell patient receiving immune checkpoint </LTTextLineHorizontal><LTTextLineHorizontal y0="368.466" y1="377.966" x0="145.673" x1="344.66" width="198.988" height="9.5" bbox="[145.673, 368.466, 344.66, 377.966]" word_margin="0.1">inhibitor therapy and also highlights immunotherapy as a </LTTextLineHorizontal><LTTextLineHorizontal y0="357.446" y1="366.946" x0="145.673" x1="339.348" width="193.676" height="9.5" bbox="[145.673, 357.446, 339.348, 366.946]" word_margin="0.1">potential cause for HLH, which has rarely been reported </LTTextLineHorizontal><LTTextLineHorizontal y0="346.426" y1="355.926" x0="145.673" x1="227.476" width="81.804" height="9.5" bbox="[145.673, 346.426, 227.476, 355.926]" word_margin="0.1">in the literature to date. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="176.44" y1="317.926" x0="145.671" x1="345.738" width="200.067" height="141.486" bbox="[145.671, 176.44, 345.738, 317.926]" index="3"><LTTextLineHorizontal y0="308.426" y1="317.926" x0="145.673" x1="204.459" width="58.786" height="9.5" bbox="[145.673, 308.426, 204.459, 317.926]" word_margin="0.1">BaCkground </LTTextLineHorizontal><LTTextLineHorizontal y0="297.648" y1="306.648" x0="145.673" x1="345.723" width="200.05" height="9.0" bbox="[145.673, 297.648, 345.723, 306.648]" word_margin="0.1">Recent advances in the use of immunotherapy </LTTextLineHorizontal><LTTextLineHorizontal y0="286.632" y1="295.632" x0="145.673" x1="345.738" width="200.066" height="9.0" bbox="[145.673, 286.632, 345.738, 295.632]" word_margin="0.1">have revolutionised the treatment of many cancers, </LTTextLineHorizontal><LTTextLineHorizontal y0="275.616" y1="284.616" x0="145.673" x1="345.736" width="200.064" height="9.0" bbox="[145.673, 275.616, 345.736, 284.616]" word_margin="0.1">including melanoma. Within the past decade, </LTTextLineHorizontal><LTTextLineHorizontal y0="264.6" y1="273.6" x0="145.673" x1="229.679" width="84.006" height="9.0" bbox="[145.673, 264.6, 229.679, 273.6]" word_margin="0.1">immune checkpoint </LTTextLineHorizontal><LTTextLineHorizontal y0="264.6" y1="273.6" x0="234.809" x1="345.734" width="110.925" height="9.0" bbox="[234.809, 264.6, 345.734, 273.6]" word_margin="0.1">inhibitors (ICIs) targeting </LTTextLineHorizontal><LTTextLineHorizontal y0="253.584" y1="262.584" x0="145.673" x1="345.73" width="200.057" height="9.0" bbox="[145.673, 253.584, 345.73, 262.584]" word_margin="0.1">programmed cell death 1 (PD- 1) and cytotoxic </LTTextLineHorizontal><LTTextLineHorizontal y0="242.568" y1="251.568" x0="145.672" x1="345.724" width="200.052" height="9.0" bbox="[145.672, 242.568, 345.724, 251.568]" word_margin="0.1">T- lymphocyte- associated antigen 4 (CTLA- 4) have </LTTextLineHorizontal><LTTextLineHorizontal y0="231.552" y1="240.552" x0="145.672" x1="345.724" width="200.051" height="9.0" bbox="[145.672, 231.552, 345.724, 240.552]" word_margin="0.1">been demonstrated to significantly prolong overall </LTTextLineHorizontal><LTTextLineHorizontal y0="220.536" y1="229.536" x0="145.672" x1="345.724" width="200.052" height="9.0" bbox="[145.672, 220.536, 345.724, 229.536]" word_margin="0.1">survival and produce durable responses in patients </LTTextLineHorizontal><LTTextLineHorizontal y0="209.488" y1="220.224" x0="145.672" x1="345.73" width="200.057" height="10.736" bbox="[145.672, 209.488, 345.73, 220.224]" word_margin="0.1">with metastatic melanoma.1 However, due to the <Annot A="&lt;PDFObjRef:263&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[252.108, 220.287, 255.426, 209.489]" x0="252.108" x1="255.426" y0="220.287" y1="209.489" height="-10.798000000000002" width="3.3179999999999836"/></LTTextLineHorizontal><LTTextLineHorizontal y0="198.472" y1="207.472" x0="145.671" x1="345.723" width="200.052" height="9.0" bbox="[145.671, 198.472, 345.723, 207.472]" word_margin="0.1">manner by which these drugs work by up- regulating </LTTextLineHorizontal><LTTextLineHorizontal y0="187.456" y1="196.456" x0="145.671" x1="345.711" width="200.039" height="9.0" bbox="[145.671, 187.456, 345.711, 196.456]" word_margin="0.1">the immune system, they have the potential to cause </LTTextLineHorizontal><LTTextLineHorizontal y0="176.44" y1="187.164" x0="145.671" x1="325.558" width="179.887" height="10.724" bbox="[145.671, 176.44, 325.558, 187.164]" word_margin="0.1">serious immune- related adverse events (irAE).1 </LTTextLineHorizontal><Annot A="&lt;PDFObjRef:264&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[322.24, 187.227, 325.559, 176.429]" x0="322.24" x1="325.559" y0="187.227" y1="176.429" height="-10.798000000000002" width="3.319000000000017"/></LTTextBoxHorizontal>
    
    <LTTextBoxHorizontal y0="479.371" y1="578.091" x0="355.723" x1="555.793" width="200.07" height="98.72" bbox="[355.723, 479.371, 555.793, 578.091]" index="5"><LTTextLineHorizontal y0="567.355" y1="578.091" x0="355.726" x1="555.775" width="200.049" height="10.736" bbox="[355.726, 567.355, 555.775, 578.091]" word_margin="0.1">haemophagocytosis on bone marrow aspirate.4 The <Annot A="&lt;PDFObjRef:267&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[532.333, 578.154, 535.651, 567.357]" x0="532.333" x1="535.651" y0="578.154" y1="567.357" height="-10.797000000000025" width="3.3179999999999836"/></LTTextLineHorizontal><LTTextLineHorizontal y0="556.357" y1="565.357" x0="355.723" x1="555.775" width="200.052" height="9.0" bbox="[355.723, 556.357, 555.775, 565.357]" word_margin="0.1">diagnostic criteria from the HLH- 2004 guidelines </LTTextLineHorizontal><LTTextLineHorizontal y0="545.359" y1="554.359" x0="355.723" x1="555.78" width="200.057" height="9.0" bbox="[355.723, 545.359, 555.78, 554.359]" word_margin="0.1">are commonly used to help confirm a diagnosis of </LTTextLineHorizontal><LTTextLineHorizontal y0="534.361" y1="543.361" x0="355.723" x1="553.273" width="197.55" height="9.0" bbox="[355.723, 534.361, 553.273, 543.361]" word_margin="0.1">HLH. Management involves addressing the under- </LTTextLineHorizontal><LTTextLineHorizontal y0="523.363" y1="532.363" x0="355.723" x1="555.793" width="200.07" height="9.0" bbox="[355.723, 523.363, 555.793, 532.363]" word_margin="0.1">lying cause in addition to the use of corticosteroids </LTTextLineHorizontal><LTTextLineHorizontal y0="512.365" y1="521.365" x0="355.723" x1="555.775" width="200.052" height="9.0" bbox="[355.723, 512.365, 555.775, 521.365]" word_margin="0.1">and chemotherapeutic agents such as etoposide. </LTTextLineHorizontal><LTTextLineHorizontal y0="501.367" y1="510.367" x0="355.723" x1="555.777" width="200.054" height="9.0" bbox="[355.723, 501.367, 555.777, 510.367]" word_margin="0.1">However, even with best available treatment, </LTTextLineHorizontal><LTTextLineHorizontal y0="490.369" y1="499.369" x0="355.723" x1="555.758" width="200.035" height="9.0" bbox="[355.723, 490.369, 555.758, 499.369]" word_margin="0.1">the prognosis is poor, with only a 55% chance of </LTTextLineHorizontal><LTTextLineHorizontal y0="479.371" y1="490.091" x0="355.723" x1="391.341" width="35.618" height="10.72" bbox="[355.723, 479.371, 391.341, 490.091]" word_margin="0.1">survival.5 </LTTextLineHorizontal><Annot A="&lt;PDFObjRef:268&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[388.024, 490.154, 391.342, 479.357]" x0="388.024" x1="391.342" y0="490.154" y1="479.357" height="-10.796999999999969" width="3.3179999999999836"/></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="435.359" y1="477.355" x0="355.724" x1="555.79" width="200.066" height="41.996" bbox="[355.724, 435.359, 555.79, 477.355]" index="6"><LTTextLineHorizontal y0="468.355" y1="477.355" x0="364.724" x1="555.769" width="191.045" height="9.0" bbox="[364.724, 468.355, 555.769, 477.355]" word_margin="0.1">To date, there have been very few cases reported </LTTextLineHorizontal><LTTextLineHorizontal y0="457.355" y1="468.091" x0="355.724" x1="555.785" width="200.061" height="10.736" bbox="[355.724, 457.355, 555.785, 468.091]" word_margin="0.1">of ICIs causing HLH.6&#8211;18 Additionally, data relating <Annot A="&lt;PDFObjRef:269&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[438.413, 468.154, 451.352, 457.357]" x0="438.413" x1="451.352" y0="468.154" y1="457.357" height="-10.796999999999969" width="12.938999999999965"/></LTTextLineHorizontal><LTTextLineHorizontal y0="446.357" y1="455.357" x0="355.727" x1="555.79" width="200.063" height="9.0" bbox="[355.727, 446.357, 555.79, 455.357]" word_margin="0.1">to outcomes of ICI rechallenge after an index </LTTextLineHorizontal><LTTextLineHorizontal y0="435.359" y1="444.359" x0="355.727" x1="484.317" width="128.59" height="9.0" bbox="[355.727, 435.359, 484.317, 444.359]" word_margin="0.1">episode of HLH are even scarcer. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="356.863" y1="421.113" x0="355.724" x1="555.785" width="200.061" height="64.25" bbox="[355.724, 356.863, 555.785, 421.113]" index="7"><LTTextLineHorizontal y0="411.613" y1="421.113" x0="355.724" x1="441.623" width="85.899" height="9.5" bbox="[355.724, 411.613, 441.623, 421.113]" word_margin="0.1">CaSe preSenTaTion </LTTextLineHorizontal><LTTextLineHorizontal y0="400.855" y1="409.855" x0="355.724" x1="555.767" width="200.043" height="9.0" bbox="[355.724, 400.855, 555.767, 409.855]" word_margin="0.1">A woman in her 40s presented with a 1- month </LTTextLineHorizontal><LTTextLineHorizontal y0="389.857" y1="398.857" x0="355.724" x1="555.785" width="200.061" height="9.0" bbox="[355.724, 389.857, 555.785, 398.857]" word_margin="0.1">history of malaise, nausea, vomiting, fatigue, </LTTextLineHorizontal><LTTextLineHorizontal y0="378.859" y1="387.859" x0="355.724" x1="555.785" width="200.061" height="9.0" bbox="[355.724, 378.859, 555.785, 387.859]" word_margin="0.1">anorexia and 14 kg of unintentional weight loss on </LTTextLineHorizontal><LTTextLineHorizontal y0="367.861" y1="376.861" x0="355.724" x1="553.281" width="197.557" height="9.0" bbox="[355.724, 367.861, 553.281, 376.861]" word_margin="0.1">a background of a right shoulder melanoma exci- </LTTextLineHorizontal><LTTextLineHorizontal y0="356.863" y1="365.863" x0="355.724" x1="406.592" width="50.868" height="9.0" bbox="[355.724, 356.863, 406.592, 365.863]" word_margin="0.1">sion in 1995. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="301.873" y1="354.865" x0="355.724" x1="555.788" width="200.064" height="52.992" bbox="[355.724, 301.873, 555.788, 354.865]" index="8"><LTTextLineHorizontal y0="345.865" y1="354.865" x0="364.724" x1="555.762" width="191.038" height="9.0" bbox="[364.724, 345.865, 555.762, 354.865]" word_margin="0.1">Her medical history was otherwise significant for </LTTextLineHorizontal><LTTextLineHorizontal y0="334.867" y1="343.867" x0="355.724" x1="555.788" width="200.064" height="9.0" bbox="[355.724, 334.867, 555.788, 343.867]" word_margin="0.1">coeliac disease, which was well controlled with a </LTTextLineHorizontal><LTTextLineHorizontal y0="323.869" y1="332.869" x0="355.724" x1="555.767" width="200.043" height="9.0" bbox="[355.724, 323.869, 555.767, 332.869]" word_margin="0.1">gluten- free diet. She previously smoked from age </LTTextLineHorizontal><LTTextLineHorizontal y0="312.871" y1="321.871" x0="355.724" x1="555.78" width="200.056" height="9.0" bbox="[355.724, 312.871, 555.78, 321.871]" word_margin="0.1">16 to 30 and infrequently drank alcohol. There was </LTTextLineHorizontal><LTTextLineHorizontal y0="301.873" y1="310.873" x0="355.724" x1="485.526" width="129.803" height="9.0" bbox="[355.724, 301.873, 485.526, 310.873]" word_margin="0.1">no known relevant family history. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="202.891" y1="299.875" x0="355.715" x1="555.784" width="200.069" height="96.984" bbox="[355.715, 202.891, 555.784, 299.875]" index="9"><LTTextLineHorizontal y0="290.875" y1="299.875" x0="364.724" x1="555.782" width="191.058" height="9.0" bbox="[364.724, 290.875, 555.782, 299.875]" word_margin="0.1">CT showed innumerable metastases in the liver, </LTTextLineHorizontal><LTTextLineHorizontal y0="279.877" y1="288.877" x0="355.724" x1="555.767" width="200.043" height="9.0" bbox="[355.724, 279.877, 555.767, 288.877]" word_margin="0.1">as well as metastases to bone and spleen. MRI of </LTTextLineHorizontal><LTTextLineHorizontal y0="268.879" y1="277.879" x0="355.724" x1="555.784" width="200.06" height="9.0" bbox="[355.724, 268.879, 555.784, 277.879]" word_margin="0.1">the brain was unremarkable. Subsequent positron </LTTextLineHorizontal><LTTextLineHorizontal y0="257.881" y1="266.881" x0="355.724" x1="555.782" width="200.058" height="9.0" bbox="[355.724, 257.881, 555.782, 266.881]" word_margin="0.1">emission tomography (PET) showed extensive </LTTextLineHorizontal><LTTextLineHorizontal y0="246.883" y1="255.883" x0="355.724" x1="555.776" width="200.052" height="9.0" bbox="[355.724, 246.883, 555.776, 255.883]" word_margin="0.1">fluorodeoxyglucose- avid (FDG) metastatic disease </LTTextLineHorizontal><LTTextLineHorizontal y0="235.885" y1="244.885" x0="355.724" x1="555.781" width="200.057" height="9.0" bbox="[355.724, 235.885, 555.781, 244.885]" word_margin="0.1">involving the liver, spleen, lung, skeleton and </LTTextLineHorizontal><LTTextLineHorizontal y0="224.887" y1="233.887" x0="355.724" x1="555.776" width="200.052" height="9.0" bbox="[355.724, 224.887, 555.776, 233.887]" word_margin="0.1">lymph nodes, consistent with stage IV melanoma </LTTextLineHorizontal><LTTextLineHorizontal y0="213.889" y1="222.889" x0="355.724" x1="555.769" width="200.045" height="9.0" bbox="[355.724, 213.889, 555.769, 222.889]" word_margin="0.1">(see figure 1). Liver biopsy confirmed BRAF V600E <Annot A="&lt;PDFObjRef:270&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[372.674, 224.654, 402.505, 213.857]" x0="372.674" x1="402.505" y0="224.654" y1="213.857" height="-10.796999999999997" width="29.831000000000017"/></LTTextLineHorizontal><LTTextLineHorizontal y0="202.891" y1="211.891" x0="355.715" x1="502.298" width="146.583" height="9.0" bbox="[355.715, 202.891, 502.298, 211.891]" word_margin="0.1">mutant- positive metastatic melanoma. </LTTextLineHorizontal></LTTextBoxHorizontal>

    <LTTextLineHorizontal y0="26.931" y1="34.931" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.931, 553.276, 34.931]" word_margin="0.1"><LTTextBoxHorizontal y0="26.931" y1="34.931" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.931, 553.276, 34.931]" index="11">1 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="488.326" y1="577.904" x0="42.0" x1="138.474" width="96.474" height="89.578" bbox="[42.0, 488.326, 138.474, 577.904]" index="12"><LTTextLineHorizontal y0="568.326" y1="577.904" x0="42.0" x1="138.474" width="96.474" height="9.578" bbox="[42.0, 568.326, 138.474, 577.904]" word_margin="0.1">1St Vincent&#8217;s Hospital Melbourne </LTTextLineHorizontal><LTTextLineHorizontal y0="558.326" y1="566.326" x0="42.002" x1="112.937" width="70.935" height="8.0" bbox="[42.002, 558.326, 112.937, 566.326]" word_margin="0.1">Pty Ltd, Fitzroy, Victoria, </LTTextLineHorizontal><LTTextLineHorizontal y0="548.326" y1="556.326" x0="42.002" x1="67.642" width="25.64" height="8.0" bbox="[42.002, 548.326, 67.642, 556.326]" word_margin="0.1">Australia </LTTextLineHorizontal><LTTextLineHorizontal y0="538.326" y1="547.904" x0="42.0" x1="117.858" width="75.858" height="9.578" bbox="[42.0, 538.326, 117.858, 547.904]" word_margin="0.1">2Peter MacCallum Cancer </LTTextLineHorizontal><LTTextLineHorizontal y0="528.326" y1="536.326" x0="42.002" x1="124.209" width="82.207" height="8.0" bbox="[42.002, 528.326, 124.209, 536.326]" word_margin="0.1">Centre, Melbourne, Victoria, </LTTextLineHorizontal><LTTextLineHorizontal y0="518.326" y1="526.326" x0="42.002" x1="67.642" width="25.64" height="8.0" bbox="[42.002, 518.326, 67.642, 526.326]" word_margin="0.1">Australia </LTTextLineHorizontal><LTTextLineHorizontal y0="508.326" y1="517.904" x0="42.0" x1="116.545" width="74.545" height="9.578" bbox="[42.0, 508.326, 116.545, 517.904]" word_margin="0.1">3Medical Oncology, Peter </LTTextLineHorizontal><LTTextLineHorizontal y0="498.326" y1="506.326" x0="42.002" x1="121.232" width="79.23" height="8.0" bbox="[42.002, 498.326, 121.232, 506.326]" word_margin="0.1">MacCallum Cancer Centre, </LTTextLineHorizontal><LTTextLineHorizontal y0="488.326" y1="496.326" x0="42.002" x1="126.897" width="84.895" height="8.0" bbox="[42.002, 488.326, 126.897, 496.326]" word_margin="0.1">Melbourne, Victoria, Australia </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="449.326" y1="475.326" x0="42.002" x1="105.346" width="63.344" height="26.0" bbox="[42.002, 449.326, 105.346, 475.326]" index="13">holmesz@ tcd. ie <LTTextLineHorizontal y0="467.326" y1="475.326" x0="42.002" x1="105.346" width="63.344" height="8.0" bbox="[42.002, 467.326, 105.346, 475.326]" word_margin="0.1">Correspondence to </LTTextLineHorizontal><LTTextLineHorizontal y0="458.326" y1="466.326" x0="42.002" x1="101.985" width="59.983" height="8.0" bbox="[42.002, 458.326, 101.985, 466.326]" word_margin="0.1">Dr Zachary Holmes; </LTTextLineHorizontal><LTTextLineHorizontal y0="449.326" y1="457.326" x0="42.002" x1="87.97" width="45.968" height="8.0" bbox="[42.002, 449.326, 87.97, 457.326]" word_margin="0.1">holmesz@tcd. ie <LTTextLineHorizontal y0="449.326" y1="457.326" x0="42.002" x1="43.922" width="1.92" height="8.0" bbox="[42.002, 449.326, 43.922, 457.326]" word_margin="0.1"> </LTTextLineHorizontal></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="427.326" y1="435.326" x0="42.002" x1="108.282" width="66.28" height="8.0" bbox="[42.002, 427.326, 108.282, 435.326]" word_margin="0.1"><LTTextBoxHorizontal y0="427.326" y1="435.326" x0="42.002" x1="108.282" width="66.28" height="8.0" bbox="[42.002, 427.326, 108.282, 435.326]" index="14">Accepted 31 July 2022 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="99.595" y1="134.595" x0="42.25" x1="131.873" width="89.623" height="35.0" bbox="[42.25, 99.595, 131.873, 134.595]" index="15"><LTTextLineHorizontal y0="126.595" y1="134.595" x0="42.25" x1="116.642" width="74.392" height="8.0" bbox="[42.25, 126.595, 116.642, 134.595]" word_margin="0.1">&#169; BMJ Publishing Group </LTTextLineHorizontal><LTTextLineHorizontal y0="117.595" y1="125.595" x0="42.25" x1="129.625" width="87.375" height="8.0" bbox="[42.25, 117.595, 129.625, 125.595]" word_margin="0.1">Limited 2022. No commercial </LTTextLineHorizontal><LTTextLineHorizontal y0="108.595" y1="116.595" x0="42.25" x1="106.674" width="64.424" height="8.0" bbox="[42.25, 108.595, 106.674, 116.595]" word_margin="0.1">re- use. See rights and </LTTextLineHorizontal><LTTextLineHorizontal y0="99.595" y1="107.595" x0="42.25" x1="131.873" width="89.623" height="8.0" bbox="[42.25, 99.595, 131.873, 107.595]" word_margin="0.1">permissions. Published by BMJ. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTLine y0="38.681" y1="38.681" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.681, 553.276, 38.681]" linewidth="0.5" pts="[[42.0, 38.681], [553.276, 38.681]]"/>
    <LTTextLineHorizontal y0="26.941" y1="34.941" x0="181.208" x1="414.365" width="233.158" height="8.0" bbox="[181.208, 26.941, 414.365, 34.941]" word_margin="0.1"><LTTextBoxHorizontal y0="26.941" y1="34.941" x0="181.208" x1="414.365" width="233.158" height="8.0" bbox="[181.208, 26.941, 414.365, 34.941]" index="0">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm0" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]">
      <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm1" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    </LTFigure>
    <LTCurve y0="20.278" y1="32.798" x0="58.887" x1="63.345" width="4.458" height="12.52" bbox="[58.887, 20.278, 63.345, 32.798]" linewidth="0.5" pts="[[59.099, 20.278], [59.091, 20.278], [58.887, 20.482], [58.914, 20.582], [60.43, 22.72], [61.282, 24.958], [61.282, 32.384], [61.695, 32.798], [62.933, 32.798], [63.345, 32.384], [63.345, 24.704], [62.325, 22.167], [61.041, 20.43], [60.746, 20.278], [59.099, 20.278]]"/>
    <LTCurve y0="23.513" y1="32.799" x0="42.0" x1="49.005" width="7.005" height="9.286" bbox="[42.0, 23.513, 49.005, 32.799]" linewidth="0.5" pts="[[47.617, 28.237], [47.664, 28.323], [48.721, 30.269], [45.872, 32.799], [42.413, 32.799], [42.0, 32.387], [42.0, 23.925], [42.413, 23.513], [46.097, 23.513], [49.005, 25.984], [47.667, 28.151], [47.617, 28.237]]">
      <LTCurve y0="25.072" y1="27.305" x0="44.061" x1="46.808" width="2.747" height="2.233" bbox="[44.061, 25.072, 46.808, 27.305]" linewidth="0.5" pts="[[45.914, 25.117], [45.219, 25.072], [44.268, 25.072], [44.061, 25.279], [44.061, 27.098], [44.268, 27.305], [45.268, 27.305], [45.914, 27.249], [46.808, 26.138], [45.914, 25.117]]"/>
      <LTCurve y0="29.082" y1="31.251" x0="44.061" x1="46.58" width="2.519" height="2.169" bbox="[44.061, 29.082, 46.58, 31.251]" linewidth="0.5" pts="[[44.061, 31.045], [44.268, 31.251], [45.117, 31.251], [46.58, 30.152], [45.168, 29.082], [44.268, 29.082], [44.061, 29.289], [44.061, 31.045]]"/>
    </LTCurve>
    <LTCurve y0="23.511" y1="32.798" x0="50.444" x1="58.893" width="8.449" height="9.287" bbox="[50.444, 23.511, 58.893, 32.798]" linewidth="0.5" pts="[[56.649, 29.032], [56.731, 29.075], [56.831, 28.977], [56.831, 23.925], [57.244, 23.511], [58.48, 23.511], [58.893, 23.925], [58.893, 32.385], [58.48, 32.798], [57.172, 32.798], [56.829, 32.614], [54.749, 29.701], [54.67, 29.663], [54.589, 29.704], [52.511, 32.614], [52.168, 32.798], [50.894, 32.798], [50.444, 32.373], [50.444, 23.925], [50.857, 23.511], [52.094, 23.511], [52.507, 23.925], [52.506, 28.977], [52.605, 29.075], [52.687, 29.032], [54.211, 26.879], [54.542, 26.713], [54.786, 26.713], [55.117, 26.879], [56.649, 29.032]]"/>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" index="0">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTRect y0="46.094" y1="94.594" x0="42.25" x1="134.556" width="92.306" height="48.5" bbox="[42.25, 46.094, 134.556, 94.594]" linewidth="0.5" pts="[[42.25, 46.094], [134.556, 46.094], [134.556, 94.594], [42.25, 94.594]]">
      <LTTextBoxHorizontal y0="47.344" y1="91.344" x0="45.5" x1="127.836" width="82.336" height="44.0" bbox="[45.5, 47.344, 127.836, 91.344]" index="16"><LTTextLineHorizontal y0="83.344" y1="91.344" x0="45.5" x1="101.731" width="56.231" height="8.0" bbox="[45.5, 83.344, 101.731, 91.344]" word_margin="0.1">To cite: Holmes Z, </LTTextLineHorizontal><LTTextLineHorizontal y0="74.344" y1="82.344" x0="45.5" x1="122.083" width="76.583" height="8.0" bbox="[45.5, 74.344, 122.083, 82.344]" word_margin="0.1">Courtney A, Hiong A. BMJ </LTTextLineHorizontal><LTTextLineHorizontal y0="65.344" y1="73.344" x0="45.5" x1="127.836" width="82.336" height="8.0" bbox="[45.5, 65.344, 127.836, 73.344]" word_margin="0.1">Case Rep 2022;0:e251052. </LTTextLineHorizontal><LTTextLineHorizontal y0="56.344" y1="64.344" x0="45.5" x1="112.123" width="66.623" height="8.0" bbox="[45.5, 56.344, 112.123, 64.344]" word_margin="0.1">doi:10.1136/bcr-2022- </LTTextLineHorizontal><LTTextLineHorizontal y0="47.344" y1="55.344" x0="45.5" x1="68.54" width="23.04" height="8.0" bbox="[45.5, 47.344, 68.54, 55.344]" word_margin="0.1">251052 </LTTextLineHorizontal></LTTextBoxHorizontal>
    </LTRect>
    <LTLine y0="480.576" y1="480.576" x0="42.0" x1="82.6" width="40.6" height="0.0" bbox="[42.0, 480.576, 82.6, 480.576]" linewidth="0.5" pts="[[42.0, 480.576], [82.6, 480.576]]"/>
    <LTLine y0="440.576" y1="440.576" x0="42.0" x1="82.6" width="40.6" height="0.0" bbox="[42.0, 440.576, 82.6, 440.576]" linewidth="0.5" pts="[[42.0, 440.576], [82.6, 440.576]]"/>
    <LTCurve y0="142.51" y1="159.742" x0="42.625" x1="133.711" width="91.086" height="17.232" bbox="[42.625, 142.51, 133.711, 159.742]" linewidth="0.75" pts="[[43.445, 159.742], [132.89, 159.742], [133.711, 158.922], [133.711, 143.331], [132.89, 142.51], [43.445, 142.51], [42.625, 143.331], [42.625, 158.922], [43.445, 159.742], [43.445, 159.742]]">
      <LTCurve y0="148.873" y1="154.704" x0="64.432" x1="69.27" width="4.838" height="5.831" bbox="[64.432, 148.873, 69.27, 154.704]" linewidth="0.5" pts="[[68.289, 152.816], [68.117, 153.259], [67.838, 153.612], [67.428, 153.842], [66.894, 153.924], [66.127, 153.744], [65.601, 153.268], [65.302, 152.587], [65.302, 151.028], [65.601, 150.342], [66.127, 149.862], [66.894, 149.682], [67.473, 149.797], [67.883, 150.108], [68.161, 150.572], [68.318, 151.126], [69.27, 151.126], [69.056, 150.215], [68.56, 149.501], [67.826, 149.038], [66.898, 148.873], [65.778, 149.104], [64.957, 149.732], [64.432, 150.658], [64.432, 152.911], [64.957, 153.838], [65.778, 154.47], [66.898, 154.704], [67.78, 154.577], [68.51, 154.203], [69.019, 153.608], [69.262, 152.788], [68.289, 152.788], [68.289, 152.816]]"/>
      <LTCurve y0="149.005" y1="154.589" x0="70.033" x1="73.594" width="3.561" height="5.584" bbox="[70.033, 149.005, 73.594, 154.589]" linewidth="0.5" pts="[[70.033, 154.589], [70.936, 154.589], [70.936, 152.537], [71.424, 152.993], [72.167, 153.177], [73.213, 152.833], [73.594, 151.803], [73.594, 149.034], [72.683, 149.034], [72.683, 151.536], [72.482, 152.226], [71.896, 152.439], [71.485, 152.357], [71.182, 152.131], [70.985, 151.791], [70.915, 151.38], [70.915, 149.005], [70.033, 149.005], [70.033, 154.589]]"/>
      <LTCurve y0="148.911" y1="153.178" x0="74.317" x1="78.169" width="3.852" height="4.267" bbox="[74.317, 148.911, 78.169, 153.178]" linewidth="0.5" pts="[[75.203, 150.806], [75.269, 150.355], [75.465, 149.974], [75.802, 149.711], [76.286, 149.613], [76.914, 149.781], [77.267, 150.285], [78.108, 150.285], [77.451, 149.268], [76.91, 149.001], [76.27, 148.911], [75.449, 149.075], [74.825, 149.486], [74.444, 150.154], [74.317, 151.012], [74.452, 151.832], [74.862, 152.509], [76.27, 153.178], [77.123, 152.981], [77.751, 152.456], [78.112, 151.705], [78.169, 150.827], [75.203, 150.827], [75.203, 150.806]]">
        <LTCurve y0="151.389" y1="152.448" x0="75.223" x1="77.295" width="2.072" height="1.059" bbox="[75.223, 151.389, 77.295, 152.448]" linewidth="0.5" pts="[[77.275, 151.389], [77.184, 151.799], [76.984, 152.14], [76.68, 152.357], [76.27, 152.448], [75.86, 152.366], [75.531, 152.14], [75.314, 151.799], [75.223, 151.389], [77.295, 151.389], [77.275, 151.389]]"/>
      </LTCurve>
      <LTCurve y0="148.919" y1="153.178" x0="78.636" x1="82.473" width="3.837" height="4.259" bbox="[78.636, 148.919, 82.473, 153.178]" linewidth="0.5" pts="[[81.566, 151.705], [81.266, 152.271], [80.647, 152.46], [80.282, 152.402], [79.925, 152.185], [79.65, 151.742], [79.551, 150.995], [79.608, 150.495], [79.797, 150.051], [80.13, 149.736], [80.622, 149.617], [81.266, 149.859], [81.582, 150.536], [82.473, 150.536], [81.877, 149.329], [80.647, 148.919], [79.826, 149.079], [79.141, 149.51], [78.764, 150.17], [78.636, 150.991], [78.759, 151.84], [79.141, 152.534], [79.761, 152.994], [80.634, 153.178], [81.303, 153.088], [81.865, 152.816], [82.275, 152.366], [82.464, 151.717], [81.566, 151.717], [81.566, 151.705]]"/>
      <LTCurve y0="149.022" y1="154.589" x0="83.204" x1="86.937" width="3.733" height="5.567" bbox="[83.204, 149.022, 86.937, 154.589]" linewidth="0.5" pts="[[83.204, 154.589], [84.094, 154.589], [84.094, 151.425], [85.699, 153.067], [86.79, 153.067], [85.247, 151.586], [86.937, 149.022], [85.854, 149.022], [84.623, 150.978], [84.094, 150.465], [84.094, 149.022], [83.204, 149.022], [83.204, 154.589]]"/>
      <LTCurve y0="149.001" y1="154.577" x0="89.137" x1="91.529" width="2.392" height="5.575" bbox="[89.137, 149.001, 91.529, 154.577]" linewidth="0.5" pts="[[89.137, 153.05], [89.809, 153.05], [89.809, 153.387], [89.891, 153.999], [90.142, 154.363], [90.494, 154.536], [90.905, 154.577], [91.529, 154.524], [91.529, 153.829], [91.344, 153.867], [91.114, 153.867], [90.807, 153.78], [90.679, 153.445], [90.679, 153.035], [91.451, 153.035], [91.451, 152.369], [90.696, 152.369], [90.696, 149.001], [89.809, 149.001], [89.809, 152.389], [89.145, 152.389], [89.145, 153.05], [89.137, 153.05]]"/>
      <LTCurve y0="148.912" y1="152.994" x0="91.922" x1="95.746" width="3.824" height="4.082" bbox="[91.922, 148.912, 95.746, 152.994]" linewidth="0.5" pts="[[93.834, 148.912], [92.972, 149.071], [92.333, 149.51], [91.922, 150.179], [91.922, 151.885], [92.333, 152.554], [92.972, 152.994], [94.696, 152.994], [95.336, 152.554], [95.746, 151.885], [95.746, 150.179], [95.336, 149.51], [94.696, 149.075], [93.834, 148.912]]">
        <LTCurve y0="149.613" y1="152.333" x0="92.755" x1="94.909" width="2.154" height="2.72" bbox="[92.755, 149.613, 94.909, 152.333]" linewidth="0.5" pts="[[93.834, 149.613], [94.348, 149.736], [94.704, 150.064], [94.909, 150.519], [94.909, 151.553], [94.704, 152.008], [94.348, 152.333], [93.317, 152.333], [92.961, 152.008], [92.755, 151.553], [92.755, 150.519], [92.961, 150.064], [93.317, 149.736], [93.834, 149.613]]"/>
      </LTCurve>
      <LTCurve y0="149.03" y1="153.157" x0="96.612" x1="98.959" width="2.347" height="4.128" bbox="[96.612, 149.03, 98.959, 153.157]" linewidth="0.5" pts="[[96.612, 153.05], [97.432, 153.05], [97.432, 152.272], [97.585, 152.59], [97.859, 152.875], [98.216, 153.079], [98.627, 153.157], [98.84, 153.157], [98.959, 153.157], [98.959, 152.299], [98.766, 152.328], [98.573, 152.328], [98.163, 152.238], [97.814, 151.971], [97.604, 151.536], [97.518, 150.946], [97.518, 149.03], [96.629, 149.03], [96.629, 153.05], [96.612, 153.05]]"/>
      <LTCurve y0="148.912" y1="153.055" x0="101.514" x1="105.061" width="3.546" height="4.143" bbox="[101.514, 148.912, 105.061, 153.055]" linewidth="0.5" pts="[[105.061, 149.022], [104.169, 149.022], [104.169, 149.583], [103.681, 149.095], [103.02, 148.912], [101.871, 149.321], [101.514, 150.511], [101.514, 153.051], [102.406, 153.051], [102.406, 150.589], [102.607, 149.842], [103.175, 149.625], [103.645, 149.711], [103.949, 149.941], [104.118, 150.29], [104.169, 150.716], [104.169, 153.055], [105.061, 153.055], [105.061, 149.026], [105.061, 149.022]]"/>
      <LTCurve y0="147.528" y1="153.161" x0="106.013" x1="109.983" width="3.97" height="5.633" bbox="[106.013, 147.528, 109.983, 153.161]" linewidth="0.5" pts="[[106.019, 153.051], [106.86, 153.051], [106.86, 152.505], [107.382, 153.01], [108.108, 153.161], [108.929, 152.993], [109.515, 152.533], [109.864, 151.853], [109.983, 151.032], [109.877, 150.244], [109.556, 149.572], [108.273, 148.911], [107.862, 148.943], [107.489, 149.058], [107.156, 149.255], [106.902, 149.538], [106.902, 147.528], [106.013, 147.528], [106.013, 153.051], [106.019, 153.051]]">
        <LTCurve y0="149.609" y1="152.456" x0="106.877" x1="109.121" width="2.244" height="2.847" bbox="[106.877, 149.609, 109.121, 152.456]" linewidth="0.5" pts="[[109.121, 151.032], [109.052, 151.561], [108.843, 152.016], [108.49, 152.337], [108.006, 152.456], [107.161, 152.066], [106.877, 151.028], [106.952, 150.461], [107.173, 150.014], [107.526, 149.719], [108.006, 149.609], [108.518, 149.732], [108.867, 150.055], [109.06, 150.507], [109.121, 151.032]]"/>
      </LTCurve>
      <LTCurve y0="148.923" y1="154.594" x0="110.595" x1="114.591" width="3.996" height="5.671" bbox="[110.595, 148.923, 114.591, 154.594]" linewidth="0.5" pts="[[114.555, 149.022], [113.714, 149.022], [113.714, 149.567], [113.196, 149.075], [112.47, 148.923], [111.649, 149.091], [111.062, 149.546], [110.714, 150.228], [110.595, 151.073], [110.743, 152.016], [111.152, 152.673], [111.715, 153.051], [112.359, 153.17], [112.741, 153.137], [113.114, 153.022], [113.446, 152.825], [113.701, 152.542], [113.701, 154.594], [114.591, 154.594], [114.591, 149.022], [114.555, 149.022]]">
        <LTCurve y0="149.732" y1="152.452" x0="111.453" x1="113.692" width="2.239" height="2.72" bbox="[111.453, 149.732, 113.692, 152.452]" linewidth="0.5" pts="[[111.453, 150.995], [111.517, 150.486], [111.719, 150.043], [112.068, 149.732], [113.077, 149.732], [113.426, 150.06], [113.627, 150.515], [113.692, 151.032], [113.392, 152.078], [112.572, 152.452], [112.048, 152.325], [111.694, 151.988], [111.501, 151.52], [111.453, 150.995]]"/>
      </LTCurve>
      <LTCurve y0="148.906" y1="153.177" x0="115.309" x1="119.325" width="4.016" height="4.271" bbox="[115.309, 148.906, 119.325, 153.177]" linewidth="0.5" pts="[[118.9, 149.92], [118.941, 149.686], [119.109, 149.616], [119.202, 149.616], [119.325, 149.616], [119.325, 149.001], [119.207, 148.964], [119.056, 148.932], [118.9, 148.906], [118.768, 148.906], [118.317, 149.018], [118.083, 149.399], [117.43, 149.025], [116.689, 148.906], [116.167, 148.981], [115.728, 149.197], [115.424, 149.563], [115.309, 150.08], [115.445, 150.687], [115.802, 151.052], [116.302, 151.241], [116.861, 151.332], [117.32, 151.397], [117.705, 151.462], [117.973, 151.606], [118.071, 151.897], [117.989, 152.176], [117.787, 152.344], [117.517, 152.422], [117.238, 152.422], [116.622, 152.267], [116.347, 151.783], [115.453, 151.783], [115.641, 152.431], [116.052, 152.841], [116.626, 153.058], [117.299, 153.177], [117.886, 153.116], [118.403, 152.915], [118.773, 152.554], [118.912, 152.012], [118.912, 149.94], [118.9, 149.92]]">
        <LTCurve y0="149.616" y1="151.044" x0="116.192" x1="118.013" width="1.821" height="1.428" bbox="[116.192, 149.616, 118.013, 151.044]" linewidth="0.5" pts="[[118.009, 151.044], [117.509, 150.884], [116.918, 150.802], [116.643, 150.736], [116.409, 150.617], [116.249, 150.424], [116.192, 150.133], [116.278, 149.883], [116.483, 149.723], [116.749, 149.642], [117.012, 149.616], [117.332, 149.652], [117.656, 149.784], [117.91, 150.022], [118.013, 150.379], [118.013, 151.04], [118.009, 151.044]]"/>
      </LTCurve>
      <LTCurve y0="148.988" y1="154.261" x0="119.424" x1="121.812" width="2.388" height="5.272" bbox="[119.424, 148.988, 121.812, 154.261]" linewidth="0.5" pts="[[119.453, 153.05], [120.122, 153.05], [120.122, 154.261], [120.991, 154.261], [120.991, 153.05], [121.812, 153.05], [121.812, 152.386], [120.991, 152.386], [120.991, 150.237], [120.991, 149.994], [121.045, 149.821], [121.173, 149.715], [121.406, 149.678], [121.595, 149.678], [121.784, 149.707], [121.784, 149.022], [121.496, 148.988], [121.209, 148.988], [120.643, 149.053], [120.307, 149.251], [120.143, 149.576], [120.094, 150.018], [120.094, 152.389], [119.424, 152.389], [119.424, 153.05], [119.453, 153.05]]"/>
      <LTCurve y0="148.911" y1="153.178" x0="122.26" x1="126.104" width="3.844" height="4.267" bbox="[122.26, 148.911, 126.104, 153.178]" linewidth="0.5" pts="[[123.146, 150.806], [123.212, 150.355], [123.408, 149.974], [123.745, 149.711], [124.23, 149.613], [124.858, 149.781], [125.21, 150.285], [126.051, 150.285], [125.395, 149.268], [124.853, 149.001], [124.225, 148.911], [123.384, 149.066], [122.769, 149.486], [122.387, 150.154], [122.26, 151.012], [122.395, 151.832], [122.806, 152.509], [124.204, 153.178], [125.058, 152.981], [125.686, 152.456], [126.047, 151.705], [126.104, 150.827], [123.142, 150.827], [123.146, 150.806]]">
        <LTCurve y0="151.389" y1="152.464" x0="123.158" x1="125.231" width="2.073" height="1.075" bbox="[123.158, 151.389, 125.231, 152.464]" linewidth="0.5" pts="[[125.218, 151.389], [125.127, 151.799], [124.927, 152.14], [124.615, 152.374], [124.204, 152.464], [123.795, 152.382], [123.466, 152.156], [123.248, 151.815], [123.158, 151.405], [125.231, 151.405], [125.218, 151.389]]"/>
      </LTCurve>
      <LTCurve y0="148.915" y1="153.153" x0="126.597" x1="130.17" width="3.573" height="4.238" bbox="[126.597, 148.915, 130.17, 153.153]" linewidth="0.5" pts="[[127.458, 150.305], [127.753, 149.76], [128.369, 149.603], [128.652, 149.603], [128.951, 149.678], [129.181, 149.838], [129.264, 150.113], [129.141, 150.391], [128.841, 150.568], [128.431, 150.682], [127.967, 150.814], [127.487, 150.945], [127.076, 151.155], [126.785, 151.495], [126.674, 152.004], [126.834, 152.554], [127.245, 152.91], [127.79, 153.099], [128.364, 153.153], [128.96, 153.087], [129.473, 152.874], [129.854, 152.488], [130.047, 151.914], [129.12, 151.914], [128.828, 152.324], [128.304, 152.435], [128.081, 152.435], [127.84, 152.377], [127.646, 152.254], [127.569, 152.041], [127.684, 151.774], [127.978, 151.606], [128.39, 151.491], [128.874, 151.389], [129.35, 151.257], [129.76, 151.048], [130.17, 150.227], [130.006, 149.62], [129.596, 149.21], [129.014, 148.984], [128.381, 148.915], [127.676, 149.001], [127.113, 149.264], [126.74, 149.698], [126.597, 150.318], [127.487, 150.318], [127.458, 150.305]]"/>
      <LTCurve y0="144.972" y1="157.281" x0="45.908" x1="58.216" width="12.308" height="12.309" bbox="[45.908, 144.972, 58.216, 157.281]" linewidth="0.5" pts="[[52.062, 157.281], [45.908, 151.126], [52.062, 144.972], [58.216, 151.126], [52.062, 157.281]]">
        <LTCurve y0="148.126" y1="156.308" x0="49.272" x1="54.852" width="5.58" height="8.182" bbox="[49.272, 148.126, 54.852, 156.308]" linewidth="0.5" pts="[[49.272, 148.126], [54.852, 151.844], [54.852, 156.308], [49.272, 156.308], [49.272, 148.126]]">
          <LTCurve y0="148.126" y1="156.308" x0="49.272" x1="54.852" width="5.58" height="8.182" bbox="[49.272, 148.126, 54.852, 156.308]" linewidth="0.5" pts="[[54.852, 148.126], [49.272, 151.844], [49.272, 156.308], [54.852, 156.308], [54.852, 148.126]]"/>
        </LTCurve>
        <LTCurve y0="146.478" y1="155.775" x0="47.413" x1="56.71" width="9.297" height="9.297" bbox="[47.413, 146.478, 56.71, 155.775]" linewidth="0.5" pts="[[52.062, 146.478], [47.413, 151.126], [52.062, 155.775], [56.71, 151.126], [52.062, 146.478]]"/>
        <LTCurve y0="145.536" y1="153.674" x0="46.461" x1="56.764" width="10.303" height="8.138" bbox="[46.461, 145.536, 56.764, 153.674]" linewidth="0.5" pts="[[55.471, 147.98], [48.915, 147.7], [47.75, 152.854], [46.461, 153.674], [49.545, 145.536], [56.764, 147.163], [55.471, 147.98]]"/>
      </LTCurve>
    </LTCurve>
    <LTLine y0="339.551" y1="339.551" x0="145.673" x1="248.225" width="102.552" height="0.0" bbox="[145.673, 339.551, 248.225, 339.551]" linewidth="0.5" pts="[[145.673, 339.551], [248.225, 339.551]]"/>
    <LTFigure y0="628.451" y1="1232.902" x0="343.336" x1="732.622" width="389.286" height="604.451" bbox="[343.336, 628.451, 732.622, 1232.902]" name="Fm2" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    <LTFigure y0="628.451" y1="1232.902" x0="258.77" x1="578.166" width="319.396" height="604.451" bbox="[258.77, 628.451, 578.166, 1232.902]" name="Fm3" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    <LTFigure y0="628.451" y1="1232.902" x0="176.361" x1="405.184" width="228.823" height="604.451" bbox="[176.361, 628.451, 405.184, 1232.902]" name="Fm4" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    <Annot A="&lt;PDFObjRef:261&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[40.0, 34.7989, 65.3448, 18.2783]" x0="40.0" x1="65.3448" y0="34.7989" y1="18.2783" height="-16.5206" width="25.344800000000006" URI="http://casereports.bmj.com/"/>
    <Annot A="&lt;PDFObjRef:262&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[40.25, 162.117, 136.086, 139.594]" x0="40.25" x1="136.086" y0="162.117" y1="139.594" height="-22.522999999999996" width="95.83600000000001" URI="http://crossmark.crossref.org/dialog/?doi=10.1136/bcr-2022-251052&amp;domain=pdf&amp;date_stamp=2022-08-04"/>
  </LTPage>
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="2" rotate="0" page_index="1" page_label="">
    <LTTextBoxHorizontal y0="417.31" y1="437.308" x0="42.0" x1="283.69" width="241.69" height="19.998" bbox="[42.0, 417.31, 283.69, 437.308]" index="1"><LTTextLineHorizontal y0="428.308" y1="437.308" x0="42.0" x1="269.547" width="227.547" height="9.0" bbox="[42.0, 428.308, 269.547, 437.308]" word_margin="0.1">Figure 1 Positron emission tomography scan showing extensive </LTTextLineHorizontal><LTTextLineHorizontal y0="417.31" y1="426.31" x0="42.0" x1="283.69" width="241.69" height="9.0" bbox="[42.0, 417.31, 283.69, 426.31]" word_margin="0.1">metastatic disease involving the liver, spleen, lung, skeleton and nodes. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="43.625" y1="74.621" x0="42.0" x1="275.554" width="233.554" height="30.996" bbox="[42.0, 43.625, 275.554, 74.621]" index="2"><LTTextLineHorizontal y0="65.621" y1="74.621" x0="42.0" x1="269.88" width="227.88" height="9.0" bbox="[42.0, 65.621, 269.88, 74.621]" word_margin="0.1">Figure 2 Positron emission tomography scan showing increased </LTTextLineHorizontal><LTTextLineHorizontal y0="54.623" y1="63.623" x0="42.0" x1="275.554" width="233.554" height="9.0" bbox="[42.0, 54.623, 275.554, 63.623]" word_margin="0.1">uptake compared with previous imaging, consistent with an interval </LTTextLineHorizontal><LTTextLineHorizontal y0="43.625" y1="52.625" x0="42.0" x1="145.959" width="103.959" height="9.0" bbox="[42.0, 43.625, 145.959, 52.625]" word_margin="0.1">response (pseudoprogression). </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="538.766" y1="745.73" x0="306.688" x1="555.792" width="249.104" height="206.964" bbox="[306.688, 538.766, 555.792, 745.73]" index="3"><LTTextLineHorizontal y0="736.73" y1="745.73" x0="306.688" x1="555.783" width="249.095" height="9.0" bbox="[306.688, 736.73, 555.783, 745.73]" word_margin="0.1">(ICU) for inotropic support. She was initially treated with broad- </LTTextLineHorizontal><LTTextLineHorizontal y0="725.732" y1="734.732" x0="306.688" x1="555.772" width="249.084" height="9.0" bbox="[306.688, 725.732, 555.772, 734.732]" word_margin="0.1">spectrum antibiotics for presumed Gram- negative sepsis from </LTTextLineHorizontal><LTTextLineHorizontal y0="714.734" y1="723.734" x0="306.688" x1="555.791" width="249.103" height="9.0" bbox="[306.688, 714.734, 555.791, 723.734]" word_margin="0.1">a hepatobiliary source on the basis of fevers, raised C reactive </LTTextLineHorizontal><LTTextLineHorizontal y0="703.736" y1="712.736" x0="306.688" x1="555.792" width="249.104" height="9.0" bbox="[306.688, 703.736, 555.792, 712.736]" word_margin="0.1">protein and deranged liver function tests (LFTs). Following an </LTTextLineHorizontal><LTTextLineHorizontal y0="692.738" y1="701.738" x0="306.688" x1="555.777" width="249.088" height="9.0" bbox="[306.688, 692.738, 555.777, 701.738]" word_margin="0.1">initial response to antibiotics and supportive care, the patient </LTTextLineHorizontal><LTTextLineHorizontal y0="681.74" y1="690.74" x0="306.688" x1="555.778" width="249.09" height="9.0" bbox="[306.688, 681.74, 555.778, 690.74]" word_margin="0.1">was transferred back to the ward haemodynamically stable. Due </LTTextLineHorizontal><LTTextLineHorizontal y0="670.742" y1="679.742" x0="306.688" x1="555.763" width="249.075" height="9.0" bbox="[306.688, 670.742, 555.763, 679.742]" word_margin="0.1">to concern about the melanoma continuing to rapidly progress </LTTextLineHorizontal><LTTextLineHorizontal y0="659.744" y1="668.744" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 659.744, 555.781, 668.744]" word_margin="0.1">in the background, the patient was commenced on encorafenib </LTTextLineHorizontal><LTTextLineHorizontal y0="648.746" y1="657.746" x0="306.688" x1="555.79" width="249.102" height="9.0" bbox="[306.688, 648.746, 555.79, 657.746]" word_margin="0.1">and binimetinib at this time. Shortly after return to the ward, </LTTextLineHorizontal><LTTextLineHorizontal y0="637.748" y1="646.748" x0="306.688" x1="555.761" width="249.073" height="9.0" bbox="[306.688, 637.748, 555.761, 646.748]" word_margin="0.1">she deteriorated again with recurrent hypotension, ongoing </LTTextLineHorizontal><LTTextLineHorizontal y0="626.75" y1="635.75" x0="306.688" x1="555.773" width="249.085" height="9.0" bbox="[306.688, 626.75, 555.773, 635.75]" word_margin="0.1">fevers and type I respiratory failure, and returned to ICU for </LTTextLineHorizontal><LTTextLineHorizontal y0="615.752" y1="624.752" x0="306.688" x1="555.761" width="249.073" height="9.0" bbox="[306.688, 615.752, 555.761, 624.752]" word_margin="0.1">non- invasive ventilation and vasopressors. Repeat imaging was </LTTextLineHorizontal><LTTextLineHorizontal y0="604.754" y1="613.754" x0="306.688" x1="553.27" width="246.582" height="9.0" bbox="[306.688, 604.754, 553.27, 613.754]" word_margin="0.1">significant only for pleural effusions, with no focus of infec- </LTTextLineHorizontal><LTTextLineHorizontal y0="593.756" y1="602.756" x0="306.688" x1="555.785" width="249.097" height="9.0" bbox="[306.688, 593.756, 555.785, 602.756]" word_margin="0.1">tion identified. Multiple sets of blood, urine and faecal cultures </LTTextLineHorizontal><LTTextLineHorizontal y0="582.758" y1="591.758" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 582.758, 555.781, 591.758]" word_margin="0.1">were all clear of micro- organisms. A pleural fluid sample was </LTTextLineHorizontal><LTTextLineHorizontal y0="571.76" y1="580.76" x0="306.688" x1="553.267" width="246.578" height="9.0" bbox="[306.688, 571.76, 553.267, 580.76]" word_margin="0.1">negative for infection, but cytology was consistent with malig- </LTTextLineHorizontal><LTTextLineHorizontal y0="560.762" y1="569.762" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 560.762, 555.781, 569.762]" word_margin="0.1">nancy. Ongoing lack of response to antibiotics, in addition to an </LTTextLineHorizontal><LTTextLineHorizontal y0="549.764" y1="558.764" x0="306.688" x1="555.775" width="249.087" height="9.0" bbox="[306.688, 549.764, 555.775, 558.764]" word_margin="0.1">entirely negative septic screen, prompted further investigation </LTTextLineHorizontal><LTTextLineHorizontal y0="538.766" y1="547.766" x0="306.688" x1="398.02" width="91.332" height="9.0" bbox="[306.688, 538.766, 398.02, 547.766]" word_margin="0.1">into the cause of fevers. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="351.76" y1="536.768" x0="306.688" x1="555.797" width="249.109" height="185.008" bbox="[306.688, 351.76, 555.797, 536.768]" index="4"><LTTextLineHorizontal y0="527.768" y1="536.768" x0="315.688" x1="553.278" width="237.59" height="9.0" bbox="[315.688, 527.768, 553.278, 536.768]" word_margin="0.1">The patient was noted to have a bicytopenia, with a haemo- </LTTextLineHorizontal><LTTextLineHorizontal y0="516.73" y1="527.466" x0="306.688" x1="555.784" width="249.096" height="10.736" bbox="[306.688, 516.73, 555.784, 527.466]" word_margin="0.1">globin of 65 g/L and platelets of 21&#215;109/L. A haemolytic screen </LTTextLineHorizontal><LTTextLineHorizontal y0="505.732" y1="514.732" x0="306.69" x1="555.781" width="249.09" height="9.0" bbox="[306.69, 505.732, 555.781, 514.732]" word_margin="0.1">showed a bilirubin of 82 umol/L, lactate dehydrogenase of 1981 </LTTextLineHorizontal><LTTextLineHorizontal y0="494.734" y1="503.734" x0="306.69" x1="553.277" width="246.586" height="9.0" bbox="[306.69, 494.734, 553.277, 503.734]" word_margin="0.1">U/L, haptoglobins of 0.3 g/L, reticulocytes of 0.1% and a nega- </LTTextLineHorizontal><LTTextLineHorizontal y0="483.736" y1="492.736" x0="306.69" x1="553.269" width="246.578" height="9.0" bbox="[306.69, 483.736, 553.269, 492.736]" word_margin="0.1">tive direct Coombs&#8217; test. A blood film showed did not demon- </LTTextLineHorizontal><LTTextLineHorizontal y0="472.738" y1="481.738" x0="306.69" x1="555.774" width="249.084" height="9.0" bbox="[306.69, 472.738, 555.774, 481.738]" word_margin="0.1">strate prominent features of haemolysis or leucoerythroblastosis. </LTTextLineHorizontal><LTTextLineHorizontal y0="461.74" y1="470.74" x0="306.69" x1="553.282" width="246.592" height="9.0" bbox="[306.69, 461.74, 553.282, 470.74]" word_margin="0.1">Serum ferritin was 19 917 &#956;g/L, which raised the index of suspi- </LTTextLineHorizontal><LTTextLineHorizontal y0="450.742" y1="459.742" x0="306.69" x1="555.774" width="249.084" height="9.0" bbox="[306.69, 450.742, 555.774, 459.742]" word_margin="0.1">cion for HLH. A bone marrow biopsy was taken from the right </LTTextLineHorizontal><LTTextLineHorizontal y0="439.744" y1="448.744" x0="306.69" x1="553.279" width="246.588" height="9.0" bbox="[306.69, 439.744, 553.279, 448.744]" word_margin="0.1">superior iliac spine. This showed a marked increase in macro- </LTTextLineHorizontal><LTTextLineHorizontal y0="428.746" y1="437.746" x0="306.69" x1="555.781" width="249.09" height="9.0" bbox="[306.69, 428.746, 555.781, 437.746]" word_margin="0.1">phages with a proportion demonstrating haemphagocytosis, but </LTTextLineHorizontal><LTTextLineHorizontal y0="417.748" y1="426.748" x0="306.69" x1="555.782" width="249.091" height="9.0" bbox="[306.69, 417.748, 555.782, 426.748]" word_margin="0.1">significantly, immunohistochemistry was negative for melanoma </LTTextLineHorizontal><LTTextLineHorizontal y0="406.75" y1="415.75" x0="306.69" x1="555.782" width="249.092" height="9.0" bbox="[306.69, 406.75, 555.782, 415.75]" word_margin="0.1">infiltration, thus supporting a diagnosis of HLH. The patient </LTTextLineHorizontal><LTTextLineHorizontal y0="395.752" y1="404.752" x0="306.69" x1="555.774" width="249.084" height="9.0" bbox="[306.69, 395.752, 555.774, 404.752]" word_margin="0.1">was treated with methylprednisolone 500 mg intravenously for </LTTextLineHorizontal><LTTextLineHorizontal y0="384.754" y1="393.754" x0="306.69" x1="553.272" width="246.582" height="9.0" bbox="[306.69, 384.754, 553.272, 393.754]" word_margin="0.1">3 days before being switched to prednisolone at a dose of 1 mg/ </LTTextLineHorizontal><LTTextLineHorizontal y0="373.756" y1="382.756" x0="306.69" x1="553.291" width="246.601" height="9.0" bbox="[306.69, 373.756, 553.291, 382.756]" word_margin="0.1">kg, which was then gradually tapered. She responded both clin- </LTTextLineHorizontal><LTTextLineHorizontal y0="362.758" y1="371.758" x0="306.69" x1="555.797" width="249.106" height="9.0" bbox="[306.69, 362.758, 555.797, 371.758]" word_margin="0.1">ically and biochemically, with a gradual reduction in ferritin </LTTextLineHorizontal><LTTextLineHorizontal y0="351.76" y1="360.76" x0="306.69" x1="510.225" width="203.535" height="9.0" bbox="[306.69, 351.76, 510.225, 360.76]" word_margin="0.1">levels back to normal range prior to discharge home. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="186.758" y1="349.762" x0="306.688" x1="555.795" width="249.106" height="163.004" bbox="[306.688, 186.758, 555.795, 349.762]" index="5"><LTTextLineHorizontal y0="340.73" y1="349.762" x0="315.69" x1="555.783" width="240.093" height="9.032" bbox="[315.69, 340.73, 555.783, 349.762]" word_margin="0.1">Interval PET scan &#8594; showed pseudoprogression (see figure 2), <Annot A="&lt;PDFObjRef:11&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[517.53, 351.529, 547.778, 340.732]" x0="517.53" x1="547.778" y0="351.529" y1="340.732" height="-10.796999999999969" width="30.248000000000047"/></LTTextLineHorizontal><LTTextLineHorizontal y0="329.732" y1="338.732" x0="306.688" x1="553.279" width="246.591" height="9.0" bbox="[306.688, 329.732, 553.279, 338.732]" word_margin="0.1">a phenomenon where imaging changes mimic tumour progres- </LTTextLineHorizontal><LTTextLineHorizontal y0="318.734" y1="327.734" x0="306.688" x1="555.785" width="249.097" height="9.0" bbox="[306.688, 318.734, 555.785, 327.734]" word_margin="0.1">sion but are actually due to other causes such as inflammation </LTTextLineHorizontal><LTTextLineHorizontal y0="307.736" y1="316.736" x0="306.688" x1="555.776" width="249.088" height="9.0" bbox="[306.688, 307.736, 555.776, 316.736]" word_margin="0.1">related to therapy. A further repeat PET 1 month after discharge </LTTextLineHorizontal><LTTextLineHorizontal y0="296.738" y1="305.738" x0="306.688" x1="555.778" width="249.09" height="9.0" bbox="[306.688, 296.738, 555.778, 305.738]" word_margin="0.1">showed a marked response, with considerable improvement in </LTTextLineHorizontal><LTTextLineHorizontal y0="285.74" y1="294.74" x0="306.688" x1="555.784" width="249.096" height="9.0" bbox="[306.688, 285.74, 555.784, 294.74]" word_margin="0.1">the volume of metastatic disease (see figure 3). She continued <Annot A="&lt;PDFObjRef:12&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[457.132, 296.529, 488.298, 285.732]" x0="457.132" x1="488.298" y0="296.529" y1="285.732" height="-10.796999999999969" width="31.165999999999997"/></LTTextLineHorizontal><LTTextLineHorizontal y0="274.742" y1="283.742" x0="306.688" x1="555.772" width="249.084" height="9.0" bbox="[306.688, 274.742, 555.772, 283.742]" word_margin="0.1">encorafenib and binimetanib. Unfortunately, a PET scan 2 months </LTTextLineHorizontal><LTTextLineHorizontal y0="263.744" y1="272.744" x0="306.688" x1="555.787" width="249.099" height="9.0" bbox="[306.688, 263.744, 555.787, 272.744]" word_margin="0.1">later showed new uptake in the liver and spleen, consistent with </LTTextLineHorizontal><LTTextLineHorizontal y0="252.746" y1="261.746" x0="306.688" x1="555.779" width="249.091" height="9.0" bbox="[306.688, 252.746, 555.779, 261.746]" word_margin="0.1">progression of melanoma, and an MRI of the brain demonstrated </LTTextLineHorizontal><LTTextLineHorizontal y0="241.748" y1="250.748" x0="306.688" x1="553.279" width="246.591" height="9.0" bbox="[306.688, 241.748, 553.279, 250.748]" word_margin="0.1">multiple supratentorial brain metastases (see figure 4). The deci- <Annot A="&lt;PDFObjRef:13&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[479.189, 252.529, 509.133, 241.732]" x0="479.189" x1="509.133" y0="252.529" y1="241.732" height="-10.796999999999997" width="29.94399999999996"/></LTTextLineHorizontal><LTTextLineHorizontal y0="230.75" y1="239.75" x0="306.688" x1="555.785" width="249.097" height="9.0" bbox="[306.688, 230.75, 555.785, 239.75]" word_margin="0.1">sion was made to rechallenge with single- agent nivolumab while </LTTextLineHorizontal><LTTextLineHorizontal y0="219.752" y1="228.752" x0="306.688" x1="555.774" width="249.086" height="9.0" bbox="[306.688, 219.752, 555.774, 228.752]" word_margin="0.1">continuing encorafenib and binimetanib, balancing the risk of </LTTextLineHorizontal><LTTextLineHorizontal y0="208.754" y1="217.754" x0="306.688" x1="555.795" width="249.106" height="9.0" bbox="[306.688, 208.754, 555.795, 217.754]" word_margin="0.1">HLH recurrence with the hope of achieving another oncological </LTTextLineHorizontal><LTTextLineHorizontal y0="197.756" y1="206.756" x0="306.688" x1="553.27" width="246.582" height="9.0" bbox="[306.688, 197.756, 553.27, 206.756]" word_margin="0.1">response. At this stage, prednisolone had been reduced to 10 mg/ </LTTextLineHorizontal><LTTextLineHorizontal y0="186.758" y1="195.758" x0="306.688" x1="486.998" width="180.31" height="9.0" bbox="[306.688, 186.758, 486.998, 195.758]" word_margin="0.1">day, and HLH remained quiescent at this dose. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="54.782" y1="184.76" x0="306.688" x1="555.786" width="249.098" height="129.978" bbox="[306.688, 54.782, 555.786, 184.76]" index="6"><LTTextLineHorizontal y0="175.76" y1="184.76" x0="315.688" x1="555.781" width="240.093" height="9.0" bbox="[315.688, 175.76, 555.781, 184.76]" word_margin="0.1">Approximately 2 weeks after the first cycle of nivolumab, the </LTTextLineHorizontal><LTTextLineHorizontal y0="164.762" y1="173.762" x0="306.688" x1="555.763" width="249.075" height="9.0" bbox="[306.688, 164.762, 555.763, 173.762]" word_margin="0.1">patient was readmitted to the hospital with fevers, lethargy and </LTTextLineHorizontal><LTTextLineHorizontal y0="153.764" y1="162.764" x0="306.688" x1="555.764" width="249.076" height="9.0" bbox="[306.688, 153.764, 555.764, 162.764]" word_margin="0.1">hypotension requiring return to ICU for vasopressor support. </LTTextLineHorizontal><LTTextLineHorizontal y0="142.766" y1="151.766" x0="306.688" x1="555.77" width="249.082" height="9.0" bbox="[306.688, 142.766, 555.77, 151.766]" word_margin="0.1">She was treated with piperacillin/tazobactam for sepsis, with a </LTTextLineHorizontal><LTTextLineHorizontal y0="131.768" y1="140.768" x0="306.688" x1="555.774" width="249.086" height="9.0" bbox="[306.688, 131.768, 555.774, 140.768]" word_margin="0.1">suspected urinary source in view of a preceding 4- week history </LTTextLineHorizontal><LTTextLineHorizontal y0="120.77" y1="129.77" x0="306.688" x1="555.768" width="249.08" height="9.0" bbox="[306.688, 120.77, 555.768, 129.77]" word_margin="0.1">of dysuria and malodorous urine, for which she had received </LTTextLineHorizontal><LTTextLineHorizontal y0="109.772" y1="118.772" x0="306.688" x1="555.778" width="249.09" height="9.0" bbox="[306.688, 109.772, 555.778, 118.772]" word_margin="0.1">multiple courses of oral antibiotics. However, urine culture as </LTTextLineHorizontal><LTTextLineHorizontal y0="98.774" y1="107.774" x0="306.688" x1="555.772" width="249.084" height="9.0" bbox="[306.688, 98.774, 555.772, 107.774]" word_margin="0.1">well as multiple blood cultures were negative. Similar to her </LTTextLineHorizontal><LTTextLineHorizontal y0="87.776" y1="96.776" x0="306.688" x1="555.786" width="249.098" height="9.0" bbox="[306.688, 87.776, 555.786, 96.776]" word_margin="0.1">previous admission, she failed to respond to antibiotics and she </LTTextLineHorizontal><LTTextLineHorizontal y0="76.778" y1="85.778" x0="306.688" x1="555.776" width="249.088" height="9.0" bbox="[306.688, 76.778, 555.776, 85.778]" word_margin="0.1">was unable to be weaned off norepinephrine while continuing to </LTTextLineHorizontal><LTTextLineHorizontal y0="65.78" y1="74.78" x0="306.688" x1="555.786" width="249.097" height="9.0" bbox="[306.688, 65.78, 555.786, 74.78]" word_margin="0.1">have recurrent fevers. Ferritin was again found to be significantly </LTTextLineHorizontal><LTTextLineHorizontal y0="54.782" y1="63.782" x0="306.688" x1="555.776" width="249.088" height="9.0" bbox="[306.688, 54.782, 555.776, 63.782]" word_margin="0.1">elevated at 11 816 ug/L, consistent with an HLH recurrence </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="26.93" y1="34.93" x0="42.0" x1="45.84" width="3.84" height="8.0" bbox="[42.0, 26.93, 45.84, 34.93]" word_margin="0.1"><LTTextBoxHorizontal y0="26.93" y1="34.93" x0="42.0" x1="45.84" width="3.84" height="8.0" bbox="[42.0, 26.93, 45.84, 34.93]" index="7">2 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="26.938" y1="34.938" x0="320.416" x1="553.574" width="233.158" height="8.0" bbox="[320.416, 26.938, 553.574, 34.938]" word_margin="0.1"><LTTextBoxHorizontal y0="26.938" y1="34.938" x0="320.416" x1="553.574" width="233.158" height="8.0" bbox="[320.416, 26.938, 553.574, 34.938]" index="8">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTLine y0="38.68" y1="38.68" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.68, 553.276, 38.68]" linewidth="0.5" pts="[[42.0, 38.68], [553.276, 38.68]]"/>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="45.7" x1="105.133" width="59.433" height="11.0" bbox="[45.7, 757.826, 105.133, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="45.7" x1="105.133" width="59.433" height="11.0" bbox="[45.7, 757.826, 105.133, 768.826]" index="0">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTImage y0="446.558" y1="745.701" x0="85.153" x1="245.434" width="160.282" height="299.143" bbox="[85.153, 446.558, 245.434, 745.701]" name="Im0" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[668, 1247]" stream="&lt;PDFStream(8): raw=380235, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 1247, 'Intent': /'RelativeColorimetric', 'Length': 380235, 'Metadata': &lt;PDFObjRef:7&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 668}&gt;">
      <LTFigure y0="446.558" y1="745.701" x0="85.153" x1="245.434" width="160.282" height="299.143" bbox="[85.153, 446.558, 245.434, 745.701]" name="Im0" matrix="[160.282, 0.0, 0.0, 299.143, 85.153, 446.558]"/>
    </LTImage>
    <LTImage y0="83.871" y1="389.557" x0="85.153" x1="245.434" width="160.282" height="305.686" bbox="[85.153, 83.871, 245.434, 389.557]" name="Im1" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[668, 1274]" stream="&lt;PDFStream(10): raw=343874, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 1274, 'Intent': /'RelativeColorimetric', 'Length': 343874, 'Metadata': &lt;PDFObjRef:9&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 668}&gt;">
      <LTFigure y0="83.871" y1="389.557" x0="85.153" x1="245.434" width="160.282" height="305.686" bbox="[85.153, 83.871, 245.434, 389.557]" name="Im1" matrix="[160.282, 0.0, 0.0, 305.686, 85.153, 83.871]"/>
    </LTImage>
  </LTPage>
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="3" rotate="0" page_index="2" page_label="">
    <LTTextBoxHorizontal y0="415.035" y1="446.031" x0="306.688" x1="551.502" width="244.814" height="30.996" bbox="[306.688, 415.035, 551.502, 446.031]" index="1"><LTTextLineHorizontal y0="437.031" y1="446.031" x0="306.688" x1="542.713" width="236.025" height="9.0" bbox="[306.688, 437.031, 542.713, 446.031]" word_margin="0.1">Figure 4 Positron emission tomography scan disease recurrence in </LTTextLineHorizontal><LTTextLineHorizontal y0="426.033" y1="435.033" x0="306.688" x1="551.502" width="244.814" height="9.0" bbox="[306.688, 426.033, 551.502, 435.033]" word_margin="0.1">the liver, stable disease in the spleen, and persistent complete response </LTTextLineHorizontal><LTTextLineHorizontal y0="415.035" y1="424.035" x0="306.688" x1="530.603" width="223.915" height="9.0" bbox="[306.688, 415.035, 530.603, 424.035]" word_margin="0.1">in osseous and nodal mets while on encorafenib and binimetanib. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="43.625" y1="74.621" x0="306.688" x1="550.538" width="243.85" height="30.996" bbox="[306.688, 43.625, 550.538, 74.621]" index="2"><LTTextLineHorizontal y0="65.621" y1="74.621" x0="306.688" x1="527.395" width="220.707" height="9.0" bbox="[306.688, 65.621, 527.395, 74.621]" word_margin="0.1">Figure 5 Positron emission tomography scan showing disease </LTTextLineHorizontal><LTTextLineHorizontal y0="54.623" y1="63.623" x0="306.688" x1="550.538" width="243.85" height="9.0" bbox="[306.688, 54.623, 550.538, 63.623]" word_margin="0.1">progression with new foci in marrow in the upper spine, upper ribs and </LTTextLineHorizontal><LTTextLineHorizontal y0="43.625" y1="52.625" x0="306.688" x1="517.932" width="211.244" height="9.0" bbox="[306.688, 43.625, 517.932, 52.625]" word_margin="0.1">bony pelvis post nivolumab plus encorafenib and binimetanib. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="26.93" y1="34.93" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.93, 553.276, 34.93]" word_margin="0.1"><LTTextBoxHorizontal y0="26.93" y1="34.93" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.93, 553.276, 34.93]" index="3">3 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="356.022" y1="387.018" x0="42.0" x1="288.526" width="246.526" height="30.996" bbox="[42.0, 356.022, 288.526, 387.018]" index="4"><LTTextLineHorizontal y0="378.018" y1="387.018" x0="42.0" x1="262.874" width="220.874" height="9.0" bbox="[42.0, 378.018, 262.874, 387.018]" word_margin="0.1">Figure 3 Positron emission tomography scan showing marked </LTTextLineHorizontal><LTTextLineHorizontal y0="367.02" y1="376.02" x0="42.0" x1="288.526" width="246.526" height="9.0" bbox="[42.0, 367.02, 288.526, 376.02]" word_margin="0.1">metabolic response, with no new sites and only small volume disease in </LTTextLineHorizontal><LTTextLineHorizontal y0="356.022" y1="365.022" x0="42.0" x1="110.949" width="68.949" height="9.0" bbox="[42.0, 356.022, 110.949, 365.022]" word_margin="0.1">the liver and spleen. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="309.509" y1="329.507" x0="42.0" x1="291.1" width="249.1" height="19.998" bbox="[42.0, 309.509, 291.1, 329.507]" index="5"><LTTextLineHorizontal y0="320.507" y1="329.507" x0="42.0" x1="291.1" width="249.1" height="9.0" bbox="[42.0, 320.507, 291.1, 329.507]" word_margin="0.1">secondary to immunotherapy. The patient was treated with </LTTextLineHorizontal><LTTextLineHorizontal y0="309.509" y1="318.509" x0="42.0" x1="278.142" width="236.142" height="9.0" bbox="[42.0, 309.509, 278.142, 318.509]" word_margin="0.1">intravenous dexamethasone 20 mg/day and improved rapidly. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="188.517" y1="307.511" x0="41.998" x1="291.105" width="249.107" height="118.994" bbox="[41.998, 188.517, 291.105, 307.511]" index="6"><LTTextLineHorizontal y0="298.511" y1="307.511" x0="51.0" x1="291.093" width="240.093" height="9.0" bbox="[51.0, 298.511, 291.093, 307.511]" word_margin="0.1">Restaging PET imaging performed 1 month after nivolumab </LTTextLineHorizontal><LTTextLineHorizontal y0="287.513" y1="296.513" x0="42.0" x1="291.087" width="249.087" height="9.0" bbox="[42.0, 287.513, 291.087, 296.513]" word_margin="0.1">rechallenge confirmed further marked progression despite </LTTextLineHorizontal><LTTextLineHorizontal y0="276.515" y1="285.515" x0="42.0" x1="291.105" width="249.105" height="9.0" bbox="[42.0, 276.515, 291.105, 285.515]" word_margin="0.1">nivolumab plus encorafenib and binimetanib (see figure 5). Due <Annot A="&lt;PDFObjRef:25&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[234.244, 287.306, 264.419, 276.509]" x0="234.244" x1="264.419" y0="287.306" y1="276.509" height="-10.796999999999969" width="30.174999999999983"/></LTTextLineHorizontal><LTTextLineHorizontal y0="265.517" y1="274.517" x0="42.0" x1="291.081" width="249.081" height="9.0" bbox="[42.0, 265.517, 291.081, 274.517]" word_margin="0.1">to her intolerance of immunotherapy and failure to respond to </LTTextLineHorizontal><LTTextLineHorizontal y0="254.519" y1="263.519" x0="42.0" x1="291.103" width="249.103" height="9.0" bbox="[42.0, 254.519, 291.103, 263.519]" word_margin="0.1">targeted therapy, the patient was commenced on temozolamide. </LTTextLineHorizontal><LTTextLineHorizontal y0="243.507" y1="252.521" x0="42.0" x1="291.092" width="249.092" height="9.014" bbox="[42.0, 243.507, 291.092, 252.521]" word_margin="0.1">Less than a month &#8594; later, the patient represented with seizures </LTTextLineHorizontal><LTTextLineHorizontal y0="232.509" y1="241.509" x0="41.998" x1="288.593" width="246.595" height="9.0" bbox="[41.998, 232.509, 288.593, 241.509]" word_margin="0.1">and right- sided hemiparesis. CT imaging showed clear enlarge- </LTTextLineHorizontal><LTTextLineHorizontal y0="221.511" y1="230.511" x0="41.998" x1="291.104" width="249.106" height="9.0" bbox="[41.998, 221.511, 291.104, 230.511]" word_margin="0.1">ment of brain metastases, particularly in the left frontal region, </LTTextLineHorizontal><LTTextLineHorizontal y0="210.513" y1="219.513" x0="41.998" x1="291.098" width="249.1" height="9.0" bbox="[41.998, 210.513, 291.098, 219.513]" word_margin="0.1">in keeping with the pattern of weakness. Unfortunately, the </LTTextLineHorizontal><LTTextLineHorizontal y0="199.515" y1="208.515" x0="41.998" x1="291.075" width="249.077" height="9.0" bbox="[41.998, 199.515, 291.075, 208.515]" word_margin="0.1">patient continued to deteriorate and treatment focus was shifted </LTTextLineHorizontal><LTTextLineHorizontal y0="188.517" y1="197.517" x0="41.998" x1="282.919" width="240.921" height="9.0" bbox="[41.998, 188.517, 282.919, 197.517]" word_margin="0.1">to comfort care shortly before she passed away in the hospital. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="87.779" y1="174.025" x0="42.0" x1="291.107" width="249.107" height="86.246" bbox="[42.0, 87.779, 291.107, 174.025]" index="7"><LTTextLineHorizontal y0="164.525" y1="174.025" x0="42.0" x1="106.534" width="64.534" height="9.5" bbox="[42.0, 164.525, 106.534, 174.025]" word_margin="0.1">inveSTigaTion </LTTextLineHorizontal><LTTextLineHorizontal y0="153.767" y1="162.767" x0="42.0" x1="291.085" width="249.085" height="9.0" bbox="[42.0, 153.767, 291.085, 162.767]" word_margin="0.1">Melanoma recurrence was suspected on initial presentation of </LTTextLineHorizontal><LTTextLineHorizontal y0="142.769" y1="151.769" x0="42.0" x1="291.066" width="249.066" height="9.0" bbox="[42.0, 142.769, 291.066, 151.769]" word_margin="0.1">the patient. CT of the chest, abdomen, pelvis was in keeping </LTTextLineHorizontal><LTTextLineHorizontal y0="131.771" y1="140.771" x0="42.0" x1="291.107" width="249.107" height="9.0" bbox="[42.0, 131.771, 291.107, 140.771]" word_margin="0.1">with metastases in the liver, bone and spleen. MRI of the brain </LTTextLineHorizontal><LTTextLineHorizontal y0="120.773" y1="129.773" x0="42.0" x1="291.095" width="249.095" height="9.0" bbox="[42.0, 120.773, 291.095, 129.773]" word_margin="0.1">revealed no central metastases, but PET imaging showed FDG </LTTextLineHorizontal><LTTextLineHorizontal y0="109.775" y1="118.775" x0="42.0" x1="291.087" width="249.087" height="9.0" bbox="[42.0, 109.775, 291.087, 118.775]" word_margin="0.1">avid disease involving liver, spleen, lung, skeleton and lymph </LTTextLineHorizontal><LTTextLineHorizontal y0="98.777" y1="107.777" x0="42.0" x1="291.102" width="249.102" height="9.0" bbox="[42.0, 98.777, 291.102, 107.777]" word_margin="0.1">nodes (see figure 1). A subsequent liver biopsy confirmed BRAF <Annot A="&lt;PDFObjRef:26&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[84.4608, 109.566, 114.645, 98.7685]" x0="84.4608" x1="114.645" y0="109.566" y1="98.7685" height="-10.7975" width="30.18419999999999"/></LTTextLineHorizontal><LTTextLineHorizontal y0="87.779" y1="96.779" x0="42.0" x1="217.932" width="175.932" height="9.0" bbox="[42.0, 87.779, 217.932, 96.779]" word_margin="0.1">V600E mutant- positive metastatic melanoma. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="43.787" y1="85.781" x0="42.0" x1="291.111" width="249.111" height="41.994" bbox="[42.0, 43.787, 291.111, 85.781]" index="8"><LTTextLineHorizontal y0="76.781" y1="85.781" x0="51.0" x1="288.582" width="237.582" height="9.0" bbox="[51.0, 76.781, 288.582, 85.781]" word_margin="0.1">Septic screen was extensive and found no source of infec- </LTTextLineHorizontal><LTTextLineHorizontal y0="65.783" y1="74.783" x0="42.0" x1="291.111" width="249.111" height="9.0" bbox="[42.0, 65.783, 291.111, 74.783]" word_margin="0.1">tion. CT imaging on admission, in addition to repeat CT of </LTTextLineHorizontal><LTTextLineHorizontal y0="54.785" y1="63.785" x0="42.0" x1="291.097" width="249.097" height="9.0" bbox="[42.0, 54.785, 291.097, 63.785]" word_margin="0.1">the chest, showed no focus of infection. A total of eight blood </LTTextLineHorizontal><LTTextLineHorizontal y0="43.787" y1="52.787" x0="42.0" x1="291.098" width="249.098" height="9.0" bbox="[42.0, 43.787, 291.098, 52.787]" word_margin="0.1">cultures, three urine cultures, two faecal cultures, one pleural </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTLine y0="38.68" y1="38.68" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.68, 553.276, 38.68]" linewidth="0.5" pts="[[42.0, 38.68], [553.276, 38.68]]"/>
    <LTTextLineHorizontal y0="26.941" y1="34.941" x0="42.0" x1="275.158" width="233.158" height="8.0" bbox="[42.0, 26.941, 275.158, 34.941]" word_margin="0.1"><LTTextBoxHorizontal y0="26.941" y1="34.941" x0="42.0" x1="275.158" width="233.158" height="8.0" bbox="[42.0, 26.941, 275.158, 34.941]" index="0">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm0" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]">
      <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm1" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    </LTFigure>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" index="0">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTImage y0="396.268" y1="745.701" x0="85.153" x1="245.434" width="160.282" height="349.433" bbox="[85.153, 396.268, 245.434, 745.701]" name="Im0" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[668, 1456]" stream="&lt;PDFStream(20): raw=357974, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 1456, 'Intent': /'RelativeColorimetric', 'Length': 357974, 'Metadata': &lt;PDFObjRef:19&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 668}&gt;">
      <LTFigure y0="396.268" y1="745.701" x0="85.153" x1="245.434" width="160.282" height="349.433" bbox="[85.153, 396.268, 245.434, 745.701]" name="Im0" matrix="[160.282, 0.0, 0.0, 349.433, 85.153, 396.268]"/>
    </LTImage>
    <LTImage y0="455.281" y1="745.701" x0="369.011" x1="490.952" width="121.941" height="290.42" bbox="[369.011, 455.281, 490.952, 745.701]" name="Im1" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[509, 1211]" stream="&lt;PDFStream(22): raw=296846, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 1211, 'Intent': /'RelativeColorimetric', 'Length': 296846, 'Metadata': &lt;PDFObjRef:21&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 509}&gt;">
      <LTFigure y0="455.281" y1="745.701" x0="369.011" x1="490.952" width="121.941" height="290.42" bbox="[369.011, 455.281, 490.952, 745.701]" name="Im1" matrix="[121.941, 0.0, 0.0, 290.42, 369.011, 455.281]"/>
    </LTImage>
    <LTImage y0="83.871" y1="397.344" x0="349.841" x1="510.122" width="160.282" height="313.474" bbox="[349.841, 83.871, 510.122, 397.344]" name="Im2" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[668, 1307]" stream="&lt;PDFStream(24): raw=352953, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 1307, 'Intent': /'RelativeColorimetric', 'Length': 352953, 'Metadata': &lt;PDFObjRef:23&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 668}&gt;">
      <LTFigure y0="83.871" y1="397.344" x0="349.841" x1="510.122" width="160.282" height="313.474" bbox="[349.841, 83.871, 510.122, 397.344]" name="Im2" matrix="[160.282, 0.0, 0.0, 313.474, 349.841, 83.871]"/>
    </LTImage>
  </LTPage>
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="4" rotate="0" page_index="3" page_label="">
    <LTTextBoxHorizontal y0="532.295" y1="552.293" x0="42.0" x1="264.705" width="222.705" height="19.998" bbox="[42.0, 532.295, 264.705, 552.293]" index="1"><LTTextLineHorizontal y0="543.293" y1="552.293" x0="42.0" x1="264.705" width="222.705" height="9.0" bbox="[42.0, 543.293, 264.705, 552.293]" word_margin="0.1">Figure 6 Microscopic image of bone marrow aspirate showing </LTTextLineHorizontal><LTTextLineHorizontal y0="532.295" y1="541.295" x0="42.0" x1="195.285" width="153.285" height="9.0" bbox="[42.0, 532.295, 195.285, 541.295]" word_margin="0.1">macrophages exhibiting haemophagocytosis. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="496.534" y1="516.532" x0="42.0" x1="291.084" width="249.084" height="19.998" bbox="[42.0, 496.534, 291.084, 516.532]" index="2"><LTTextLineHorizontal y0="507.532" y1="516.532" x0="42.0" x1="291.084" width="249.084" height="9.0" bbox="[42.0, 507.532, 291.084, 516.532]" word_margin="0.1">fluid sample and a respiratory viral swab including COVID- 19 </LTTextLineHorizontal><LTTextLineHorizontal y0="496.534" y1="505.534" x0="42.0" x1="109.23" width="67.23" height="9.0" bbox="[42.0, 496.534, 109.23, 505.534]" word_margin="0.1">were all negative. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="441.544" y1="494.536" x0="42.0" x1="291.111" width="249.111" height="52.992" bbox="[42.0, 441.544, 291.111, 494.536]" index="3"><LTTextLineHorizontal y0="485.536" y1="494.536" x0="51.0" x1="291.098" width="240.098" height="9.0" bbox="[51.0, 485.536, 291.098, 494.536]" word_margin="0.1">Haemolytic screen was performed to investigate bicytopenia. </LTTextLineHorizontal><LTTextLineHorizontal y0="474.538" y1="483.538" x0="42.0" x1="291.103" width="249.103" height="9.0" bbox="[42.0, 474.538, 291.103, 483.538]" word_margin="0.1">It was significant for anaemia, hyperbilirubinaemia, elevated </LTTextLineHorizontal><LTTextLineHorizontal y0="463.54" y1="472.54" x0="42.0" x1="291.07" width="249.07" height="9.0" bbox="[42.0, 463.54, 291.07, 472.54]" word_margin="0.1">LDH and low haptoglobins, but the lack of any relevant features </LTTextLineHorizontal><LTTextLineHorizontal y0="452.542" y1="461.542" x0="42.0" x1="291.111" width="249.111" height="9.0" bbox="[42.0, 452.542, 291.111, 461.542]" word_margin="0.1">on blood film, in addition to a low reticulocyte count and a </LTTextLineHorizontal><LTTextLineHorizontal y0="441.544" y1="450.544" x0="42.0" x1="271.671" width="229.671" height="9.0" bbox="[42.0, 441.544, 271.671, 450.544]" word_margin="0.1">negative direct Coombs test, outruled a haemolytic process. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="375.556" y1="439.546" x0="42.0" x1="291.1" width="249.1" height="63.99" bbox="[42.0, 375.556, 291.1, 439.546]" index="4"><LTTextLineHorizontal y0="430.546" y1="439.546" x0="51.0" x1="291.1" width="240.1" height="9.0" bbox="[51.0, 430.546, 291.1, 439.546]" word_margin="0.1">HLH diagnosis was aided by the presence of bicytopenia, </LTTextLineHorizontal><LTTextLineHorizontal y0="419.548" y1="428.548" x0="42.0" x1="291.092" width="249.092" height="9.0" bbox="[42.0, 419.548, 291.092, 428.548]" word_margin="0.1">hepatitis, hypertriglyceridaemia, elevated ferritin, elevated </LTTextLineHorizontal><LTTextLineHorizontal y0="408.55" y1="417.55" x0="42.0" x1="291.095" width="249.095" height="9.0" bbox="[42.0, 408.55, 291.095, 417.55]" word_margin="0.1">LDH and a bone marrow aspirate showing a marked increase in </LTTextLineHorizontal><LTTextLineHorizontal y0="397.552" y1="406.552" x0="42.0" x1="288.588" width="246.588" height="9.0" bbox="[42.0, 397.552, 288.588, 406.552]" word_margin="0.1">macrophage activity, with a proportion exhibiting haemophago- </LTTextLineHorizontal><LTTextLineHorizontal y0="386.554" y1="395.554" x0="42.0" x1="291.089" width="249.089" height="9.0" bbox="[42.0, 386.554, 291.089, 395.554]" word_margin="0.1">cytosis (see figure 6). NK cell activity and soluble CD 25 were <Annot A="&lt;PDFObjRef:39&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[88.5779, 397.331, 119.305, 386.534]" x0="88.5779" x1="119.305" y0="397.331" y1="386.534" height="-10.797000000000025" width="30.727100000000007"/></LTTextLineHorizontal><LTTextLineHorizontal y0="375.556" y1="384.556" x0="42.0" x1="82.563" width="40.563" height="9.0" bbox="[42.0, 375.556, 82.563, 384.556]" word_margin="0.1">not tested. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="309.568" y1="373.558" x0="42.0" x1="291.099" width="249.099" height="63.99" bbox="[42.0, 309.568, 291.099, 373.558]" index="5"><LTTextLineHorizontal y0="364.558" y1="373.558" x0="51.0" x1="291.084" width="240.084" height="9.0" bbox="[51.0, 364.558, 291.084, 373.558]" word_margin="0.1">Imaging prior to discharge showed a significant oncological </LTTextLineHorizontal><LTTextLineHorizontal y0="353.56" y1="362.56" x0="42.0" x1="291.098" width="249.098" height="9.0" bbox="[42.0, 353.56, 291.098, 362.56]" word_margin="0.1">response, likely due to immunotherapy (see figure 3). However, <Annot A="&lt;PDFObjRef:40&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[212.699, 364.331, 242.83, 353.534]" x0="212.699" x1="242.83" y0="364.331" y1="353.534" height="-10.797000000000025" width="30.131"/></LTTextLineHorizontal><LTTextLineHorizontal y0="342.562" y1="351.562" x0="42.0" x1="291.099" width="249.099" height="9.0" bbox="[42.0, 342.562, 291.099, 351.562]" word_margin="0.1">follow- up imaging a month after discharge was in keeping with </LTTextLineHorizontal><LTTextLineHorizontal y0="331.564" y1="340.564" x0="42.0" x1="291.094" width="249.094" height="9.0" bbox="[42.0, 331.564, 291.094, 340.564]" word_margin="0.1">progression, despite treatment with encorafenib and binimetanib </LTTextLineHorizontal><LTTextLineHorizontal y0="320.566" y1="329.566" x0="42.0" x1="291.084" width="249.084" height="9.0" bbox="[42.0, 320.566, 291.084, 329.566]" word_margin="0.1">(see figure 4). The patient progressed further despite nivolumab <Annot A="&lt;PDFObjRef:41&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[59.2245, 331.331, 89.3294, 320.534]" x0="59.2245" x1="89.3294" y0="331.331" y1="320.534" height="-10.797000000000025" width="30.104900000000008"/></LTTextLineHorizontal><LTTextLineHorizontal y0="309.568" y1="318.568" x0="42.0" x1="140.865" width="98.865" height="9.0" bbox="[42.0, 309.568, 140.865, 318.568]" word_margin="0.1">rechallenge (see figure 5). <Annot A="&lt;PDFObjRef:42&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[105.325, 320.331, 135.366, 309.534]" x0="105.325" x1="135.366" y0="320.331" y1="309.534" height="-10.797000000000025" width="30.04100000000001"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="298.57" y1="307.57" x0="51.0" x1="288.6" width="237.6" height="9.0" bbox="[51.0, 298.57, 288.6, 307.57]" word_margin="0.1"><LTTextBoxHorizontal y0="298.57" y1="307.57" x0="51.0" x1="288.6" width="237.6" height="9.0" bbox="[51.0, 298.57, 288.6, 307.57]" index="6">A timeline of ferritin and LDH levels, their relation to immu- </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="287.572" y1="296.572" x0="42.0" x1="271.221" width="229.221" height="9.0" bbox="[42.0, 287.572, 271.221, 296.572]" word_margin="0.1"><LTTextBoxHorizontal y0="287.572" y1="296.572" x0="42.0" x1="271.221" width="229.221" height="9.0" bbox="[42.0, 287.572, 271.221, 296.572]" index="7">notherapy and response to steroids is illustrated in figure 7. <Annot A="&lt;PDFObjRef:43&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[238.682, 298.331, 268.723, 287.534]" x0="238.682" x1="268.723" y0="298.331" y1="287.534" height="-10.797000000000025" width="30.041000000000025"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="43.625" y1="74.621" x0="42.0" x1="283.179" width="241.179" height="30.996" bbox="[42.0, 43.625, 283.179, 74.621]" index="8"><LTTextLineHorizontal y0="65.621" y1="74.621" x0="42.0" x1="283.179" width="241.179" height="9.0" bbox="[42.0, 65.621, 283.179, 74.621]" word_margin="0.1">Figure 7 Graph showing ferritin and LDH trend, their relationship to </LTTextLineHorizontal><LTTextLineHorizontal y0="54.623" y1="63.623" x0="42.0" x1="281.692" width="239.692" height="9.0" bbox="[42.0, 54.623, 281.692, 63.623]" word_margin="0.1">immunotherapy and response to steroids. Created by Zachary Holmes. </LTTextLineHorizontal><LTTextLineHorizontal y0="43.625" y1="52.625" x0="42.0" x1="138.937" width="96.937" height="9.0" bbox="[42.0, 43.625, 138.937, 52.625]" word_margin="0.1">LDH, lactate dehydrogenase. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="483.487" y1="745.701" x0="306.688" x1="555.796" width="249.107" height="262.214" bbox="[306.688, 483.487, 555.796, 745.701]" index="9"><LTTextLineHorizontal y0="736.201" y1="745.701" x0="306.688" x1="412.642" width="105.954" height="9.5" bbox="[306.688, 736.201, 412.642, 745.701]" word_margin="0.1">diFFerenTial diagnoSiS </LTTextLineHorizontal><LTTextLineHorizontal y0="725.443" y1="734.443" x0="306.688" x1="553.279" width="246.591" height="9.0" bbox="[306.688, 725.443, 553.279, 734.443]" word_margin="0.1">The patient&#8217;s initial deterioration, characterised by fevers, tachy- </LTTextLineHorizontal><LTTextLineHorizontal y0="714.445" y1="723.445" x0="306.688" x1="555.783" width="249.095" height="9.0" bbox="[306.688, 714.445, 555.783, 723.445]" word_margin="0.1">cardia and hypotension, was highly suspicions for infection, with </LTTextLineHorizontal><LTTextLineHorizontal y0="703.447" y1="712.447" x0="306.688" x1="555.789" width="249.101" height="9.0" bbox="[306.688, 703.447, 555.789, 712.447]" word_margin="0.1">a hepatobiliary source felt to be likely due to a derangement in </LTTextLineHorizontal><LTTextLineHorizontal y0="692.449" y1="701.449" x0="306.688" x1="555.779" width="249.09" height="9.0" bbox="[306.688, 692.449, 555.779, 701.449]" word_margin="0.1">LFTs and the known presence of extensive liver metastases, </LTTextLineHorizontal><LTTextLineHorizontal y0="681.451" y1="690.451" x0="306.688" x1="555.776" width="249.088" height="9.0" bbox="[306.688, 681.451, 555.776, 690.451]" word_margin="0.1">which could theoretically impede biliary outflow. However, the </LTTextLineHorizontal><LTTextLineHorizontal y0="670.453" y1="679.453" x0="306.688" x1="555.786" width="249.098" height="9.0" bbox="[306.688, 670.453, 555.786, 679.453]" word_margin="0.1">patient did not respond to antibiotics, and an extensive septic </LTTextLineHorizontal><LTTextLineHorizontal y0="659.455" y1="668.455" x0="306.688" x1="555.774" width="249.086" height="9.0" bbox="[306.688, 659.455, 555.774, 668.455]" word_margin="0.1">screen identified no focus of infection. Cancer- related fevers </LTTextLineHorizontal><LTTextLineHorizontal y0="648.457" y1="657.457" x0="306.688" x1="555.769" width="249.08" height="9.0" bbox="[306.688, 648.457, 555.769, 657.457]" word_margin="0.1">were considered but would not have explained the persistent </LTTextLineHorizontal><LTTextLineHorizontal y0="637.459" y1="646.459" x0="306.688" x1="555.775" width="249.087" height="9.0" bbox="[306.688, 637.459, 555.775, 646.459]" word_margin="0.1">and severe hypotension. Fever and constitutional symptoms are </LTTextLineHorizontal><LTTextLineHorizontal y0="626.461" y1="635.461" x0="306.688" x1="555.762" width="249.073" height="9.0" bbox="[306.688, 626.461, 555.762, 635.461]" word_margin="0.1">common side effects of BRAF and MEK inhibitors, but the onset </LTTextLineHorizontal><LTTextLineHorizontal y0="615.463" y1="624.463" x0="306.688" x1="555.792" width="249.104" height="9.0" bbox="[306.688, 615.463, 555.792, 624.463]" word_margin="0.1">of deterioration preceded the commencement of encorafenib and </LTTextLineHorizontal><LTTextLineHorizontal y0="604.465" y1="613.465" x0="306.688" x1="555.772" width="249.084" height="9.0" bbox="[306.688, 604.465, 555.772, 613.465]" word_margin="0.1">binimetanib in our patient. A haemolytic process was thought </LTTextLineHorizontal><LTTextLineHorizontal y0="593.467" y1="602.467" x0="306.688" x1="555.782" width="249.094" height="9.0" bbox="[306.688, 593.467, 555.782, 602.467]" word_margin="0.1">to be possible. Bicytopenia, hyperbilirubinaemia, elevated LDH </LTTextLineHorizontal><LTTextLineHorizontal y0="582.469" y1="591.469" x0="306.688" x1="553.296" width="246.607" height="9.0" bbox="[306.688, 582.469, 553.296, 591.469]" word_margin="0.1">and low haptoglobins were all in keeping with this, but low retic- </LTTextLineHorizontal><LTTextLineHorizontal y0="571.471" y1="580.471" x0="306.688" x1="555.79" width="249.102" height="9.0" bbox="[306.688, 571.471, 555.79, 580.471]" word_margin="0.1">ulocyte count, a negative direct Coombs test and a blood film </LTTextLineHorizontal><LTTextLineHorizontal y0="560.473" y1="569.473" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 560.473, 555.781, 569.473]" word_margin="0.1">with no features of haemolysis effectively ruled this out. The </LTTextLineHorizontal><LTTextLineHorizontal y0="549.475" y1="558.475" x0="306.688" x1="553.279" width="246.591" height="9.0" bbox="[306.688, 549.475, 553.279, 558.475]" word_margin="0.1">results of the haemolysis screen, in addition to the ongoing bicy- </LTTextLineHorizontal><LTTextLineHorizontal y0="538.477" y1="547.477" x0="306.688" x1="555.789" width="249.101" height="9.0" bbox="[306.688, 538.477, 555.789, 547.477]" word_margin="0.1">topenia, pointed towards a bone marrow pathology, with clinical </LTTextLineHorizontal><LTTextLineHorizontal y0="527.479" y1="536.479" x0="306.688" x1="555.783" width="249.095" height="9.0" bbox="[306.688, 527.479, 555.783, 536.479]" word_margin="0.1">suspicion for HLH increased by a significantly elevated ferritin. </LTTextLineHorizontal><LTTextLineHorizontal y0="516.481" y1="525.481" x0="306.688" x1="555.796" width="249.107" height="9.0" bbox="[306.688, 516.481, 555.796, 525.481]" word_margin="0.1">The diagnosis was further supported on bone marrow aspirate, </LTTextLineHorizontal><LTTextLineHorizontal y0="505.483" y1="514.483" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 505.483, 555.781, 514.483]" word_margin="0.1">with the patient fulfilling five of the eight HLH- 2004 diagnostic </LTTextLineHorizontal><LTTextLineHorizontal y0="494.485" y1="503.485" x0="306.688" x1="555.778" width="249.089" height="9.0" bbox="[306.688, 494.485, 555.778, 503.485]" word_margin="0.1">criteria, namely, fever, bicytopenia, hypertriglyceridaemia, </LTTextLineHorizontal><LTTextLineHorizontal y0="483.487" y1="492.487" x0="306.688" x1="528.082" width="221.394" height="9.0" bbox="[306.688, 483.487, 528.082, 492.487]" word_margin="0.1">elevated ferritin and haemophagocytosis in bone marrow. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="384.505" y1="481.489" x0="306.688" x1="555.791" width="249.103" height="96.984" bbox="[306.688, 384.505, 555.791, 481.489]" index="10"><LTTextLineHorizontal y0="472.489" y1="481.489" x0="315.688" x1="555.776" width="240.088" height="9.0" bbox="[315.688, 472.489, 555.776, 481.489]" word_margin="0.1">The aetiology of HLH was initially unclear and was thought </LTTextLineHorizontal><LTTextLineHorizontal y0="461.491" y1="470.491" x0="306.688" x1="555.785" width="249.097" height="9.0" bbox="[306.688, 461.491, 555.785, 470.491]" word_margin="0.1">to be likely due to the immunotherapy, cancer disease burden or </LTTextLineHorizontal><LTTextLineHorizontal y0="450.493" y1="459.493" x0="306.688" x1="555.754" width="249.066" height="9.0" bbox="[306.688, 450.493, 555.754, 459.493]" word_margin="0.1">a combination of the two. A subsequent recurrence of the HLH, </LTTextLineHorizontal><LTTextLineHorizontal y0="439.495" y1="448.495" x0="306.688" x1="553.292" width="246.604" height="9.0" bbox="[306.688, 439.495, 553.292, 448.495]" word_margin="0.1">although at a lower severity, shortly after the patient was rechal- </LTTextLineHorizontal><LTTextLineHorizontal y0="428.497" y1="437.497" x0="306.688" x1="553.283" width="246.595" height="9.0" bbox="[306.688, 428.497, 553.283, 437.497]" word_margin="0.1">lenged with a single checkpoint inhibitor, confirmed immuno- </LTTextLineHorizontal><LTTextLineHorizontal y0="417.499" y1="426.499" x0="306.688" x1="555.791" width="249.103" height="9.0" bbox="[306.688, 417.499, 555.791, 426.499]" word_margin="0.1">therapy as the cause. We applied Naranjo&#8217;s algorithm and the </LTTextLineHorizontal><LTTextLineHorizontal y0="406.501" y1="415.501" x0="306.688" x1="555.765" width="249.077" height="9.0" bbox="[306.688, 406.501, 555.765, 415.501]" word_margin="0.1">WHO&#8211;Uppsala Monitoring Centre system for adverse event </LTTextLineHorizontal><LTTextLineHorizontal y0="395.503" y1="404.503" x0="306.688" x1="555.789" width="249.101" height="9.0" bbox="[306.688, 395.503, 555.789, 404.503]" word_margin="0.1">causality assessment, which both regarded this case as a definite </LTTextLineHorizontal><LTTextLineHorizontal y0="384.505" y1="393.505" x0="306.688" x1="434.716" width="128.028" height="9.0" bbox="[306.688, 384.505, 434.716, 393.505]" word_margin="0.1">adverse event to immunotherapy. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="311.222" y1="364.474" x0="306.688" x1="555.785" width="249.097" height="53.252" bbox="[306.688, 311.222, 555.785, 364.474]" index="11"><LTTextLineHorizontal y0="354.974" y1="364.474" x0="306.688" x1="355.784" width="49.096" height="9.5" bbox="[306.688, 354.974, 355.784, 364.474]" word_margin="0.1">TreaTmenT </LTTextLineHorizontal><LTTextLineHorizontal y0="344.216" y1="353.216" x0="306.688" x1="555.78" width="249.092" height="9.0" bbox="[306.688, 344.216, 555.78, 353.216]" word_margin="0.1">Treatments used for melanoma included ipilimumab and </LTTextLineHorizontal><LTTextLineHorizontal y0="333.218" y1="342.218" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 333.218, 555.781, 342.218]" word_margin="0.1">nivolumab combination, nivolumab monotherapy, dabrafenib, </LTTextLineHorizontal><LTTextLineHorizontal y0="322.22" y1="331.22" x0="306.688" x1="555.785" width="249.097" height="9.0" bbox="[306.688, 322.22, 555.785, 331.22]" word_margin="0.1">encorafenib and binimetanib combination and temozolamide. </LTTextLineHorizontal><LTTextLineHorizontal y0="311.222" y1="320.222" x0="306.688" x1="529.276" width="222.588" height="9.0" bbox="[306.688, 311.222, 529.276, 320.222]" word_margin="0.1">Radiotherapy was given for symptomatic liver metastases. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="300.224" y1="309.224" x0="315.688" x1="553.279" width="237.591" height="9.0" bbox="[315.688, 300.224, 553.279, 309.224]" word_margin="0.1"><LTTextBoxHorizontal y0="300.224" y1="309.224" x0="315.688" x1="553.279" width="237.591" height="9.0" bbox="[315.688, 300.224, 553.279, 309.224]" index="12">Treatments used for HLH included intravenous methylpred- </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="289.226" y1="298.226" x0="306.688" x1="540.958" width="234.27" height="9.0" bbox="[306.688, 289.226, 540.958, 298.226]" word_margin="0.1"><LTTextBoxHorizontal y0="289.226" y1="298.226" x0="306.688" x1="540.958" width="234.27" height="9.0" bbox="[306.688, 289.226, 540.958, 298.226]" index="13">nisolone, intravenous dexamethasone and oral prednisolone. </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="183.002" y1="269.248" x0="306.688" x1="555.783" width="249.095" height="86.246" bbox="[306.688, 183.002, 555.783, 269.248]" index="14"><LTTextLineHorizontal y0="259.748" y1="269.248" x0="306.688" x1="418.627" width="111.938" height="9.5" bbox="[306.688, 259.748, 418.627, 269.248]" word_margin="0.1">ouTCome anF Follow-up </LTTextLineHorizontal><LTTextLineHorizontal y0="248.989" y1="257.99" x0="306.688" x1="553.279" width="246.591" height="9.0" bbox="[306.688, 248.989, 553.279, 257.99]" word_margin="0.1">HLH on both occasions was responsive to steroids. Unfortu- </LTTextLineHorizontal><LTTextLineHorizontal y0="237.992" y1="246.992" x0="306.688" x1="553.27" width="246.582" height="9.0" bbox="[306.688, 237.992, 553.27, 246.992]" word_margin="0.1">nately, both combination and single- agent checkpoint inhibi- </LTTextLineHorizontal><LTTextLineHorizontal y0="226.994" y1="235.994" x0="306.688" x1="555.769" width="249.08" height="9.0" bbox="[306.688, 226.994, 555.769, 235.994]" word_margin="0.1">tors were shown to cause HLH in this patient. There was also </LTTextLineHorizontal><LTTextLineHorizontal y0="215.996" y1="224.996" x0="306.688" x1="555.783" width="249.095" height="9.0" bbox="[306.688, 215.996, 555.783, 224.996]" word_margin="0.1">evidence of progression with nivolumab, despite also receiving </LTTextLineHorizontal><LTTextLineHorizontal y0="204.998" y1="213.998" x0="306.688" x1="555.781" width="249.093" height="9.0" bbox="[306.688, 204.998, 555.781, 213.998]" word_margin="0.1">BRAF inhibitors, leaving limited treatment options for this </LTTextLineHorizontal><LTTextLineHorizontal y0="194.0" y1="203.0" x0="306.688" x1="553.274" width="246.586" height="9.0" bbox="[306.688, 194.0, 553.274, 203.0]" word_margin="0.1">patient. She was trialled on temozolamide but died approxi- </LTTextLineHorizontal><LTTextLineHorizontal y0="183.002" y1="192.002" x0="306.688" x1="388.279" width="81.59" height="9.0" bbox="[306.688, 183.002, 388.279, 192.002]" word_margin="0.1">mately 1 month later. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="43.781" y1="163.021" x0="306.688" x1="555.801" width="249.113" height="119.24" bbox="[306.688, 43.781, 555.801, 163.021]" index="15"><LTTextLineHorizontal y0="153.521" y1="163.021" x0="306.688" x1="356.554" width="49.865" height="9.5" bbox="[306.688, 153.521, 356.554, 163.021]" word_margin="0.1">diSCuSSion </LTTextLineHorizontal><LTTextLineHorizontal y0="142.763" y1="151.763" x0="306.688" x1="555.789" width="249.101" height="9.0" bbox="[306.688, 142.763, 555.789, 151.763]" word_margin="0.1">Checkpoint inhibitors target transmembrane proteins such as </LTTextLineHorizontal><LTTextLineHorizontal y0="131.765" y1="140.765" x0="306.688" x1="555.79" width="249.102" height="9.0" bbox="[306.688, 131.765, 555.79, 140.765]" word_margin="0.1">PD- 1, PDL- 1 and CTLA- 4 in order to induce a native T- cell </LTTextLineHorizontal><LTTextLineHorizontal y0="120.767" y1="129.767" x0="306.697" x1="555.791" width="249.094" height="9.0" bbox="[306.697, 120.767, 555.791, 129.767]" word_margin="0.1">response and ultimately promote tumour apoptosis. The use of </LTTextLineHorizontal><LTTextLineHorizontal y0="109.769" y1="118.769" x0="306.697" x1="555.789" width="249.091" height="9.0" bbox="[306.697, 109.769, 555.789, 118.769]" word_margin="0.1">combination checkpoint blockade has been proven to be more </LTTextLineHorizontal><LTTextLineHorizontal y0="98.771" y1="107.771" x0="306.697" x1="553.288" width="246.591" height="9.0" bbox="[306.697, 98.771, 553.288, 107.771]" word_margin="0.1">effective in terms of response rates when compared with mono- </LTTextLineHorizontal><LTTextLineHorizontal y0="87.773" y1="96.773" x0="306.697" x1="555.783" width="249.086" height="9.0" bbox="[306.697, 87.773, 555.783, 96.773]" word_margin="0.1">therapy in metastatic melanoma. However, they frequently </LTTextLineHorizontal><LTTextLineHorizontal y0="76.775" y1="85.775" x0="306.697" x1="555.781" width="249.084" height="9.0" bbox="[306.697, 76.775, 555.781, 85.775]" word_margin="0.1">cause irAEs such as dermatitis, thyroiditis, colitis, hepatitis and </LTTextLineHorizontal><LTTextLineHorizontal y0="65.777" y1="74.777" x0="306.697" x1="555.801" width="249.104" height="9.0" bbox="[306.697, 65.777, 555.801, 74.777]" word_margin="0.1">pneumonitis. Rarer, but more severe irAEs related to checkpoint </LTTextLineHorizontal><LTTextLineHorizontal y0="54.779" y1="63.779" x0="306.697" x1="555.776" width="249.079" height="9.0" bbox="[306.697, 54.779, 555.776, 63.779]" word_margin="0.1">inhibitors include autoimmune haemolytic anaemia, pure red </LTTextLineHorizontal><LTTextLineHorizontal y0="43.781" y1="52.781" x0="306.697" x1="390.613" width="83.916" height="9.0" bbox="[306.697, 43.781, 390.613, 52.781]" word_margin="0.1">cell aplasia and HLH. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="26.93" y1="34.93" x0="42.0" x1="45.84" width="3.84" height="8.0" bbox="[42.0, 26.93, 45.84, 34.93]" word_margin="0.1"><LTTextBoxHorizontal y0="26.93" y1="34.93" x0="42.0" x1="45.84" width="3.84" height="8.0" bbox="[42.0, 26.93, 45.84, 34.93]" index="16">4 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="26.938" y1="34.938" x0="320.416" x1="553.574" width="233.158" height="8.0" bbox="[320.416, 26.938, 553.574, 34.938]" word_margin="0.1"><LTTextBoxHorizontal y0="26.938" y1="34.938" x0="320.416" x1="553.574" width="233.158" height="8.0" bbox="[320.416, 26.938, 553.574, 34.938]" index="17">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTLine y0="38.68" y1="38.68" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.68, 553.276, 38.68]" linewidth="0.5" pts="[[42.0, 38.68], [553.276, 38.68]]"/>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="45.7" x1="105.133" width="59.433" height="11.0" bbox="[45.7, 757.826, 105.133, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="45.7" x1="105.133" width="59.433" height="11.0" bbox="[45.7, 757.826, 105.133, 768.826]" index="0">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTImage y0="561.543" y1="745.701" x0="42.0" x1="288.587" width="246.587" height="184.158" bbox="[42.0, 561.543, 288.587, 745.701]" name="Im0" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[1028, 768]" stream="&lt;PDFStream(36): raw=670413, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 768, 'Intent': /'RelativeColorimetric', 'Length': 670413, 'Metadata': &lt;PDFObjRef:35&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 1028}&gt;">
      <LTFigure y0="561.543" y1="745.701" x0="42.0" x1="288.587" width="246.587" height="184.158" bbox="[42.0, 561.543, 288.587, 745.701]" name="Im0" matrix="[246.587, 0.0, 0.0, 184.158, 42.0, 561.543]"/>
    </LTImage>
    <LTImage y0="83.871" y1="271.597" x0="42.0" x1="288.587" width="246.587" height="187.726" bbox="[42.0, 83.871, 288.587, 271.597]" name="Im1" colorspace="[&quot;&lt;PDFObjRef:205&gt;&quot;]" bits="8" imagemask="null" srcsize="[1028, 783]" stream="&lt;PDFStream(38): raw=168735, {'BitsPerComponent': 8, 'ColorSpace': &lt;PDFObjRef:205&gt;, 'Filter': /'JPXDecode', 'Height': 783, 'Intent': /'RelativeColorimetric', 'Length': 168735, 'Metadata': &lt;PDFObjRef:37&gt;, 'Name': /'X', 'Subtype': /'Image', 'Type': /'XObject', 'Width': 1028}&gt;">
      <LTFigure y0="83.871" y1="271.597" x0="42.0" x1="288.587" width="246.587" height="187.726" bbox="[42.0, 83.871, 288.587, 271.597]" name="Im1" matrix="[246.587, 0.0, 0.0, 187.726, 42.0, 83.871]"/>
    </LTImage>
  </LTPage>
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="5" rotate="0" page_index="4" page_label="">
    <LTTextBoxHorizontal y0="530.327" y1="546.826" x0="46.0" x1="562.467" width="516.467" height="16.499" bbox="[46.0, 530.327, 562.467, 546.826]" index="95"><LTTextLineHorizontal y0="539.826" y1="546.826" x0="46.0" x1="562.467" width="516.467" height="7.0" bbox="[46.0, 539.826, 562.467, 546.826]" word_margin="0.1">CR, complete response; F, female; HLH, haemophagocytic lymphohistiocytosis; HNSCC, head and neck squamous cell carcinoma; M, male; MMF, mycophenolate mofetil; NSCLC, non- small cell lung </LTTextLineHorizontal><LTTextLineHorizontal y0="530.327" y1="537.327" x0="46.0" x1="210.497" width="164.496" height="7.0" bbox="[46.0, 530.327, 210.497, 537.327]" word_margin="0.1">cancer; PD, progressive disease; PR, partial response; RIP, died. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="298.437" y1="505.435" x0="41.997" x1="291.1" width="249.103" height="206.998" bbox="[41.997, 298.437, 291.1, 505.435]" index="96"><LTTextLineHorizontal y0="496.435" y1="505.435" x0="51.0" x1="291.084" width="240.084" height="9.0" bbox="[51.0, 496.435, 291.084, 505.435]" word_margin="0.1">Searching the pharmacovigilance databases found that 92 </LTTextLineHorizontal><LTTextLineHorizontal y0="485.437" y1="494.437" x0="42.0" x1="291.069" width="249.069" height="9.0" bbox="[42.0, 485.437, 291.069, 494.437]" word_margin="0.1">cases of HLH secondary to nivolumab and 61 cases secondary </LTTextLineHorizontal><LTTextLineHorizontal y0="474.439" y1="483.439" x0="42.0" x1="291.078" width="249.078" height="9.0" bbox="[42.0, 474.439, 291.078, 483.439]" word_margin="0.1">to ipilimumab had been reported to WHO&#8217;s Vigibase, while 93 </LTTextLineHorizontal><LTTextLineHorizontal y0="463.441" y1="472.441" x0="42.0" x1="288.601" width="246.601" height="9.0" bbox="[42.0, 463.441, 288.601, 472.441]" word_margin="0.1">cases secondary to nivolumab and 65 cases secondary to ipilim- </LTTextLineHorizontal><LTTextLineHorizontal y0="452.435" y1="463.171" x0="42.0" x1="291.091" width="249.091" height="10.736" bbox="[42.0, 452.435, 291.091, 463.171]" word_margin="0.1">umab have been reported to the EudraVigilance database.19 20 It <Annot A="&lt;PDFObjRef:74&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[264.928, 463.234, 279.949, 452.437]" x0="264.928" x1="279.949" y0="463.234" y1="452.437" height="-10.796999999999969" width="15.021000000000015"/></LTTextLineHorizontal><LTTextLineHorizontal y0="441.437" y1="450.437" x0="41.998" x1="291.076" width="249.078" height="9.0" bbox="[41.998, 441.437, 291.076, 450.437]" word_margin="0.1">is unclear from these databases whether these immunotherapies </LTTextLineHorizontal><LTTextLineHorizontal y0="430.439" y1="439.439" x0="41.998" x1="291.1" width="249.102" height="9.0" bbox="[41.998, 430.439, 291.1, 439.439]" word_margin="0.1">were given in combination or if any of them were a rechallenge. </LTTextLineHorizontal><LTTextLineHorizontal y0="419.441" y1="428.441" x0="41.998" x1="288.597" width="246.599" height="9.0" bbox="[41.998, 419.441, 288.597, 428.441]" word_margin="0.1">A small number of cases of HLH secondary to checkpoint inhib- </LTTextLineHorizontal><LTTextLineHorizontal y0="408.443" y1="417.443" x0="41.998" x1="291.073" width="249.075" height="9.0" bbox="[41.998, 408.443, 291.073, 417.443]" word_margin="0.1">itor therapy have been published in the literature to date and are </LTTextLineHorizontal><LTTextLineHorizontal y0="397.445" y1="406.445" x0="41.998" x1="291.091" width="249.093" height="9.0" bbox="[41.998, 397.445, 291.091, 406.445]" word_margin="0.1">summarised previously (table 1). All patients received steroids as <Annot A="&lt;PDFObjRef:75&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[135.218, 408.234, 161.116, 397.437]" x0="135.218" x1="161.116" y0="408.234" y1="397.437" height="-10.796999999999969" width="25.898000000000025"/></LTTextLineHorizontal><LTTextLineHorizontal y0="386.447" y1="395.447" x0="41.998" x1="291.096" width="249.098" height="9.0" bbox="[41.998, 386.447, 291.096, 395.447]" word_margin="0.1">treatment for HLH, with four patients also receiving etoposide, </LTTextLineHorizontal><LTTextLineHorizontal y0="375.449" y1="384.449" x0="41.998" x1="291.09" width="249.092" height="9.0" bbox="[41.998, 375.449, 291.09, 384.449]" word_margin="0.1">mycophenolate or plasmapheresis. The majority of patients had </LTTextLineHorizontal><LTTextLineHorizontal y0="364.451" y1="373.451" x0="41.998" x1="291.088" width="249.089" height="9.0" bbox="[41.998, 364.451, 291.088, 373.451]" word_margin="0.1">a complete response with regard to HLH, which is a strikingly </LTTextLineHorizontal><LTTextLineHorizontal y0="353.435" y1="364.171" x0="41.998" x1="291.087" width="249.088" height="10.736" bbox="[41.998, 353.435, 291.087, 364.171]" word_margin="0.1">better outcome than those seen in primary HLH.5 Most patients <Annot A="&lt;PDFObjRef:76&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[230.208, 364.234, 233.526, 353.437]" x0="230.208" x1="233.526" y0="364.234" y1="353.437" height="-10.796999999999969" width="3.318000000000012"/></LTTextLineHorizontal><LTTextLineHorizontal y0="342.437" y1="351.437" x0="41.997" x1="291.069" width="249.071" height="9.0" bbox="[41.997, 342.437, 291.069, 351.437]" word_margin="0.1">had at least a partial response to their cancer, with one study, by </LTTextLineHorizontal><LTTextLineHorizontal y0="331.439" y1="340.439" x0="41.997" x1="288.598" width="246.601" height="9.0" bbox="[41.997, 331.439, 288.598, 340.439]" word_margin="0.1">Kalmuk et al, describing a patient who was successfully rechal- </LTTextLineHorizontal><LTTextLineHorizontal y0="320.441" y1="329.441" x0="41.997" x1="291.081" width="249.084" height="9.0" bbox="[41.997, 320.441, 291.081, 329.441]" word_margin="0.1">lenged with pembrolizumab for head and neck squamous cell </LTTextLineHorizontal><LTTextLineHorizontal y0="309.435" y1="320.171" x0="41.997" x1="291.085" width="249.088" height="10.736" bbox="[41.997, 309.435, 291.085, 320.171]" word_margin="0.1">carcinoma progression without HLH recurrence.11 Notably, no <Annot A="&lt;PDFObjRef:77&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[233.12, 320.234, 239.757, 309.437]" x0="233.12" x1="239.757" y0="320.234" y1="309.437" height="-10.796999999999969" width="6.6370000000000005"/></LTTextLineHorizontal><LTTextLineHorizontal y0="298.437" y1="307.437" x0="42.0" x1="291.08" width="249.08" height="9.0" bbox="[42.0, 298.437, 291.08, 307.437]" word_margin="0.1">patients with HLH secondary to ipilumab and nivolumab were </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="485.439" y1="505.437" x0="306.69" x1="555.787" width="249.097" height="19.998" bbox="[306.69, 485.439, 555.787, 505.437]" index="99"><LTTextLineHorizontal y0="496.437" y1="505.437" x0="306.69" x1="555.787" width="249.097" height="9.0" bbox="[306.69, 496.437, 555.787, 505.437]" word_margin="0.1">rechallanged with nivolumab monotherapy, making our case </LTTextLineHorizontal><LTTextLineHorizontal y0="485.439" y1="494.439" x0="306.69" x1="335.607" width="28.917" height="9.0" bbox="[306.69, 485.439, 335.607, 494.439]" word_margin="0.1">unique. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="415.568" y1="450.568" x0="306.688" x1="554.413" width="247.725" height="35.0" bbox="[306.688, 415.568, 554.413, 450.568]" index="100"><LTTextLineHorizontal y0="442.568" y1="450.568" x0="306.688" x1="544.383" width="237.694" height="8.0" bbox="[306.688, 442.568, 544.383, 450.568]" word_margin="0.1">Contributors ZH provided care to the patient while she was in the hospital and </LTTextLineHorizontal><LTTextLineHorizontal y0="433.568" y1="441.568" x0="306.688" x1="554.413" width="247.725" height="8.0" bbox="[306.688, 433.568, 554.413, 441.568]" word_margin="0.1">was also the principal contributor to the drafting of the report. AH also provided care </LTTextLineHorizontal><LTTextLineHorizontal y0="424.568" y1="432.568" x0="306.688" x1="548.768" width="242.08" height="8.0" bbox="[306.688, 424.568, 548.768, 432.568]" word_margin="0.1">to the patient during her admission and also contributed to the writing and editing </LTTextLineHorizontal><LTTextLineHorizontal y0="415.568" y1="423.568" x0="306.688" x1="536.461" width="229.773" height="8.0" bbox="[306.688, 415.568, 536.461, 423.568]" word_margin="0.1">of the report. AC contributed significantly to researching and editing the article. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="393.568" y1="410.568" x0="306.688" x1="549.047" width="242.358" height="17.0" bbox="[306.688, 393.568, 549.047, 410.568]" index="101"><LTTextLineHorizontal y0="402.568" y1="410.568" x0="306.688" x1="549.047" width="242.358" height="8.0" bbox="[306.688, 402.568, 549.047, 410.568]" word_margin="0.1">Funding The authors have not declared a specific grant for this research from any </LTTextLineHorizontal><LTTextLineHorizontal y0="393.568" y1="401.568" x0="306.688" x1="496.56" width="189.871" height="8.0" bbox="[306.688, 393.568, 496.56, 401.568]" word_margin="0.1">funding agency in the public, commercial or not- for- profit sectors. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="380.568" y1="388.568" x0="306.688" x1="422.488" width="115.8" height="8.0" bbox="[306.688, 380.568, 422.488, 388.568]" word_margin="0.1"><LTTextBoxHorizontal y0="380.568" y1="388.568" x0="306.688" x1="422.488" width="115.8" height="8.0" bbox="[306.688, 380.568, 422.488, 388.568]" index="102">Competing interests None declared. </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="367.568" y1="375.568" x0="306.688" x1="457.72" width="151.031" height="8.0" bbox="[306.688, 367.568, 457.72, 375.568]" word_margin="0.1"><LTTextBoxHorizontal y0="367.568" y1="375.568" x0="306.688" x1="457.72" width="151.031" height="8.0" bbox="[306.688, 367.568, 457.72, 375.568]" index="103">patient consent for publication Not applicable. </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="354.568" y1="362.568" x0="306.688" x1="535.487" width="228.799" height="8.0" bbox="[306.688, 354.568, 535.487, 362.568]" word_margin="0.1"><LTTextBoxHorizontal y0="354.568" y1="362.568" x0="306.688" x1="535.487" width="228.799" height="8.0" bbox="[306.688, 354.568, 535.487, 362.568]" index="104">provenance and peer review Not commissioned; externally peer reviewed. </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="323.568" y1="349.568" x0="306.688" x1="555.11" width="248.422" height="26.0" bbox="[306.688, 323.568, 555.11, 349.568]" index="105"><LTTextLineHorizontal y0="341.568" y1="349.568" x0="306.688" x1="546.559" width="239.871" height="8.0" bbox="[306.688, 341.568, 546.559, 349.568]" word_margin="0.1">Case reports provide a valuable learning resource for the scientific community and </LTTextLineHorizontal><LTTextLineHorizontal y0="332.568" y1="340.568" x0="306.688" x1="555.11" width="248.422" height="8.0" bbox="[306.688, 332.568, 555.11, 340.568]" word_margin="0.1">can indicate areas of interest for future research. They should not be used in isolation </LTTextLineHorizontal><LTTextLineHorizontal y0="323.568" y1="331.568" x0="306.688" x1="451.88" width="145.192" height="8.0" bbox="[306.688, 323.568, 451.88, 331.568]" word_margin="0.1">to guide treatment choices or public health policy. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="277.793" y1="295.793" x0="306.688" x1="550.415" width="243.727" height="18.0" bbox="[306.688, 277.793, 550.415, 295.793]" index="106">1 Larkin J, Chiarion- Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or <LTTextLineHorizontal y0="286.293" y1="295.793" x0="306.688" x1="356.839" width="50.151" height="9.5" bbox="[306.688, 286.293, 356.839, 295.793]" word_margin="0.1">RefeRenCes </LTTextLineHorizontal><LTTextLineHorizontal y0="277.793" y1="285.293" x0="306.688" x1="550.415" width="243.727" height="7.5" bbox="[306.688, 277.793, 550.415, 285.293]" word_margin="0.1"> 1 Larkin J, Chiarion- Sileni V, Gonzalez R, et al. Combined nivolumab and ipilimumab or </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="259.793" y1="276.293" x0="306.688" x1="519.306" width="212.617" height="16.5" bbox="[306.688, 259.793, 519.306, 276.293]" index="107">2 Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into <LTTextLineHorizontal y0="268.793" y1="276.293" x0="319.288" x1="510.531" width="191.243" height="7.5" bbox="[319.288, 268.793, 510.531, 276.293]" word_margin="0.1">monotherapy in untreated melanoma. N Engl J Med 2015;373:23&#8211;34. <Annot A="&lt;PDFObjRef:78&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[423.889, 277.56, 459.978, 268.793]" x0="423.889" x1="459.978" y0="277.56" y1="268.793" height="-8.766999999999996" width="36.089" URI="http://dx.doi.org/10.1056/NEJMoa1504030"/></LTTextLineHorizontal><LTTextLineHorizontal y0="259.793" y1="267.293" x0="306.688" x1="519.306" width="212.617" height="7.5" bbox="[306.688, 259.793, 519.306, 267.293]" word_margin="0.1"> 2 Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="241.793" y1="258.293" x0="319.288" x1="514.941" width="195.652" height="16.5" bbox="[319.288, 241.793, 514.941, 258.293]" index="108"><LTTextLineHorizontal y0="250.793" y1="258.293" x0="319.288" x1="514.941" width="195.652" height="7.5" bbox="[319.288, 250.793, 514.941, 258.293]" word_margin="0.1">pathophysiology and practical guidelines. Biol Blood Marrow Transplant <Annot A="&lt;PDFObjRef:79&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[432.761, 259.56, 513.138, 250.793]" x0="432.761" x1="513.138" y0="259.56" y1="250.793" height="-8.766999999999996" width="80.37700000000001" URI="http://dx.doi.org/10.1016/j.bbmt.2009.11.014"/></LTTextLineHorizontal><LTTextLineHorizontal y0="241.793" y1="249.293" x0="319.288" x1="364.033" width="44.745" height="7.5" bbox="[319.288, 241.793, 364.033, 249.293]" word_margin="0.1">2010;16:S82&#8211;9. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="232.793" y1="240.293" x0="306.688" x1="534.995" width="228.307" height="7.5" bbox="[306.688, 232.793, 534.995, 240.293]" word_margin="0.1"><LTTextBoxHorizontal y0="232.793" y1="240.293" x0="306.688" x1="534.995" width="228.307" height="7.5" bbox="[306.688, 232.793, 534.995, 240.293]" index="109"> 3 Henter JI, Elinder G, S&#246;der O, et al. Incidence in Sweden and clinical features of </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="223.793" y1="231.293" x0="319.288" x1="547.776" width="228.487" height="7.5" bbox="[319.288, 223.793, 547.776, 231.293]" word_margin="0.1"><LTTextBoxHorizontal y0="223.793" y1="231.293" x0="319.288" x1="547.776" width="228.487" height="7.5" bbox="[319.288, 223.793, 547.776, 231.293]" index="110">familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991;80:428&#8211;35. <Annot A="&lt;PDFObjRef:80&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[442.796, 232.56, 497.223, 223.793]" x0="442.796" x1="497.223" y0="232.56" y1="223.793" height="-8.766999999999996" width="54.42700000000002" URI="http://dx.doi.org/10.1111/j.1651-2227.1991.tb11878.x"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="26.93" y1="34.93" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.93, 553.276, 34.93]" word_margin="0.1"><LTTextBoxHorizontal y0="26.93" y1="34.93" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.93, 553.276, 34.93]" index="124">5 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTLine y0="38.68" y1="38.68" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.68, 553.276, 38.68]" linewidth="0.5" pts="[[42.0, 38.68], [553.276, 38.68]]"/>
    <LTTextLineHorizontal y0="26.941" y1="34.941" x0="42.0" x1="275.158" width="233.158" height="8.0" bbox="[42.0, 26.941, 275.158, 34.941]" word_margin="0.1"><LTTextBoxHorizontal y0="26.941" y1="34.941" x0="42.0" x1="275.158" width="233.158" height="8.0" bbox="[42.0, 26.941, 275.158, 34.941]" index="0">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm0" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" index="8">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTRect y0="254.724" y1="273.849" x0="42.0" x1="288.587" width="246.587" height="19.125" bbox="[42.0, 254.724, 288.587, 273.849]" linewidth="0.5" pts="[[42.0, 254.724], [288.587, 254.724], [288.587, 273.849], [42.0, 273.849]]">
      <LTTextLineHorizontal y0="258.349" y1="267.849" x0="48.0" x1="128.332" width="80.332" height="9.5" bbox="[48.0, 258.349, 128.332, 267.849]" word_margin="0.1"><LTTextBoxHorizontal y0="258.349" y1="267.849" x0="48.0" x1="128.332" width="80.332" height="9.5" bbox="[48.0, 258.349, 128.332, 267.849]" index="97">patients perspective </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTRect y0="45.871" y1="251.996" x0="42.0" x1="288.587" width="246.587" height="206.125" bbox="[42.0, 45.871, 288.587, 251.996]" linewidth="0.5" pts="[[42.0, 45.871], [288.587, 45.871], [288.587, 251.996], [42.0, 251.996]]">
      <LTTextBoxHorizontal y0="192.492" y1="245.996" x0="48.0" x1="278.346" width="230.346" height="53.504" bbox="[48.0, 192.492, 278.346, 245.996]" index="98"><LTTextLineHorizontal y0="236.496" y1="245.996" x0="48.0" x1="278.346" width="230.346" height="9.5" bbox="[48.0, 236.496, 278.346, 245.996]" word_margin="0.1">The whole experience was quite frightening and frustrating. My </LTTextLineHorizontal><LTTextLineHorizontal y0="225.495" y1="234.995" x0="48.0" x1="275.724" width="227.724" height="9.5" bbox="[48.0, 225.495, 275.724, 234.995]" word_margin="0.1">main concerns with trying the immunotherapy was will it work </LTTextLineHorizontal><LTTextLineHorizontal y0="214.494" y1="223.994" x0="48.0" x1="270.756" width="222.756" height="9.5" bbox="[48.0, 214.494, 270.756, 223.994]" word_margin="0.1">and what side effects will I get. I had heard that some people </LTTextLineHorizontal><LTTextLineHorizontal y0="203.493" y1="212.993" x0="48.0" x1="272.38" width="224.38" height="9.5" bbox="[48.0, 203.493, 272.38, 212.993]" word_margin="0.1">respond really well to this type of immunotherapy though so I </LTTextLineHorizontal><LTTextLineHorizontal y0="192.492" y1="201.992" x0="48.0" x1="139.571" width="91.571" height="9.5" bbox="[48.0, 192.492, 139.571, 201.992]" word_margin="0.1">was eager to give it a try. </LTTextLineHorizontal></LTTextBoxHorizontal>
      <LTTextLineHorizontal y0="181.491" y1="190.991" x0="57.5" x1="275.515" width="218.015" height="9.5" bbox="[57.5, 181.491, 275.515, 190.991]" word_margin="0.1"><LTTextBoxHorizontal y0="181.491" y1="190.991" x0="57.5" x1="275.515" width="218.015" height="9.5" bbox="[57.5, 181.491, 275.515, 190.991]" index="111">My first stay in hospital was really scary because I felt awful </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextBoxHorizontal y0="60.48" y1="179.99" x0="48.0" x1="282.374" width="234.374" height="119.51" bbox="[48.0, 60.48, 282.374, 179.99]" index="113"><LTTextLineHorizontal y0="170.49" y1="179.99" x0="48.0" x1="260.058" width="212.058" height="9.5" bbox="[48.0, 170.49, 260.058, 179.99]" word_margin="0.1">and they didn&#8217;t know what was causing it. Eventually they </LTTextLineHorizontal><LTTextLineHorizontal y0="159.489" y1="168.989" x0="48.0" x1="274.679" width="226.679" height="9.5" bbox="[48.0, 159.489, 274.679, 168.989]" word_margin="0.1">found something rare called HLH, which they thought was due </LTTextLineHorizontal><LTTextLineHorizontal y0="148.488" y1="157.988" x0="48.0" x1="266.775" width="218.775" height="9.5" bbox="[48.0, 148.488, 266.775, 157.988]" word_margin="0.1">to the immunotherapy for my melanoma. This was obviously </LTTextLineHorizontal><LTTextLineHorizontal y0="137.487" y1="146.987" x0="48.0" x1="248.288" width="200.288" height="9.5" bbox="[48.0, 137.487, 248.288, 146.987]" word_margin="0.1">disappointing, especially considering I had such a good </LTTextLineHorizontal><LTTextLineHorizontal y0="126.486" y1="135.986" x0="48.0" x1="278.85" width="230.85" height="9.5" bbox="[48.0, 126.486, 278.85, 135.986]" word_margin="0.1">response on my initial scans. The risks and benefits of trying the </LTTextLineHorizontal><LTTextLineHorizontal y0="115.485" y1="124.985" x0="48.0" x1="278.859" width="230.859" height="9.5" bbox="[48.0, 115.485, 278.859, 124.985]" word_margin="0.1">immunotherapy again were explained to me. My priority was to </LTTextLineHorizontal><LTTextLineHorizontal y0="104.484" y1="113.984" x0="48.0" x1="274.603" width="226.603" height="9.5" bbox="[48.0, 104.484, 274.603, 113.984]" word_margin="0.1">be able to spend as much time as possible with my family, so I </LTTextLineHorizontal><LTTextLineHorizontal y0="93.483" y1="102.983" x0="48.0" x1="278.726" width="230.726" height="9.5" bbox="[48.0, 93.483, 278.726, 102.983]" word_margin="0.1">thought taking the risk and going for the immunotherapy again </LTTextLineHorizontal><LTTextLineHorizontal y0="82.482" y1="91.982" x0="48.0" x1="282.374" width="234.374" height="9.5" bbox="[48.0, 82.482, 282.374, 91.982]" word_margin="0.1">would give me the best chance. Unfortunately, it didn&#8217;t work out </LTTextLineHorizontal><LTTextLineHorizontal y0="71.481" y1="80.981" x0="48.0" x1="274.831" width="226.831" height="9.5" bbox="[48.0, 71.481, 274.831, 80.981]" word_margin="0.1">and I got HLH again. This was devastating as I knew that there </LTTextLineHorizontal><LTTextLineHorizontal y0="60.48" y1="69.98" x0="48.0" x1="214.145" width="166.145" height="9.5" bbox="[48.0, 60.48, 214.145, 69.98]" word_margin="0.1">are limited options left to treat my melanoma. </LTTextLineHorizontal></LTTextBoxHorizontal>
    </LTRect>
    <LTRect y0="177.724" y1="196.849" x0="306.688" x1="553.275" width="246.587" height="19.125" bbox="[306.688, 177.724, 553.275, 196.849]" linewidth="0.5" pts="[[306.688, 177.724], [553.275, 177.724], [553.275, 196.849], [306.688, 196.849]]">
      <LTTextLineHorizontal y0="181.349" y1="190.849" x0="312.688" x1="374.466" width="61.778" height="9.5" bbox="[312.688, 181.349, 374.466, 190.849]" word_margin="0.1"><LTTextBoxHorizontal y0="181.349" y1="190.849" x0="312.688" x1="374.466" width="61.778" height="9.5" bbox="[312.688, 181.349, 374.466, 190.849]" index="112">learning points </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTRect y0="45.871" y1="174.996" x0="306.688" x1="553.275" width="246.587" height="129.125" bbox="[306.688, 45.871, 553.275, 174.996]" linewidth="0.5" pts="[[306.688, 45.871], [553.275, 45.871], [553.275, 174.996], [306.688, 174.996]]">
      <LTTextLineHorizontal y0="159.271" y1="168.996" x0="312.686" x1="539.435" width="226.749" height="9.725" bbox="[312.686, 159.271, 539.435, 168.996]" word_margin="0.1"><LTTextBoxHorizontal y0="159.271" y1="168.996" x0="312.686" x1="539.435" width="226.749" height="9.725" bbox="[312.686, 159.271, 539.435, 168.996]" index="114"> &#9658; Consider haemophagocytic lymphohistiocytosis (HLH) in an </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="148.495" y1="157.995" x0="324.688" x1="491.593" width="166.905" height="9.5" bbox="[324.688, 148.495, 491.593, 157.995]" word_margin="0.1"><LTTextBoxHorizontal y0="148.495" y1="157.995" x0="324.688" x1="491.593" width="166.905" height="9.5" bbox="[324.688, 148.495, 491.593, 157.995]" index="115">unwell patient with fevers of unknown source. </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="137.271" y1="146.996" x0="312.686" x1="549.448" width="236.762" height="9.725" bbox="[312.686, 137.271, 549.448, 146.996]" word_margin="0.1"><LTTextBoxHorizontal y0="137.271" y1="146.996" x0="312.686" x1="549.448" width="236.762" height="9.725" bbox="[312.686, 137.271, 549.448, 146.996]" index="116"> &#9658; Immune checkpoint inhibitors cause a wide range of immune- </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="126.495" y1="135.995" x0="324.688" x1="461.64" width="136.952" height="9.5" bbox="[324.688, 126.495, 461.64, 135.995]" word_margin="0.1"><LTTextBoxHorizontal y0="126.495" y1="135.995" x0="324.688" x1="461.64" width="136.952" height="9.5" bbox="[324.688, 126.495, 461.64, 135.995]" index="117">related adverse events, including HLH. </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="115.271" y1="124.996" x0="312.686" x1="527.475" width="214.789" height="9.725" bbox="[312.686, 115.271, 527.475, 124.996]" word_margin="0.1"><LTTextBoxHorizontal y0="115.271" y1="124.996" x0="312.686" x1="527.475" width="214.789" height="9.725" bbox="[312.686, 115.271, 527.475, 124.996]" index="118"> &#9658; Single- agent and combination checkpoint inhibitors can </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="104.495" y1="113.995" x0="324.688" x1="364.426" width="39.738" height="9.5" bbox="[324.688, 104.495, 364.426, 113.995]" word_margin="0.1"><LTTextBoxHorizontal y0="104.495" y1="113.995" x0="324.688" x1="364.426" width="39.738" height="9.5" bbox="[324.688, 104.495, 364.426, 113.995]" index="119">cause HLH. </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="93.271" y1="102.996" x0="312.686" x1="532.842" width="220.156" height="9.725" bbox="[312.686, 93.271, 532.842, 102.996]" word_margin="0.1"><LTTextBoxHorizontal y0="93.271" y1="102.996" x0="312.686" x1="532.842" width="220.156" height="9.725" bbox="[312.686, 93.271, 532.842, 102.996]" index="120"> &#9658; Immune- related HLH is likely more susceptible to steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="82.495" y1="91.995" x0="324.688" x1="390.095" width="65.407" height="9.5" bbox="[324.688, 82.495, 390.095, 91.995]" word_margin="0.1"><LTTextBoxHorizontal y0="82.495" y1="91.995" x0="324.688" x1="390.095" width="65.407" height="9.5" bbox="[324.688, 82.495, 390.095, 91.995]" index="121">than primary HLH. </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextLineHorizontal y0="71.271" y1="80.996" x0="312.686" x1="535.854" width="223.168" height="9.725" bbox="[312.686, 71.271, 535.854, 80.996]" word_margin="0.1"><LTTextBoxHorizontal y0="71.271" y1="80.996" x0="312.686" x1="535.854" width="223.168" height="9.725" bbox="[312.686, 71.271, 535.854, 80.996]" index="122"> &#9658; There is more to be learnt about the optimal management </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextBoxHorizontal y0="49.494" y1="69.995" x0="324.688" x1="541.468" width="216.78" height="20.501" bbox="[324.688, 49.494, 541.468, 69.995]" index="123"><LTTextLineHorizontal y0="60.495" y1="69.995" x0="324.688" x1="541.468" width="216.78" height="9.5" bbox="[324.688, 60.495, 541.468, 69.995]" word_margin="0.1">of this entity and the risk of HLH relapse after rechallenging </LTTextLineHorizontal><LTTextLineHorizontal y0="49.494" y1="58.994" x0="324.688" x1="402.075" width="77.387" height="9.5" bbox="[324.688, 49.494, 402.075, 58.994]" word_margin="0.1">with immunotherapy. </LTTextLineHorizontal></LTTextBoxHorizontal>
    </LTRect>
    <LTRect y0="532.076" y1="745.701" x0="42.0" x1="573.275" width="531.275" height="213.625" bbox="[42.0, 532.076, 573.275, 745.701]" linewidth="0.5" pts="[[42.0, 532.076], [573.275, 532.076], [573.275, 745.701], [42.0, 745.701]]">
      <LTTextLineHorizontal y0="731.201" y1="740.201" x0="46.0" x1="458.331" width="412.331" height="9.0" bbox="[46.0, 731.201, 458.331, 740.201]" word_margin="0.1"><LTTextBoxHorizontal y0="731.201" y1="740.201" x0="46.0" x1="458.331" width="412.331" height="9.0" bbox="[46.0, 731.201, 458.331, 740.201]" index="0">Table 1 Summary of cases of HLH secondary to immune checkpoint inhibitor therapy published in the literature to date </LTTextBoxHorizontal></LTTextLineHorizontal>
      <LTTextBoxHorizontal y0="634.326" y1="713.055" x0="45.99" x1="96.155" width="50.165" height="78.729" bbox="[45.99, 634.326, 96.155, 713.055]" index="9"><LTTextLineHorizontal y0="704.073" y1="713.055" x0="45.993" x1="95.238" width="49.246" height="8.982" bbox="[45.993, 704.073, 95.238, 713.055]" word_margin="0.1">Sadaat and Jang6 </LTTextLineHorizontal><LTTextLineHorizontal y0="692.451" y1="701.43" x0="45.99" x1="81.281" width="35.291" height="8.979" bbox="[45.99, 692.451, 81.281, 701.43]" word_margin="0.1">Hantel et al7 <Annot A="&lt;PDFObjRef:82&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[78.8941, 701.293, 81.2808, 692.451]" x0="78.8941" x1="81.2808" y0="701.293" y1="692.451" height="-8.841999999999985" width="2.3867000000000047"/></LTTextLineHorizontal><LTTextLineHorizontal y0="680.826" y1="689.805" x0="45.99" x1="82.398" width="36.408" height="8.979" bbox="[45.99, 680.826, 82.398, 689.805]" word_margin="0.1">Mizuta et al9 </LTTextLineHorizontal><LTTextLineHorizontal y0="669.201" y1="678.18" x0="45.99" x1="77.983" width="31.993" height="8.979" bbox="[45.99, 669.201, 77.983, 678.18]" word_margin="0.1">Chin et al10 <Annot A="&lt;PDFObjRef:84&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[73.2092, 678.043, 77.9828, 669.201]" x0="73.2092" x1="77.9828" y0="678.043" y1="669.201" height="-8.841999999999985" width="4.773600000000002"/></LTTextLineHorizontal><LTTextLineHorizontal y0="657.576" y1="666.555" x0="45.99" x1="86.45" width="40.46" height="8.979" bbox="[45.99, 657.576, 86.45, 666.555]" word_margin="0.1">Kalmuk et al11 </LTTextLineHorizontal><LTTextLineHorizontal y0="645.951" y1="654.93" x0="45.99" x1="96.155" width="50.165" height="8.979" bbox="[45.99, 645.951, 96.155, 654.93]" word_margin="0.1">Al- Samkari et al12 <Annot A="&lt;PDFObjRef:86&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[91.3811, 654.793, 96.1547, 645.951]" x0="91.3811" x1="96.1547" y0="654.793" y1="645.951" height="-8.841999999999985" width="4.773600000000002"/></LTTextLineHorizontal><LTTextLineHorizontal y0="634.326" y1="643.305" x0="45.99" x1="90.193" width="44.203" height="8.979" bbox="[45.99, 634.326, 90.193, 643.305]" word_margin="0.1">Malissen et al13 <Annot A="&lt;PDFObjRef:87&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[85.419, 643.168, 90.1926, 634.326]" x0="85.419" x1="90.1926" y0="643.168" y1="634.326" height="-8.841999999999985" width="4.773600000000002"/></LTTextLineHorizontal><Annot A="&lt;PDFObjRef:81&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[92.8516, 712.918, 95.2384, 704.076]" x0="92.8516" x1="95.2384" y0="712.918" y1="704.076" height="-8.841999999999985" width="2.386799999999994"/><Annot A="&lt;PDFObjRef:83&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[80.0117, 689.668, 82.3985, 680.826]" x0="80.0117" x1="82.3985" y0="689.668" y1="680.826" height="-8.841999999999985" width="2.386799999999994"/><Annot A="&lt;PDFObjRef:85&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[81.6766, 666.418, 86.4501, 657.576]" x0="81.6766" x1="86.4501" y0="666.418" y1="657.576" height="-8.841999999999985" width="4.773500000000013"/></LTTextBoxHorizontal>
      <LTTextBoxHorizontal y0="552.951" y1="608.43" x0="45.975" x1="91.43" width="45.455" height="55.479" bbox="[45.975, 552.951, 91.43, 608.43]" index="10"><LTTextLineHorizontal y0="599.451" y1="608.43" x0="45.975" x1="79.093" width="33.118" height="8.979" bbox="[45.975, 599.451, 79.093, 608.43]" word_margin="0.1">Shah et al14 <Annot A="&lt;PDFObjRef:88&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[74.3193, 608.293, 79.0928, 599.451]" x0="74.3193" x1="79.0928" y0="608.293" y1="599.451" height="-8.841999999999985" width="4.7734999999999985"/></LTTextLineHorizontal><LTTextLineHorizontal y0="587.826" y1="596.805" x0="45.99" x1="91.43" width="45.44" height="8.979" bbox="[45.99, 587.826, 91.43, 596.805]" word_margin="0.1">Takeshita et al15 <Annot A="&lt;PDFObjRef:89&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[86.6564, 596.668, 91.43, 587.826]" x0="86.6564" x1="91.43" y0="596.668" y1="587.826" height="-8.841999999999985" width="4.773600000000002"/></LTTextLineHorizontal><LTTextLineHorizontal y0="576.201" y1="585.18" x0="45.99" x1="86.157" width="40.167" height="8.979" bbox="[45.99, 576.201, 86.157, 585.18]" word_margin="0.1">Satzger et al16 </LTTextLineHorizontal><LTTextLineHorizontal y0="564.576" y1="573.555" x0="45.99" x1="83.81" width="37.82" height="8.979" bbox="[45.99, 564.576, 83.81, 573.555]" word_margin="0.1">Lorenz et al17 </LTTextLineHorizontal><LTTextLineHorizontal y0="552.951" y1="561.93" x0="45.99" x1="84.928" width="38.938" height="8.979" bbox="[45.99, 552.951, 84.928, 561.93]" word_margin="0.1">Okawa et al18 <Annot A="&lt;PDFObjRef:92&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[80.1544, 561.793, 84.9279, 552.951]" x0="80.1544" x1="84.9279" y0="561.793" y1="552.951" height="-8.841999999999985" width="4.7734999999999985"/></LTTextLineHorizontal><Annot A="&lt;PDFObjRef:90&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[81.3839, 585.043, 86.1575, 576.201]" x0="81.3839" x1="86.1575" y0="585.043" y1="576.201" height="-8.841999999999985" width="4.773600000000002"/><Annot A="&lt;PDFObjRef:91&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[79.0367, 573.418, 83.8102, 564.576]" x0="79.0367" x1="83.8102" y0="573.418" y1="564.576" height="-8.841999999999985" width="4.7734999999999985"/></LTTextBoxHorizontal>
      <LTLine y0="745.701" y1="745.701" x0="42.0" x1="573.275" width="531.275" height="0.0" bbox="[42.0, 745.701, 573.275, 745.701]" linewidth="0.5" pts="[[42.0, 745.701], [573.275, 745.701]]"/>
      <LTRect y0="715.576" y1="729.201" x0="42.0" x1="101.0" width="59.0" height="13.625" bbox="[42.0, 715.576, 101.0, 729.201]" linewidth="0.5" pts="[[42.0, 729.201], [101.0, 729.201], [101.0, 715.576], [42.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="46.0" x1="67.675" width="21.675" height="7.5" bbox="[46.0, 717.701, 67.675, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="46.0" x1="67.675" width="21.675" height="7.5" bbox="[46.0, 717.701, 67.675, 725.201]" index="1">author </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="715.576" y1="715.576" x0="42.075" x1="101.0" width="58.925" height="0.0" bbox="[42.075, 715.576, 101.0, 715.576]" linewidth="0.5" pts="[[42.075, 715.576], [101.0, 715.576]]"/>
        <LTLine y0="715.576" y1="728.951" x0="42.0" x1="42.0" width="0.0" height="13.375" bbox="[42.0, 715.576, 42.0, 728.951]" linewidth="0.15" pts="[[42.0, 715.576], [42.0, 728.951]]"/>
      </LTRect>
      <LTRect y0="715.576" y1="729.201" x0="101.0" x1="176.0" width="75.0" height="13.625" bbox="[101.0, 715.576, 176.0, 729.201]" linewidth="0.5" pts="[[101.0, 729.201], [176.0, 729.201], [176.0, 715.576], [101.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="105.002" x1="146.747" width="41.744" height="7.5" bbox="[105.002, 717.701, 146.747, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="105.002" x1="146.747" width="41.744" height="7.5" bbox="[105.002, 717.701, 146.747, 725.201]" index="2">demographic </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="729.201" y1="729.201" x0="101.0" x1="176.0" width="75.0" height="0.0" bbox="[101.0, 729.201, 176.0, 729.201]" linewidth="0.5" pts="[[101.0, 729.201], [176.0, 729.201]]"/>
        <LTLine y0="715.576" y1="715.576" x0="101.0" x1="176.0" width="75.0" height="0.0" bbox="[101.0, 715.576, 176.0, 715.576]" linewidth="0.5" pts="[[101.0, 715.576], [176.0, 715.576]]"/>
      </LTRect>
      <LTRect y0="715.576" y1="729.201" x0="176.0" x1="251.0" width="75.0" height="13.625" bbox="[176.0, 715.576, 251.0, 729.201]" linewidth="0.5" pts="[[176.0, 729.201], [251.0, 729.201], [251.0, 715.576], [176.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="180.002" x1="201.4" width="21.397" height="7.5" bbox="[180.002, 717.701, 201.4, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="180.002" x1="201.4" width="21.397" height="7.5" bbox="[180.002, 717.701, 201.4, 725.201]" index="3">Cancer </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="729.201" y1="729.201" x0="176.0" x1="251.0" width="75.0" height="0.0" bbox="[176.0, 729.201, 251.0, 729.201]" linewidth="0.5" pts="[[176.0, 729.201], [251.0, 729.201]]"/>
        <LTLine y0="715.576" y1="715.576" x0="176.0" x1="251.0" width="75.0" height="0.0" bbox="[176.0, 715.576, 251.0, 715.576]" linewidth="0.5" pts="[[176.0, 715.576], [251.0, 715.576]]"/>
      </LTRect>
      <LTRect y0="715.576" y1="729.201" x0="251.0" x1="336.0" width="85.0" height="13.625" bbox="[251.0, 715.576, 336.0, 729.201]" linewidth="0.5" pts="[[251.0, 729.201], [336.0, 729.201], [336.0, 715.576], [251.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="255.002" x1="304.668" width="49.665" height="7.5" bbox="[255.002, 717.701, 304.668, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="255.002" x1="304.668" width="49.665" height="7.5" bbox="[255.002, 717.701, 304.668, 725.201]" index="4">immunotherapy </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="729.201" y1="729.201" x0="251.0" x1="336.0" width="85.0" height="0.0" bbox="[251.0, 729.201, 336.0, 729.201]" linewidth="0.5" pts="[[251.0, 729.201], [336.0, 729.201]]"/>
        <LTLine y0="715.576" y1="715.576" x0="251.0" x1="336.0" width="85.0" height="0.0" bbox="[251.0, 715.576, 336.0, 715.576]" linewidth="0.5" pts="[[251.0, 715.576], [336.0, 715.576]]"/>
      </LTRect>
      <LTRect y0="715.576" y1="729.201" x0="336.0" x1="421.0" width="85.0" height="13.625" bbox="[336.0, 715.576, 421.0, 729.201]" linewidth="0.5" pts="[[336.0, 729.201], [421.0, 729.201], [421.0, 715.576], [336.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="340.0" x1="385.907" width="45.907" height="7.5" bbox="[340.0, 717.701, 385.907, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="340.0" x1="385.907" width="45.907" height="7.5" bbox="[340.0, 717.701, 385.907, 725.201]" index="5">HlH treatment </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="729.201" y1="729.201" x0="336.0" x1="421.0" width="85.0" height="0.0" bbox="[336.0, 729.201, 421.0, 729.201]" linewidth="0.5" pts="[[336.0, 729.201], [421.0, 729.201]]"/>
        <LTLine y0="715.576" y1="715.576" x0="336.0" x1="421.0" width="85.0" height="0.0" bbox="[336.0, 715.576, 421.0, 715.576]" linewidth="0.5" pts="[[336.0, 715.576], [421.0, 715.576]]"/>
      </LTRect>
      <LTRect y0="715.576" y1="729.201" x0="421.0" x1="497.0" width="76.0" height="13.625" bbox="[421.0, 715.576, 497.0, 729.201]" linewidth="0.5" pts="[[421.0, 729.201], [497.0, 729.201], [497.0, 715.576], [421.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="424.998" x1="466.81" width="41.812" height="7.5" bbox="[424.998, 717.701, 466.81, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="424.998" x1="466.81" width="41.812" height="7.5" bbox="[424.998, 717.701, 466.81, 725.201]" index="6">HlH outcome </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="729.201" y1="729.201" x0="421.0" x1="497.0" width="76.0" height="0.0" bbox="[421.0, 729.201, 497.0, 729.201]" linewidth="0.5" pts="[[421.0, 729.201], [497.0, 729.201]]"/>
        <LTLine y0="715.576" y1="715.576" x0="421.0" x1="497.0" width="76.0" height="0.0" bbox="[421.0, 715.576, 497.0, 715.576]" linewidth="0.5" pts="[[421.0, 715.576], [497.0, 715.576]]"/>
      </LTRect>
      <LTRect y0="715.576" y1="729.201" x0="497.0" x1="573.275" width="76.275" height="13.625" bbox="[497.0, 715.576, 573.275, 729.201]" linewidth="0.5" pts="[[497.0, 729.201], [573.275, 729.201], [573.275, 715.576], [497.0, 715.576]]">
        <LTTextLineHorizontal y0="717.701" y1="725.201" x0="500.995" x1="551.71" width="50.715" height="7.5" bbox="[500.995, 717.701, 551.71, 725.201]" word_margin="0.1"><LTTextBoxHorizontal y0="717.701" y1="725.201" x0="500.995" x1="551.71" width="50.715" height="7.5" bbox="[500.995, 717.701, 551.71, 725.201]" index="7">Cancer outcome </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="715.576" y1="715.576" x0="497.0" x1="573.2" width="76.2" height="0.0" bbox="[497.0, 715.576, 573.2, 715.576]" linewidth="0.5" pts="[[497.0, 715.576], [573.2, 715.576]]"/>
        <LTLine y0="715.576" y1="728.951" x0="573.275" x1="573.275" width="0.0" height="13.375" bbox="[573.275, 715.576, 573.275, 728.951]" linewidth="0.15" pts="[[573.275, 715.576], [573.275, 728.951]]"/>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 690.326, 101.0, 701.951]" linewidth="0.5" pts="[[42.0, 701.951], [101.0, 701.951], [101.0, 690.326], [42.0, 690.326]]">
        <LTLine y0="690.326" y1="701.951" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 690.326, 42.0, 701.951]" linewidth="0.15" pts="[[42.0, 690.326], [42.0, 701.951]]"/>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 690.326, 176.0, 701.951]" linewidth="0.5" pts="[[101.0, 701.951], [176.0, 701.951], [176.0, 690.326], [101.0, 690.326]]">
        <LTTextLineHorizontal y0="692.451" y1="699.951" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 692.451, 115.395, 699.951]" word_margin="0.1"><LTTextBoxHorizontal y0="692.451" y1="699.951" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 692.451, 115.395, 699.951]" index="12">35F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 690.326, 251.0, 701.951]" linewidth="0.5" pts="[[176.0, 701.951], [251.0, 701.951], [251.0, 690.326], [176.0, 690.326]]">
        <LTTextLineHorizontal y0="692.451" y1="699.951" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 692.451, 210.42, 699.951]" word_margin="0.1"><LTTextBoxHorizontal y0="692.451" y1="699.951" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 692.451, 210.42, 699.951]" index="26">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 690.326, 336.0, 701.951]" linewidth="0.5" pts="[[251.0, 701.951], [336.0, 701.951], [336.0, 690.326], [251.0, 690.326]]">
        <LTTextLineHorizontal y0="692.451" y1="699.951" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 692.451, 318.75, 699.951]" word_margin="0.1"><LTTextBoxHorizontal y0="692.451" y1="699.951" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 692.451, 318.75, 699.951]" index="33">Ipilimumab/nivolumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 690.326, 421.0, 701.951]" linewidth="0.5" pts="[[336.0, 701.951], [421.0, 701.951], [421.0, 690.326], [336.0, 690.326]]">
        <LTTextLineHorizontal y0="692.451" y1="699.951" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 692.451, 362.76, 699.951]" word_margin="0.1"><LTTextBoxHorizontal y0="692.451" y1="699.951" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 692.451, 362.76, 699.951]" index="45">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 690.326, 497.0, 701.951]" linewidth="0.5" pts="[[421.0, 701.951], [497.0, 701.951], [497.0, 690.326], [421.0, 690.326]]">
        <LTTextLineHorizontal y0="692.451" y1="699.951" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 692.451, 432.915, 699.951]" word_margin="0.1"><LTTextBoxHorizontal y0="692.451" y1="699.951" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 692.451, 432.915, 699.951]" index="68">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="690.326" y1="701.951" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 690.326, 573.275, 701.951]" linewidth="0.5" pts="[[497.0, 701.951], [573.275, 701.951], [573.275, 690.326], [497.0, 690.326]]">
        <LTTextLineHorizontal y0="692.451" y1="699.951" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 692.451, 508.912, 699.951]" word_margin="0.1"><LTTextBoxHorizontal y0="692.451" y1="699.951" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 692.451, 508.912, 699.951]" index="82">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="690.326" y1="701.951" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 690.326, 573.275, 701.951]" linewidth="0.15" pts="[[573.275, 690.326], [573.275, 701.951]]"/>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 667.076, 101.0, 678.701]" linewidth="0.5" pts="[[42.0, 678.701], [101.0, 678.701], [101.0, 667.076], [42.0, 667.076]]">
        <LTLine y0="667.076" y1="678.701" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 667.076, 42.0, 678.701]" linewidth="0.15" pts="[[42.0, 667.076], [42.0, 678.701]]"/>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 667.076, 176.0, 678.701]" linewidth="0.5" pts="[[101.0, 678.701], [176.0, 678.701], [176.0, 667.076], [101.0, 667.076]]">
        <LTTextLineHorizontal y0="669.201" y1="676.701" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 669.201, 115.395, 676.701]" word_margin="0.1"><LTTextBoxHorizontal y0="669.201" y1="676.701" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 669.201, 115.395, 676.701]" index="14">69F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 667.076, 251.0, 678.701]" linewidth="0.5" pts="[[176.0, 678.701], [251.0, 678.701], [251.0, 667.076], [176.0, 667.076]]">
        <LTTextLineHorizontal y0="669.201" y1="676.701" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 669.201, 210.42, 676.701]" word_margin="0.1"><LTTextBoxHorizontal y0="669.201" y1="676.701" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 669.201, 210.42, 676.701]" index="28">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 667.076, 336.0, 678.701]" linewidth="0.5" pts="[[251.0, 678.701], [336.0, 678.701], [336.0, 667.076], [251.0, 667.076]]">
        <LTTextLineHorizontal y0="669.201" y1="676.701" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 669.201, 318.75, 676.701]" word_margin="0.1"><LTTextBoxHorizontal y0="669.201" y1="676.701" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 669.201, 318.75, 676.701]" index="35">Ipilimumab/nivolumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 667.076, 421.0, 678.701]" linewidth="0.5" pts="[[336.0, 678.701], [421.0, 678.701], [421.0, 667.076], [336.0, 667.076]]">
        <LTTextLineHorizontal y0="669.201" y1="676.701" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 669.201, 362.76, 676.701]" word_margin="0.1"><LTTextBoxHorizontal y0="669.201" y1="676.701" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 669.201, 362.76, 676.701]" index="47">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 667.076, 497.0, 678.701]" linewidth="0.5" pts="[[421.0, 678.701], [497.0, 678.701], [497.0, 667.076], [421.0, 667.076]]">
        <LTTextLineHorizontal y0="669.201" y1="676.701" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 669.201, 432.915, 676.701]" word_margin="0.1"><LTTextBoxHorizontal y0="669.201" y1="676.701" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 669.201, 432.915, 676.701]" index="70">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="667.076" y1="678.701" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 667.076, 573.275, 678.701]" linewidth="0.5" pts="[[497.0, 678.701], [573.275, 678.701], [573.275, 667.076], [497.0, 667.076]]">
        <LTTextLineHorizontal y0="669.201" y1="676.701" x0="500.993" x1="508.905" width="7.913" height="7.5" bbox="[500.993, 669.201, 508.905, 676.701]" word_margin="0.1"><LTTextBoxHorizontal y0="669.201" y1="676.701" x0="500.993" x1="508.905" width="7.913" height="7.5" bbox="[500.993, 669.201, 508.905, 676.701]" index="84">PD </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="667.076" y1="678.701" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 667.076, 573.275, 678.701]" linewidth="0.15" pts="[[573.275, 667.076], [573.275, 678.701]]"/>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 643.826, 101.0, 655.451]" linewidth="0.5" pts="[[42.0, 655.451], [101.0, 655.451], [101.0, 643.826], [42.0, 643.826]]">
        <LTLine y0="643.826" y1="655.451" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 643.826, 42.0, 655.451]" linewidth="0.15" pts="[[42.0, 643.826], [42.0, 655.451]]"/>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 643.826, 176.0, 655.451]" linewidth="0.5" pts="[[101.0, 655.451], [176.0, 655.451], [176.0, 643.826], [101.0, 643.826]]">
        <LTTextLineHorizontal y0="645.951" y1="653.451" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 645.951, 115.395, 653.451]" word_margin="0.1"><LTTextBoxHorizontal y0="645.951" y1="653.451" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 645.951, 115.395, 653.451]" index="16">58F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 643.826, 251.0, 655.451]" linewidth="0.5" pts="[[176.0, 655.451], [251.0, 655.451], [251.0, 643.826], [176.0, 643.826]]">
        <LTTextLineHorizontal y0="645.951" y1="653.451" x0="180.0" x1="197.91" width="17.91" height="7.5" bbox="[180.0, 645.951, 197.91, 653.451]" word_margin="0.1"><LTTextBoxHorizontal y0="645.951" y1="653.451" x0="180.0" x1="197.91" width="17.91" height="7.5" bbox="[180.0, 645.951, 197.91, 653.451]" index="30">Breast </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 643.826, 336.0, 655.451]" linewidth="0.5" pts="[[251.0, 655.451], [336.0, 655.451], [336.0, 643.826], [251.0, 643.826]]">
        <LTTextLineHorizontal y0="645.951" y1="653.451" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 645.951, 298.875, 653.451]" word_margin="0.1"><LTTextBoxHorizontal y0="645.951" y1="653.451" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 645.951, 298.875, 653.451]" index="37">Pembrolizumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 643.826, 421.0, 655.451]" linewidth="0.5" pts="[[336.0, 655.451], [421.0, 655.451], [421.0, 643.826], [336.0, 643.826]]">
        <LTTextLineHorizontal y0="645.951" y1="653.451" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 645.951, 362.76, 653.451]" word_margin="0.1"><LTTextBoxHorizontal y0="645.951" y1="653.451" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 645.951, 362.76, 653.451]" index="49">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 643.826, 497.0, 655.451]" linewidth="0.5" pts="[[421.0, 655.451], [497.0, 655.451], [497.0, 643.826], [421.0, 643.826]]">
        <LTTextLineHorizontal y0="645.951" y1="653.451" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 645.951, 432.915, 653.451]" word_margin="0.1"><LTTextBoxHorizontal y0="645.951" y1="653.451" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 645.951, 432.915, 653.451]" index="72">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="643.826" y1="655.451" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 643.826, 573.275, 655.451]" linewidth="0.5" pts="[[497.0, 655.451], [573.275, 655.451], [573.275, 643.826], [497.0, 643.826]]">
        <LTTextLineHorizontal y0="645.951" y1="653.451" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 645.951, 508.912, 653.451]" word_margin="0.1"><LTTextBoxHorizontal y0="645.951" y1="653.451" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 645.951, 508.912, 653.451]" index="86">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="643.826" y1="655.451" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 643.826, 573.275, 655.451]" linewidth="0.15" pts="[[573.275, 643.826], [573.275, 655.451]]"/>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 597.326, 101.0, 608.951]" linewidth="0.5" pts="[[42.0, 608.951], [101.0, 608.951], [101.0, 597.326], [42.0, 597.326]]">
        <LTLine y0="597.326" y1="608.951" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 597.326, 42.0, 608.951]" linewidth="0.15" pts="[[42.0, 597.326], [42.0, 608.951]]"/>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 597.326, 176.0, 608.951]" linewidth="0.5" pts="[[101.0, 608.951], [176.0, 608.951], [176.0, 597.326], [101.0, 597.326]]">
        <LTTextLineHorizontal y0="599.451" y1="606.951" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 599.451, 118.035, 606.951]" word_margin="0.1"><LTTextBoxHorizontal y0="599.451" y1="606.951" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 599.451, 118.035, 606.951]" index="20">76M </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 597.326, 251.0, 608.951]" linewidth="0.5" pts="[[176.0, 608.951], [251.0, 608.951], [251.0, 597.326], [176.0, 597.326]]">
        <LTTextLineHorizontal y0="599.451" y1="606.951" x0="180.0" x1="201.795" width="21.795" height="7.5" bbox="[180.0, 599.451, 201.795, 606.951]" word_margin="0.1"><LTTextBoxHorizontal y0="599.451" y1="606.951" x0="180.0" x1="201.795" width="21.795" height="7.5" bbox="[180.0, 599.451, 201.795, 606.951]" index="62">Bladder </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 597.326, 336.0, 608.951]" linewidth="0.5" pts="[[251.0, 608.951], [336.0, 608.951], [336.0, 597.326], [251.0, 597.326]]">
        <LTTextLineHorizontal y0="599.451" y1="606.951" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 599.451, 298.875, 606.951]" word_margin="0.1"><LTTextBoxHorizontal y0="599.451" y1="606.951" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 599.451, 298.875, 606.951]" index="42">Pembrolizumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 597.326, 421.0, 608.951]" linewidth="0.5" pts="[[336.0, 608.951], [421.0, 608.951], [421.0, 597.326], [336.0, 597.326]]">
        <LTTextLineHorizontal y0="599.451" y1="606.951" x0="339.998" x1="395.025" width="55.027" height="7.5" bbox="[339.998, 599.451, 395.025, 606.951]" word_margin="0.1"><LTTextBoxHorizontal y0="599.451" y1="606.951" x0="339.998" x1="395.025" width="55.027" height="7.5" bbox="[339.998, 599.451, 395.025, 606.951]" index="53">Steroids+etoposide </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 597.326, 497.0, 608.951]" linewidth="0.5" pts="[[421.0, 608.951], [497.0, 608.951], [497.0, 597.326], [421.0, 597.326]]">
        <LTTextLineHorizontal y0="599.451" y1="606.951" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 599.451, 432.915, 606.951]" word_margin="0.1"><LTTextBoxHorizontal y0="599.451" y1="606.951" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 599.451, 432.915, 606.951]" index="76">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="597.326" y1="608.951" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 597.326, 573.275, 608.951]" linewidth="0.5" pts="[[497.0, 608.951], [573.275, 608.951], [573.275, 597.326], [497.0, 597.326]]">
        <LTTextLineHorizontal y0="599.451" y1="606.951" x0="500.993" x1="528.36" width="27.368" height="7.5" bbox="[500.993, 599.451, 528.36, 606.951]" word_margin="0.1"><LTTextBoxHorizontal y0="599.451" y1="606.951" x0="500.993" x1="528.36" width="27.368" height="7.5" bbox="[500.993, 599.451, 528.36, 606.951]" index="90">Unknown </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="597.326" y1="608.951" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 597.326, 573.275, 608.951]" linewidth="0.15" pts="[[573.275, 597.326], [573.275, 608.951]]"/>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 574.076, 101.0, 585.701]" linewidth="0.5" pts="[[42.0, 585.701], [101.0, 585.701], [101.0, 574.076], [42.0, 574.076]]">
        <LTLine y0="574.076" y1="585.701" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 574.076, 42.0, 585.701]" linewidth="0.15" pts="[[42.0, 574.076], [42.0, 585.701]]"/>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 574.076, 176.0, 585.701]" linewidth="0.5" pts="[[101.0, 585.701], [176.0, 585.701], [176.0, 574.076], [101.0, 574.076]]">
        <LTTextLineHorizontal y0="576.201" y1="583.701" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 576.201, 115.395, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 576.201, 115.395, 583.701]" index="22">26F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 574.076, 251.0, 585.701]" linewidth="0.5" pts="[[176.0, 585.701], [251.0, 585.701], [251.0, 574.076], [176.0, 574.076]]">
        <LTTextLineHorizontal y0="576.201" y1="583.701" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 576.201, 210.42, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 576.201, 210.42, 583.701]" index="64">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 574.076, 336.0, 585.701]" linewidth="0.5" pts="[[251.0, 585.701], [336.0, 585.701], [336.0, 574.076], [251.0, 574.076]]">
        <LTTextLineHorizontal y0="576.201" y1="583.701" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 576.201, 318.75, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 576.201, 318.75, 583.701]" index="55">Ipilimumab/nivolumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 574.076, 421.0, 585.701]" linewidth="0.5" pts="[[336.0, 585.701], [421.0, 585.701], [421.0, 574.076], [336.0, 574.076]]">
        <LTTextLineHorizontal y0="576.201" y1="583.701" x0="339.998" x1="382.125" width="42.127" height="7.5" bbox="[339.998, 576.201, 382.125, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="339.998" x1="382.125" width="42.127" height="7.5" bbox="[339.998, 576.201, 382.125, 583.701]" index="56">Steroids+MMF </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 574.076, 497.0, 585.701]" linewidth="0.5" pts="[[421.0, 585.701], [497.0, 585.701], [497.0, 574.076], [421.0, 574.076]]">
        <LTTextLineHorizontal y0="576.201" y1="583.701" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 576.201, 432.915, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 576.201, 432.915, 583.701]" index="78">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="574.076" y1="585.701" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 574.076, 573.275, 585.701]" linewidth="0.5" pts="[[497.0, 585.701], [573.275, 585.701], [573.275, 574.076], [497.0, 574.076]]">
        <LTTextLineHorizontal y0="576.201" y1="583.701" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 576.201, 508.912, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 576.201, 508.912, 583.701]" index="92">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="574.076" y1="585.701" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 574.076, 573.275, 585.701]" linewidth="0.15" pts="[[573.275, 574.076], [573.275, 585.701]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 550.826, 101.0, 562.451]" linewidth="0.5" pts="[[42.0, 562.451], [101.0, 562.451], [101.0, 550.826], [42.0, 550.826]]">
        <LTLine y0="550.826" y1="550.826" x0="42.075" x1="101.0" width="58.925" height="0.0" bbox="[42.075, 550.826, 101.0, 550.826]" linewidth="0.5" pts="[[42.075, 550.826], [101.0, 550.826]]"/>
        <LTLine y0="550.826" y1="562.451" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 550.826, 42.0, 562.451]" linewidth="0.15" pts="[[42.0, 550.826], [42.0, 562.451]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 550.826, 176.0, 562.451]" linewidth="0.5" pts="[[101.0, 562.451], [176.0, 562.451], [176.0, 550.826], [101.0, 550.826]]">
        <LTTextLineHorizontal y0="552.951" y1="560.451" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 552.951, 118.035, 560.451]" word_margin="0.1"><LTTextBoxHorizontal y0="552.951" y1="560.451" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 552.951, 118.035, 560.451]" index="24">78M </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="550.826" y1="550.826" x0="101.0" x1="176.0" width="75.0" height="0.0" bbox="[101.0, 550.826, 176.0, 550.826]" linewidth="0.5" pts="[[101.0, 550.826], [176.0, 550.826]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 550.826, 251.0, 562.451]" linewidth="0.5" pts="[[176.0, 562.451], [251.0, 562.451], [251.0, 550.826], [176.0, 550.826]]">
        <LTTextLineHorizontal y0="552.951" y1="560.451" x0="180.0" x1="199.028" width="19.028" height="7.5" bbox="[180.0, 552.951, 199.028, 560.451]" word_margin="0.1"><LTTextBoxHorizontal y0="552.951" y1="560.451" x0="180.0" x1="199.028" width="19.028" height="7.5" bbox="[180.0, 552.951, 199.028, 560.451]" index="66">NSCLC </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="550.826" y1="550.826" x0="176.0" x1="251.0" width="75.0" height="0.0" bbox="[176.0, 550.826, 251.0, 550.826]" linewidth="0.5" pts="[[176.0, 550.826], [251.0, 550.826]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 550.826, 336.0, 562.451]" linewidth="0.5" pts="[[251.0, 562.451], [336.0, 562.451], [336.0, 550.826], [251.0, 550.826]]">
        <LTTextLineHorizontal y0="552.951" y1="560.451" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 552.951, 298.875, 560.451]" word_margin="0.1"><LTTextBoxHorizontal y0="552.951" y1="560.451" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 552.951, 298.875, 560.451]" index="58">Pembrolizumab </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="550.826" y1="550.826" x0="251.0" x1="336.0" width="85.0" height="0.0" bbox="[251.0, 550.826, 336.0, 550.826]" linewidth="0.5" pts="[[251.0, 550.826], [336.0, 550.826]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 550.826, 421.0, 562.451]" linewidth="0.5" pts="[[336.0, 562.451], [421.0, 562.451], [421.0, 550.826], [336.0, 550.826]]">
        <LTTextLineHorizontal y0="552.951" y1="560.451" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 552.951, 362.76, 560.451]" word_margin="0.1"><LTTextBoxHorizontal y0="552.951" y1="560.451" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 552.951, 362.76, 560.451]" index="60">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="550.826" y1="550.826" x0="336.0" x1="421.0" width="85.0" height="0.0" bbox="[336.0, 550.826, 421.0, 550.826]" linewidth="0.5" pts="[[336.0, 550.826], [421.0, 550.826]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 550.826, 497.0, 562.451]" linewidth="0.5" pts="[[421.0, 562.451], [497.0, 562.451], [497.0, 550.826], [421.0, 550.826]]">
        <LTTextLineHorizontal y0="552.951" y1="560.451" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 552.951, 432.915, 560.451]" word_margin="0.1"><LTTextBoxHorizontal y0="552.951" y1="560.451" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 552.951, 432.915, 560.451]" index="80">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="550.826" y1="550.826" x0="421.0" x1="497.0" width="76.0" height="0.0" bbox="[421.0, 550.826, 497.0, 550.826]" linewidth="0.5" pts="[[421.0, 550.826], [497.0, 550.826]]"/>
      </LTRect>
      <LTRect y0="550.826" y1="562.451" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 550.826, 573.275, 562.451]" linewidth="0.5" pts="[[497.0, 562.451], [573.275, 562.451], [573.275, 550.826], [497.0, 550.826]]">
        <LTTextLineHorizontal y0="552.951" y1="560.451" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 552.951, 508.493, 560.451]" word_margin="0.1"><LTTextBoxHorizontal y0="552.951" y1="560.451" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 552.951, 508.493, 560.451]" index="94">PR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="550.826" y1="550.826" x0="497.0" x1="573.2" width="76.2" height="0.0" bbox="[497.0, 550.826, 573.2, 550.826]" linewidth="0.5" pts="[[497.0, 550.826], [573.2, 550.826]]"/>
        <LTLine y0="550.826" y1="562.451" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 550.826, 573.275, 562.451]" linewidth="0.15" pts="[[573.275, 550.826], [573.275, 562.451]]"/>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="42.0" x1="101.0" width="59.0" height="13.625" bbox="[42.0, 701.951, 101.0, 715.576]" linewidth="0.5" pts="[[42.0, 715.576], [101.0, 715.576], [101.0, 701.951], [42.0, 701.951]]">
        <LTLine y0="701.951" y1="715.576" x0="42.0" x1="42.0" width="0.0" height="13.625" bbox="[42.0, 701.951, 42.0, 715.576]" linewidth="0.15" pts="[[42.0, 701.951], [42.0, 715.576]]"/>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="101.0" x1="176.0" width="75.0" height="13.625" bbox="[101.0, 701.951, 176.0, 715.576]" linewidth="0.5" pts="[[101.0, 715.576], [176.0, 715.576], [176.0, 701.951], [101.0, 701.951]]">
        <LTTextLineHorizontal y0="704.076" y1="711.576" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 704.076, 118.035, 711.576]" word_margin="0.1"><LTTextBoxHorizontal y0="704.076" y1="711.576" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 704.076, 118.035, 711.576]" index="11">58M </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="176.0" x1="251.0" width="75.0" height="13.625" bbox="[176.0, 701.951, 251.0, 715.576]" linewidth="0.5" pts="[[176.0, 715.576], [251.0, 715.576], [251.0, 701.951], [176.0, 701.951]]">
        <LTTextLineHorizontal y0="704.076" y1="711.576" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 704.076, 210.42, 711.576]" word_margin="0.1"><LTTextBoxHorizontal y0="704.076" y1="711.576" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 704.076, 210.42, 711.576]" index="25">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="251.0" x1="336.0" width="85.0" height="13.625" bbox="[251.0, 701.951, 336.0, 715.576]" linewidth="0.5" pts="[[251.0, 715.576], [336.0, 715.576], [336.0, 701.951], [251.0, 701.951]]">
        <LTTextLineHorizontal y0="704.076" y1="711.576" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 704.076, 298.875, 711.576]" word_margin="0.1"><LTTextBoxHorizontal y0="704.076" y1="711.576" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 704.076, 298.875, 711.576]" index="32">Pembrolizumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="336.0" x1="421.0" width="85.0" height="13.625" bbox="[336.0, 701.951, 421.0, 715.576]" linewidth="0.5" pts="[[336.0, 715.576], [421.0, 715.576], [421.0, 701.951], [336.0, 701.951]]">
        <LTTextLineHorizontal y0="704.076" y1="711.576" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 704.076, 362.76, 711.576]" word_margin="0.1"><LTTextBoxHorizontal y0="704.076" y1="711.576" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 704.076, 362.76, 711.576]" index="44">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="421.0" x1="497.0" width="76.0" height="13.625" bbox="[421.0, 701.951, 497.0, 715.576]" linewidth="0.5" pts="[[421.0, 715.576], [497.0, 715.576], [497.0, 701.951], [421.0, 701.951]]">
        <LTTextLineHorizontal y0="704.076" y1="711.576" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 704.076, 432.915, 711.576]" word_margin="0.1"><LTTextBoxHorizontal y0="704.076" y1="711.576" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 704.076, 432.915, 711.576]" index="67">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="701.951" y1="715.576" x0="497.0" x1="573.275" width="76.275" height="13.625" bbox="[497.0, 701.951, 573.275, 715.576]" linewidth="0.5" pts="[[497.0, 715.576], [573.275, 715.576], [573.275, 701.951], [497.0, 701.951]]">
        <LTTextLineHorizontal y0="704.076" y1="711.576" x0="500.993" x1="508.905" width="7.913" height="7.5" bbox="[500.993, 704.076, 508.905, 711.576]" word_margin="0.1"><LTTextBoxHorizontal y0="704.076" y1="711.576" x0="500.993" x1="508.905" width="7.913" height="7.5" bbox="[500.993, 704.076, 508.905, 711.576]" index="81">PD </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="701.951" y1="715.576" x0="573.275" x1="573.275" width="0.0" height="13.625" bbox="[573.275, 701.951, 573.275, 715.576]" linewidth="0.15" pts="[[573.275, 701.951], [573.275, 715.576]]"/>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 678.701, 101.0, 690.326]" linewidth="0.5" pts="[[42.0, 690.326], [101.0, 690.326], [101.0, 678.701], [42.0, 678.701]]">
        <LTLine y0="678.701" y1="690.326" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 678.701, 42.0, 690.326]" linewidth="0.15" pts="[[42.0, 678.701], [42.0, 690.326]]"/>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 678.701, 176.0, 690.326]" linewidth="0.5" pts="[[101.0, 690.326], [176.0, 690.326], [176.0, 678.701], [101.0, 678.701]]">
        <LTTextLineHorizontal y0="680.826" y1="688.326" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 680.826, 115.395, 688.326]" word_margin="0.1"><LTTextBoxHorizontal y0="680.826" y1="688.326" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 680.826, 115.395, 688.326]" index="13">69F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 678.701, 251.0, 690.326]" linewidth="0.5" pts="[[176.0, 690.326], [251.0, 690.326], [251.0, 678.701], [176.0, 678.701]]">
        <LTTextLineHorizontal y0="680.826" y1="688.326" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 680.826, 210.42, 688.326]" word_margin="0.1"><LTTextBoxHorizontal y0="680.826" y1="688.326" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 680.826, 210.42, 688.326]" index="27">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 678.701, 336.0, 690.326]" linewidth="0.5" pts="[[251.0, 690.326], [336.0, 690.326], [336.0, 678.701], [251.0, 678.701]]">
        <LTTextLineHorizontal y0="680.826" y1="688.326" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 680.826, 318.75, 688.326]" word_margin="0.1"><LTTextBoxHorizontal y0="680.826" y1="688.326" x0="255.0" x1="318.75" width="63.75" height="7.5" bbox="[255.0, 680.826, 318.75, 688.326]" index="34">Ipilimumab/nivolumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 678.701, 421.0, 690.326]" linewidth="0.5" pts="[[336.0, 690.326], [421.0, 690.326], [421.0, 678.701], [336.0, 678.701]]">
        <LTTextLineHorizontal y0="680.826" y1="688.326" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 680.826, 362.76, 688.326]" word_margin="0.1"><LTTextBoxHorizontal y0="680.826" y1="688.326" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 680.826, 362.76, 688.326]" index="46">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 678.701, 497.0, 690.326]" linewidth="0.5" pts="[[421.0, 690.326], [497.0, 690.326], [497.0, 678.701], [421.0, 678.701]]">
        <LTTextLineHorizontal y0="680.826" y1="688.326" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 680.826, 432.915, 688.326]" word_margin="0.1"><LTTextBoxHorizontal y0="680.826" y1="688.326" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 680.826, 432.915, 688.326]" index="69">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="678.701" y1="690.326" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 678.701, 573.275, 690.326]" linewidth="0.5" pts="[[497.0, 690.326], [573.275, 690.326], [573.275, 678.701], [497.0, 678.701]]">
        <LTTextLineHorizontal y0="680.826" y1="688.326" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 680.826, 508.493, 688.326]" word_margin="0.1"><LTTextBoxHorizontal y0="680.826" y1="688.326" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 680.826, 508.493, 688.326]" index="83">PR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="678.701" y1="690.326" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 678.701, 573.275, 690.326]" linewidth="0.15" pts="[[573.275, 678.701], [573.275, 690.326]]"/>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 655.451, 101.0, 667.076]" linewidth="0.5" pts="[[42.0, 667.076], [101.0, 667.076], [101.0, 655.451], [42.0, 655.451]]">
        <LTLine y0="655.451" y1="667.076" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 655.451, 42.0, 667.076]" linewidth="0.15" pts="[[42.0, 655.451], [42.0, 667.076]]"/>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 655.451, 176.0, 667.076]" linewidth="0.5" pts="[[101.0, 667.076], [176.0, 667.076], [176.0, 655.451], [101.0, 655.451]]">
        <LTTextLineHorizontal y0="657.576" y1="665.076" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 657.576, 118.035, 665.076]" word_margin="0.1"><LTTextBoxHorizontal y0="657.576" y1="665.076" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 657.576, 118.035, 665.076]" index="15">61M </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 655.451, 251.0, 667.076]" linewidth="0.5" pts="[[176.0, 667.076], [251.0, 667.076], [251.0, 655.451], [176.0, 655.451]]">
        <LTTextLineHorizontal y0="657.576" y1="665.076" x0="180.0" x1="200.28" width="20.28" height="7.5" bbox="[180.0, 657.576, 200.28, 665.076]" word_margin="0.1"><LTTextBoxHorizontal y0="657.576" y1="665.076" x0="180.0" x1="200.28" width="20.28" height="7.5" bbox="[180.0, 657.576, 200.28, 665.076]" index="29">HNSCC </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 655.451, 336.0, 667.076]" linewidth="0.5" pts="[[251.0, 667.076], [336.0, 667.076], [336.0, 655.451], [251.0, 655.451]]">
        <LTTextLineHorizontal y0="657.576" y1="665.076" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 657.576, 298.875, 665.076]" word_margin="0.1"><LTTextBoxHorizontal y0="657.576" y1="665.076" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 657.576, 298.875, 665.076]" index="36">Pembrolizumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 655.451, 421.0, 667.076]" linewidth="0.5" pts="[[336.0, 667.076], [421.0, 667.076], [421.0, 655.451], [336.0, 655.451]]">
        <LTTextLineHorizontal y0="657.576" y1="665.076" x0="339.998" x1="395.025" width="55.027" height="7.5" bbox="[339.998, 657.576, 395.025, 665.076]" word_margin="0.1"><LTTextBoxHorizontal y0="657.576" y1="665.076" x0="339.998" x1="395.025" width="55.027" height="7.5" bbox="[339.998, 657.576, 395.025, 665.076]" index="48">Steroids+etoposide </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 655.451, 497.0, 667.076]" linewidth="0.5" pts="[[421.0, 667.076], [497.0, 667.076], [497.0, 655.451], [421.0, 655.451]]">
        <LTTextLineHorizontal y0="657.576" y1="665.076" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 657.576, 432.915, 665.076]" word_margin="0.1"><LTTextBoxHorizontal y0="657.576" y1="665.076" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 657.576, 432.915, 665.076]" index="71">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="655.451" y1="667.076" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 655.451, 573.275, 667.076]" linewidth="0.5" pts="[[497.0, 667.076], [573.275, 667.076], [573.275, 655.451], [497.0, 655.451]]">
        <LTTextLineHorizontal y0="657.576" y1="665.076" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 657.576, 508.493, 665.076]" word_margin="0.1"><LTTextBoxHorizontal y0="657.576" y1="665.076" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 657.576, 508.493, 665.076]" index="85">PR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="655.451" y1="667.076" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 655.451, 573.275, 667.076]" linewidth="0.15" pts="[[573.275, 655.451], [573.275, 667.076]]"/>
      </LTRect>
      <LTRect y0="608.951" y1="643.826" x0="42.0" x1="101.0" width="59.0" height="34.875" bbox="[42.0, 608.951, 101.0, 643.826]" linewidth="0.5" pts="[[42.0, 643.826], [101.0, 643.826], [101.0, 608.951], [42.0, 608.951]]">
        <LTLine y0="632.201" y1="643.826" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 632.201, 42.0, 643.826]" linewidth="0.15" pts="[[42.0, 632.201], [42.0, 643.826]]"/>
        <LTLine y0="620.576" y1="632.201" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 620.576, 42.0, 632.201]" linewidth="0.15" pts="[[42.0, 620.576], [42.0, 632.201]]"/>
        <LTLine y0="608.951" y1="620.576" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 608.951, 42.0, 620.576]" linewidth="0.15" pts="[[42.0, 608.951], [42.0, 620.576]]"/>
      </LTRect>
      <LTRect y0="632.201" y1="643.826" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 632.201, 176.0, 643.826]" linewidth="0.5" pts="[[101.0, 643.826], [176.0, 643.826], [176.0, 632.201], [101.0, 632.201]]">
        <LTTextLineHorizontal y0="634.326" y1="641.826" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 634.326, 118.035, 641.826]" word_margin="0.1"><LTTextBoxHorizontal y0="634.326" y1="641.826" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 634.326, 118.035, 641.826]" index="17">42M </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="632.201" y1="643.826" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 632.201, 251.0, 643.826]" linewidth="0.5" pts="[[176.0, 643.826], [251.0, 643.826], [251.0, 632.201], [176.0, 632.201]]">
        <LTTextLineHorizontal y0="634.326" y1="641.826" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 634.326, 210.42, 641.826]" word_margin="0.1"><LTTextBoxHorizontal y0="634.326" y1="641.826" x0="180.0" x1="210.42" width="30.42" height="7.5" bbox="[180.0, 634.326, 210.42, 641.826]" index="31">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="632.201" y1="643.826" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 632.201, 336.0, 643.826]" linewidth="0.5" pts="[[251.0, 643.826], [336.0, 643.826], [336.0, 632.201], [251.0, 632.201]]">
        <LTTextLineHorizontal y0="634.326" y1="641.826" x0="255.0" x1="286.942" width="31.942" height="7.5" bbox="[255.0, 634.326, 286.942, 641.826]" word_margin="0.1"><LTTextBoxHorizontal y0="634.326" y1="641.826" x0="255.0" x1="286.942" width="31.942" height="7.5" bbox="[255.0, 634.326, 286.942, 641.826]" index="38">Ipilimumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="632.201" y1="643.826" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 632.201, 421.0, 643.826]" linewidth="0.5" pts="[[336.0, 643.826], [421.0, 643.826], [421.0, 632.201], [336.0, 632.201]]">
        <LTTextLineHorizontal y0="634.326" y1="641.826" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 634.326, 362.76, 641.826]" word_margin="0.1"><LTTextBoxHorizontal y0="634.326" y1="641.826" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 634.326, 362.76, 641.826]" index="50">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="632.201" y1="643.826" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 632.201, 497.0, 643.826]" linewidth="0.5" pts="[[421.0, 643.826], [497.0, 643.826], [497.0, 632.201], [421.0, 632.201]]">
        <LTTextLineHorizontal y0="634.326" y1="641.826" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 634.326, 432.915, 641.826]" word_margin="0.1"><LTTextBoxHorizontal y0="634.326" y1="641.826" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 634.326, 432.915, 641.826]" index="73">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="632.201" y1="643.826" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 632.201, 573.275, 643.826]" linewidth="0.5" pts="[[497.0, 643.826], [573.275, 643.826], [573.275, 632.201], [497.0, 632.201]]">
        <LTTextLineHorizontal y0="634.326" y1="641.826" x0="500.993" x1="528.36" width="27.368" height="7.5" bbox="[500.993, 634.326, 528.36, 641.826]" word_margin="0.1"><LTTextBoxHorizontal y0="634.326" y1="641.826" x0="500.993" x1="528.36" width="27.368" height="7.5" bbox="[500.993, 634.326, 528.36, 641.826]" index="87">Unknown </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="632.201" y1="643.826" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 632.201, 573.275, 643.826]" linewidth="0.15" pts="[[573.275, 632.201], [573.275, 643.826]]"/>
      </LTRect>
      <LTRect y0="620.576" y1="632.201" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 620.576, 176.0, 632.201]" linewidth="0.5" pts="[[101.0, 632.201], [176.0, 632.201], [176.0, 620.576], [101.0, 620.576]]">
        <LTTextLineHorizontal y0="622.701" y1="630.201" x0="104.993" x1="115.388" width="10.395" height="7.5" bbox="[104.993, 622.701, 115.388, 630.201]" word_margin="0.1"><LTTextBoxHorizontal y0="622.701" y1="630.201" x0="104.993" x1="115.388" width="10.395" height="7.5" bbox="[104.993, 622.701, 115.388, 630.201]" index="18">81F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="620.576" y1="632.201" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 620.576, 251.0, 632.201]" linewidth="0.5" pts="[[176.0, 632.201], [251.0, 632.201], [251.0, 620.576], [176.0, 620.576]]">
        <LTTextLineHorizontal y0="622.701" y1="630.201" x0="179.993" x1="241.913" width="61.92" height="7.5" bbox="[179.993, 622.701, 241.913, 630.201]" word_margin="0.1"><LTTextBoxHorizontal y0="622.701" y1="630.201" x0="179.993" x1="241.913" width="61.92" height="7.5" bbox="[179.993, 622.701, 241.913, 630.201]" index="39">Merkel cell carcinoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="620.576" y1="632.201" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 620.576, 336.0, 632.201]" linewidth="0.5" pts="[[251.0, 632.201], [336.0, 632.201], [336.0, 620.576], [251.0, 620.576]]">
        <LTTextLineHorizontal y0="622.701" y1="630.201" x0="254.993" x1="283.598" width="28.605" height="7.5" bbox="[254.993, 622.701, 283.598, 630.201]" word_margin="0.1"><LTTextBoxHorizontal y0="622.701" y1="630.201" x0="254.993" x1="283.598" width="28.605" height="7.5" bbox="[254.993, 622.701, 283.598, 630.201]" index="40">Avelumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="620.576" y1="632.201" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 620.576, 421.0, 632.201]" linewidth="0.5" pts="[[336.0, 632.201], [421.0, 632.201], [421.0, 620.576], [336.0, 620.576]]">
        <LTTextLineHorizontal y0="622.701" y1="630.201" x0="339.99" x1="362.752" width="22.762" height="7.5" bbox="[339.99, 622.701, 362.752, 630.201]" word_margin="0.1"><LTTextBoxHorizontal y0="622.701" y1="630.201" x0="339.99" x1="362.752" width="22.762" height="7.5" bbox="[339.99, 622.701, 362.752, 630.201]" index="51">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="620.576" y1="632.201" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 620.576, 497.0, 632.201]" linewidth="0.5" pts="[[421.0, 632.201], [497.0, 632.201], [497.0, 620.576], [421.0, 620.576]]">
        <LTTextLineHorizontal y0="622.701" y1="630.201" x0="424.988" x1="434.303" width="9.315" height="7.5" bbox="[424.988, 622.701, 434.303, 630.201]" word_margin="0.1"><LTTextBoxHorizontal y0="622.701" y1="630.201" x0="424.988" x1="434.303" width="9.315" height="7.5" bbox="[424.988, 622.701, 434.303, 630.201]" index="74">RIP </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="620.576" y1="632.201" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 620.576, 573.275, 632.201]" linewidth="0.5" pts="[[497.0, 632.201], [573.275, 632.201], [573.275, 620.576], [497.0, 620.576]]">
        <LTTextLineHorizontal y0="622.701" y1="630.201" x0="500.985" x1="510.3" width="9.315" height="7.5" bbox="[500.985, 622.701, 510.3, 630.201]" word_margin="0.1"><LTTextBoxHorizontal y0="622.701" y1="630.201" x0="500.985" x1="510.3" width="9.315" height="7.5" bbox="[500.985, 622.701, 510.3, 630.201]" index="88">RIP </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="620.576" y1="632.201" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 620.576, 573.275, 632.201]" linewidth="0.15" pts="[[573.275, 620.576], [573.275, 632.201]]"/>
      </LTRect>
      <LTRect y0="608.951" y1="620.576" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 608.951, 176.0, 620.576]" linewidth="0.5" pts="[[101.0, 620.576], [176.0, 620.576], [176.0, 608.951], [101.0, 608.951]]">
        <LTTextLineHorizontal y0="611.076" y1="618.576" x0="104.985" x1="118.02" width="13.035" height="7.5" bbox="[104.985, 611.076, 118.02, 618.576]" word_margin="0.1"><LTTextBoxHorizontal y0="611.076" y1="618.576" x0="104.985" x1="118.02" width="13.035" height="7.5" bbox="[104.985, 611.076, 118.02, 618.576]" index="19">77M </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="608.951" y1="620.576" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 608.951, 251.0, 620.576]" linewidth="0.5" pts="[[176.0, 620.576], [251.0, 620.576], [251.0, 608.951], [176.0, 608.951]]">
        <LTTextLineHorizontal y0="611.076" y1="618.576" x0="179.985" x1="210.405" width="30.42" height="7.5" bbox="[179.985, 611.076, 210.405, 618.576]" word_margin="0.1"><LTTextBoxHorizontal y0="611.076" y1="618.576" x0="179.985" x1="210.405" width="30.42" height="7.5" bbox="[179.985, 611.076, 210.405, 618.576]" index="61">Melanoma </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="608.951" y1="620.576" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 608.951, 336.0, 620.576]" linewidth="0.5" pts="[[251.0, 620.576], [336.0, 620.576], [336.0, 608.951], [251.0, 608.951]]">
        <LTTextLineHorizontal y0="611.076" y1="618.576" x0="254.985" x1="285.825" width="30.84" height="7.5" bbox="[254.985, 611.076, 285.825, 618.576]" word_margin="0.1"><LTTextBoxHorizontal y0="611.076" y1="618.576" x0="254.985" x1="285.825" width="30.84" height="7.5" bbox="[254.985, 611.076, 285.825, 618.576]" index="41">Nivolumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="608.951" y1="620.576" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 608.951, 421.0, 620.576]" linewidth="0.5" pts="[[336.0, 620.576], [421.0, 620.576], [421.0, 608.951], [336.0, 608.951]]">
        <LTTextLineHorizontal y0="611.076" y1="618.576" x0="339.983" x1="362.745" width="22.762" height="7.5" bbox="[339.983, 611.076, 362.745, 618.576]" word_margin="0.1"><LTTextBoxHorizontal y0="611.076" y1="618.576" x0="339.983" x1="362.745" width="22.762" height="7.5" bbox="[339.983, 611.076, 362.745, 618.576]" index="52">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="608.951" y1="620.576" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 608.951, 497.0, 620.576]" linewidth="0.5" pts="[[421.0, 620.576], [497.0, 620.576], [497.0, 608.951], [421.0, 608.951]]">
        <LTTextLineHorizontal y0="611.076" y1="618.576" x0="424.98" x1="434.295" width="9.315" height="7.5" bbox="[424.98, 611.076, 434.295, 618.576]" word_margin="0.1"><LTTextBoxHorizontal y0="611.076" y1="618.576" x0="424.98" x1="434.295" width="9.315" height="7.5" bbox="[424.98, 611.076, 434.295, 618.576]" index="75">RIP </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="608.951" y1="620.576" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 608.951, 573.275, 620.576]" linewidth="0.5" pts="[[497.0, 620.576], [573.275, 620.576], [573.275, 608.951], [497.0, 608.951]]">
        <LTTextLineHorizontal y0="611.076" y1="618.576" x0="500.978" x1="510.293" width="9.315" height="7.5" bbox="[500.978, 611.076, 510.293, 618.576]" word_margin="0.1"><LTTextBoxHorizontal y0="611.076" y1="618.576" x0="500.978" x1="510.293" width="9.315" height="7.5" bbox="[500.978, 611.076, 510.293, 618.576]" index="89">RIP </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="608.951" y1="620.576" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 608.951, 573.275, 620.576]" linewidth="0.15" pts="[[573.275, 608.951], [573.275, 620.576]]"/>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 585.701, 101.0, 597.326]" linewidth="0.5" pts="[[42.0, 597.326], [101.0, 597.326], [101.0, 585.701], [42.0, 585.701]]">
        <LTLine y0="585.701" y1="597.326" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 585.701, 42.0, 597.326]" linewidth="0.15" pts="[[42.0, 585.701], [42.0, 597.326]]"/>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 585.701, 176.0, 597.326]" linewidth="0.5" pts="[[101.0, 597.326], [176.0, 597.326], [176.0, 585.701], [101.0, 585.701]]">
        <LTTextLineHorizontal y0="587.826" y1="595.326" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 587.826, 115.395, 595.326]" word_margin="0.1"><LTTextBoxHorizontal y0="587.826" y1="595.326" x0="105.0" x1="115.395" width="10.395" height="7.5" bbox="[105.0, 587.826, 115.395, 595.326]" index="21">63F </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 585.701, 251.0, 597.326]" linewidth="0.5" pts="[[176.0, 597.326], [251.0, 597.326], [251.0, 585.701], [176.0, 585.701]]">
        <LTTextLineHorizontal y0="587.826" y1="595.326" x0="180.0" x1="199.028" width="19.028" height="7.5" bbox="[180.0, 587.826, 199.028, 595.326]" word_margin="0.1"><LTTextBoxHorizontal y0="587.826" y1="595.326" x0="180.0" x1="199.028" width="19.028" height="7.5" bbox="[180.0, 587.826, 199.028, 595.326]" index="63">NSCLC </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 585.701, 336.0, 597.326]" linewidth="0.5" pts="[[251.0, 597.326], [336.0, 597.326], [336.0, 585.701], [251.0, 585.701]]">
        <LTTextLineHorizontal y0="587.826" y1="595.326" x0="255.0" x1="285.84" width="30.84" height="7.5" bbox="[255.0, 587.826, 285.84, 595.326]" word_margin="0.1"><LTTextBoxHorizontal y0="587.826" y1="595.326" x0="255.0" x1="285.84" width="30.84" height="7.5" bbox="[255.0, 587.826, 285.84, 595.326]" index="43">Nivolumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 585.701, 421.0, 597.326]" linewidth="0.5" pts="[[336.0, 597.326], [421.0, 597.326], [421.0, 585.701], [336.0, 585.701]]">
        <LTTextLineHorizontal y0="587.826" y1="595.326" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 587.826, 362.76, 595.326]" word_margin="0.1"><LTTextBoxHorizontal y0="587.826" y1="595.326" x0="339.998" x1="362.76" width="22.762" height="7.5" bbox="[339.998, 587.826, 362.76, 595.326]" index="54">Steroids </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 585.701, 497.0, 597.326]" linewidth="0.5" pts="[[421.0, 597.326], [497.0, 597.326], [497.0, 585.701], [421.0, 585.701]]">
        <LTTextLineHorizontal y0="587.826" y1="595.326" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 587.826, 432.915, 595.326]" word_margin="0.1"><LTTextBoxHorizontal y0="587.826" y1="595.326" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 587.826, 432.915, 595.326]" index="77">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="585.701" y1="597.326" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 585.701, 573.275, 597.326]" linewidth="0.5" pts="[[497.0, 597.326], [573.275, 597.326], [573.275, 585.701], [497.0, 585.701]]">
        <LTTextLineHorizontal y0="587.826" y1="595.326" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 587.826, 508.493, 595.326]" word_margin="0.1"><LTTextBoxHorizontal y0="587.826" y1="595.326" x0="500.993" x1="508.493" width="7.5" height="7.5" bbox="[500.993, 587.826, 508.493, 595.326]" index="91">PR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="585.701" y1="597.326" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 585.701, 573.275, 597.326]" linewidth="0.15" pts="[[573.275, 585.701], [573.275, 597.326]]"/>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="42.0" x1="101.0" width="59.0" height="11.625" bbox="[42.0, 562.451, 101.0, 574.076]" linewidth="0.5" pts="[[42.0, 574.076], [101.0, 574.076], [101.0, 562.451], [42.0, 562.451]]">
        <LTLine y0="562.451" y1="574.076" x0="42.0" x1="42.0" width="0.0" height="11.625" bbox="[42.0, 562.451, 42.0, 574.076]" linewidth="0.15" pts="[[42.0, 562.451], [42.0, 574.076]]"/>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="101.0" x1="176.0" width="75.0" height="11.625" bbox="[101.0, 562.451, 176.0, 574.076]" linewidth="0.5" pts="[[101.0, 574.076], [176.0, 574.076], [176.0, 562.451], [101.0, 562.451]]">
        <LTTextLineHorizontal y0="564.576" y1="572.076" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 564.576, 118.035, 572.076]" word_margin="0.1"><LTTextBoxHorizontal y0="564.576" y1="572.076" x0="105.0" x1="118.035" width="13.035" height="7.5" bbox="[105.0, 564.576, 118.035, 572.076]" index="23">68M </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="176.0" x1="251.0" width="75.0" height="11.625" bbox="[176.0, 562.451, 251.0, 574.076]" linewidth="0.5" pts="[[176.0, 574.076], [251.0, 574.076], [251.0, 562.451], [176.0, 562.451]]">
        <LTTextLineHorizontal y0="564.576" y1="572.076" x0="180.0" x1="203.46" width="23.46" height="7.5" bbox="[180.0, 564.576, 203.46, 572.076]" word_margin="0.1"><LTTextBoxHorizontal y0="564.576" y1="572.076" x0="180.0" x1="203.46" width="23.46" height="7.5" bbox="[180.0, 564.576, 203.46, 572.076]" index="65">Prostate </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="251.0" x1="336.0" width="85.0" height="11.625" bbox="[251.0, 562.451, 336.0, 574.076]" linewidth="0.5" pts="[[251.0, 574.076], [336.0, 574.076], [336.0, 562.451], [251.0, 562.451]]">
        <LTTextLineHorizontal y0="564.576" y1="572.076" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 564.576, 298.875, 572.076]" word_margin="0.1"><LTTextBoxHorizontal y0="564.576" y1="572.076" x0="255.0" x1="298.875" width="43.875" height="7.5" bbox="[255.0, 564.576, 298.875, 572.076]" index="57">Pembrolizumab </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="336.0" x1="421.0" width="85.0" height="11.625" bbox="[336.0, 562.451, 421.0, 574.076]" linewidth="0.5" pts="[[336.0, 574.076], [421.0, 574.076], [421.0, 562.451], [336.0, 562.451]]">
        <LTTextLineHorizontal y0="564.576" y1="572.076" x0="339.998" x1="410.985" width="70.988" height="7.5" bbox="[339.998, 564.576, 410.985, 572.076]" word_margin="0.1"><LTTextBoxHorizontal y0="564.576" y1="572.076" x0="339.998" x1="410.985" width="70.988" height="7.5" bbox="[339.998, 564.576, 410.985, 572.076]" index="59">Steroids+plasmapheresis </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="421.0" x1="497.0" width="76.0" height="11.625" bbox="[421.0, 562.451, 497.0, 574.076]" linewidth="0.5" pts="[[421.0, 574.076], [497.0, 574.076], [497.0, 562.451], [421.0, 562.451]]">
        <LTTextLineHorizontal y0="564.576" y1="572.076" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 564.576, 432.915, 572.076]" word_margin="0.1"><LTTextBoxHorizontal y0="564.576" y1="572.076" x0="424.995" x1="432.915" width="7.92" height="7.5" bbox="[424.995, 564.576, 432.915, 572.076]" index="79">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
      </LTRect>
      <LTRect y0="562.451" y1="574.076" x0="497.0" x1="573.275" width="76.275" height="11.625" bbox="[497.0, 562.451, 573.275, 574.076]" linewidth="0.5" pts="[[497.0, 574.076], [573.275, 574.076], [573.275, 562.451], [497.0, 562.451]]">
        <LTTextLineHorizontal y0="564.576" y1="572.076" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 564.576, 508.912, 572.076]" word_margin="0.1"><LTTextBoxHorizontal y0="564.576" y1="572.076" x0="500.993" x1="508.912" width="7.92" height="7.5" bbox="[500.993, 564.576, 508.912, 572.076]" index="93">CR </LTTextBoxHorizontal></LTTextLineHorizontal>
        <LTLine y0="562.451" y1="574.076" x0="573.275" x1="573.275" width="0.0" height="11.625" bbox="[573.275, 562.451, 573.275, 574.076]" linewidth="0.15" pts="[[573.275, 562.451], [573.275, 574.076]]"/>
      </LTRect>
      <LTRect y0="532.076" y1="550.826" x0="42.0" x1="573.275" width="531.275" height="18.75" bbox="[42.0, 532.076, 573.275, 550.826]" linewidth="0.5" pts="[[42.0, 550.826], [573.275, 550.826], [573.275, 532.076], [42.0, 532.076]]">
        <LTLine y0="532.076" y1="550.826" x0="42.0" x1="42.0" width="0.0" height="18.75" bbox="[42.0, 532.076, 42.0, 550.826]" linewidth="0.15" pts="[[42.0, 532.076], [42.0, 550.826]]"/>
        <LTLine y0="532.076" y1="550.826" x0="573.275" x1="573.275" width="0.0" height="18.75" bbox="[573.275, 532.076, 573.275, 550.826]" linewidth="0.15" pts="[[573.275, 532.076], [573.275, 550.826]]"/>
        <LTLine y0="532.076" y1="532.076" x0="46.0" x1="573.275" width="527.275" height="0.0" bbox="[46.0, 532.076, 573.275, 532.076]" linewidth="1" pts="[[46.0, 532.076], [573.275, 532.076]]"/>
      </LTRect>
    </LTRect>
    <LTLine y0="729.201" y1="729.201" x0="41.925" x1="101.0" width="59.075" height="0.0" bbox="[41.925, 729.201, 101.0, 729.201]" linewidth="0.5" pts="[[41.925, 729.201], [101.0, 729.201]]"/>
    <LTLine y0="729.201" y1="729.201" x0="497.0" x1="573.35" width="76.35" height="0.0" bbox="[497.0, 729.201, 573.35, 729.201]" linewidth="0.5" pts="[[497.0, 729.201], [573.35, 729.201]]"/>
    <LTTextLineHorizontal y0="474.441" y1="483.441" x0="315.69" x1="318.192" width="2.502" height="9.0" bbox="[315.69, 474.441, 318.192, 483.441]" word_margin="0.1"> </LTTextLineHorizontal>
  </LTPage>
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="6" rotate="0" page_index="5" page_label="">
    <LTTextLineHorizontal y0="738.201" y1="745.701" x0="42.0" x1="290.355" width="248.355" height="7.5" bbox="[42.0, 738.201, 290.355, 745.701]" word_margin="0.1"><LTTextBoxHorizontal y0="738.201" y1="745.701" x0="42.0" x1="290.355" width="248.355" height="7.5" bbox="[42.0, 738.201, 290.355, 745.701]" index="1"> 4 Hejblum G, Lambotte O, Galicier L, et al. A web- based Delphi study for eliciting helpful </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="738.201" y1="745.701" x0="306.69" x1="544.447" width="237.757" height="7.5" bbox="[306.69, 738.201, 544.447, 745.701]" word_margin="0.1">12 Al- Samkari H, Snyder GD, Nikiforow S, et al. Haemophagocytic lymphohistiocytosis <LTTextBoxHorizontal y0="738.201" y1="745.701" x0="306.69" x1="544.447" width="237.757" height="7.5" bbox="[306.69, 738.201, 544.447, 745.701]" index="2">12Al- Samkari H, Snyder GD, Nikiforow S, et al. Haemophagocytic lymphohistiocytosis <LTTextLineHorizontal y0="738.201" y1="745.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 738.201, 308.49, 745.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="720.201" y1="736.701" x0="54.6" x1="286.155" width="231.555" height="16.5" bbox="[54.6, 720.201, 286.155, 736.701]" index="3"><LTTextLineHorizontal y0="729.201" y1="736.701" x0="54.6" x1="286.155" width="231.555" height="7.5" bbox="[54.6, 729.201, 286.155, 736.701]" word_margin="0.1">criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS <Annot A="&lt;PDFObjRef:114&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[271.286, 737.968, 286.151, 729.201]" x0="271.286" x1="286.151" y0="737.968" y1="729.201" height="-8.766999999999939" width="14.865000000000009" URI="http://dx.doi.org/10.1371/journal.pone.0094024"/></LTTextLineHorizontal><LTTextLineHorizontal y0="720.201" y1="727.701" x0="54.6" x1="112.118" width="57.518" height="7.5" bbox="[54.6, 720.201, 112.118, 727.701]" word_margin="0.1">One 2014;9:e94024. <Annot A="&lt;PDFObjRef:115&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[54.6, 728.968, 65.7224, 720.201]" x0="54.6" x1="65.7224" y0="728.968" y1="720.201" height="-8.766999999999939" width="11.122399999999992" URI="http://dx.doi.org/10.1371/journal.pone.0094024"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="720.201" y1="736.701" x0="319.29" x1="552.067" width="232.777" height="16.5" bbox="[319.29, 720.201, 552.067, 736.701]" index="4"><LTTextLineHorizontal y0="729.201" y1="736.701" x0="319.29" x1="552.067" width="232.777" height="7.5" bbox="[319.29, 729.201, 552.067, 736.701]" word_margin="0.1">complicating pembrolizumab treatment for metastatic breast cancer in a patient with </LTTextLineHorizontal><LTTextLineHorizontal y0="720.201" y1="727.701" x0="319.29" x1="498.713" width="179.423" height="7.5" bbox="[319.29, 720.201, 498.713, 727.701]" word_margin="0.1">the PRF1A91V gene polymorphism. J Med Genet 2019;56:39&#8211;42. <Annot A="&lt;PDFObjRef:123&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[417.462, 728.968, 451.759, 720.201]" x0="417.462" x1="451.759" y0="728.968" y1="720.201" height="-8.766999999999939" width="34.297000000000025" URI="http://dx.doi.org/10.1136/jmedgenet-2018-105485"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="693.201" y1="718.701" x0="42.0" x1="265.297" width="223.297" height="25.5" bbox="[42.0, 693.201, 265.297, 718.701]" index="5"><LTTextLineHorizontal y0="711.201" y1="718.701" x0="42.0" x1="265.297" width="223.297" height="7.5" bbox="[42.0, 711.201, 265.297, 718.701]" word_margin="0.1"> 5 Henter J- I, Samuelsson- Horne A, Aric&#242; M, et al. Treatment of hemophagocytic </LTTextLineHorizontal><LTTextLineHorizontal y0="702.201" y1="709.701" x0="54.6" x1="257.835" width="203.235" height="7.5" bbox="[54.6, 702.201, 257.835, 709.701]" word_margin="0.1">lymphohistiocytosis with HLH- 94 immunochemotherapy and bone marrow </LTTextLineHorizontal><LTTextLineHorizontal y0="693.201" y1="700.701" x0="54.6" x1="172.65" width="118.05" height="7.5" bbox="[54.6, 693.201, 172.65, 700.701]" word_margin="0.1">transplantation. Blood 2002;100:2367&#8211;73. <Annot A="&lt;PDFObjRef:116&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[99.1868, 701.968, 114.899, 693.201]" x0="99.1868" x1="114.899" y0="701.968" y1="693.201" height="-8.766999999999939" width="15.712199999999996" URI="http://dx.doi.org/10.1182/blood-2002-01-0172"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="711.201" y1="718.701" x0="306.69" x1="542.287" width="235.597" height="7.5" bbox="[306.69, 711.201, 542.287, 718.701]" word_margin="0.1">13 Malissen N, Lacotte J, Du- Thanh A, et al. Macrophage activation syndrome: a new <LTTextBoxHorizontal y0="711.201" y1="718.701" x0="306.69" x1="542.287" width="235.597" height="7.5" bbox="[306.69, 711.201, 542.287, 718.701]" index="6">13Malissen N, Lacotte J, Du- Thanh A, et al. Macrophage activation syndrome: a new <LTTextLineHorizontal y0="711.201" y1="718.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 711.201, 308.49, 718.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="702.201" y1="709.701" x0="319.29" x1="499.282" width="179.993" height="7.5" bbox="[319.29, 702.201, 499.282, 709.701]" word_margin="0.1"><LTTextBoxHorizontal y0="702.201" y1="709.701" x0="319.29" x1="499.282" width="179.993" height="7.5" bbox="[319.29, 702.201, 499.282, 709.701]" index="7">complication of checkpoint inhibitors. Eur J Cancer 2017;77:88&#8211;9. <Annot A="&lt;PDFObjRef:124&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[422.509, 710.968, 455.928, 702.201]" x0="422.509" x1="455.928" y0="710.968" y1="702.201" height="-8.766999999999939" width="33.41899999999998" URI="http://dx.doi.org/10.1016/j.ejca.2017.02.016"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="693.201" y1="700.701" x0="306.69" x1="537.037" width="230.347" height="7.5" bbox="[306.69, 693.201, 537.037, 700.701]" word_margin="0.1">14 Shah D, Shrestha R, Ramlal R, et al. Pembrolizumab associated hemophagocytic <LTTextBoxHorizontal y0="693.201" y1="700.701" x0="306.69" x1="537.037" width="230.347" height="7.5" bbox="[306.69, 693.201, 537.037, 700.701]" index="8">14Shah D, Shrestha R, Ramlal R, et al. Pembrolizumab associated hemophagocytic <LTTextLineHorizontal y0="693.201" y1="700.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 693.201, 308.49, 700.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="684.201" y1="691.701" x0="42.0" x1="279.39" width="237.39" height="7.5" bbox="[42.0, 684.201, 279.39, 691.701]" word_margin="0.1"><LTTextBoxHorizontal y0="684.201" y1="691.701" x0="42.0" x1="279.39" width="237.39" height="7.5" bbox="[42.0, 684.201, 279.39, 691.701]" index="9"> 6 Sadaat M, Jang S. Hemophagocytic lymphohistiocytosis with immunotherapy: brief </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="684.201" y1="691.701" x0="319.29" x1="446.565" width="127.275" height="7.5" bbox="[319.29, 684.201, 446.565, 691.701]" word_margin="0.1"><LTTextBoxHorizontal y0="684.201" y1="691.701" x0="319.29" x1="446.565" width="127.275" height="7.5" bbox="[319.29, 684.201, 446.565, 691.701]" index="10">lymphohistiocytosis. Ann Oncol 2017;28:1403. <Annot A="&lt;PDFObjRef:125&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[374.87, 692.968, 403.362, 684.201]" x0="374.87" x1="403.362" y0="692.968" y1="684.201" height="-8.766999999999939" width="28.49200000000002" URI="http://dx.doi.org/10.1093/annonc/mdx113"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="675.201" y1="682.701" x0="54.6" x1="209.879" width="155.279" height="7.5" bbox="[54.6, 675.201, 209.879, 682.701]" word_margin="0.1"><LTTextBoxHorizontal y0="675.201" y1="682.701" x0="54.6" x1="209.879" width="155.279" height="7.5" bbox="[54.6, 675.201, 209.879, 682.701]" index="11">review and case report. J Immunother Cancer 2018;6:49. <Annot A="&lt;PDFObjRef:117&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[119.729, 683.968, 177.478, 675.201]" x0="119.729" x1="177.478" y0="683.968" y1="675.201" height="-8.766999999999939" width="57.74900000000001" URI="http://dx.doi.org/10.1186/s40425-018-0365-3"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="675.201" y1="682.701" x0="306.69" x1="538.702" width="232.012" height="7.5" bbox="[306.69, 675.201, 538.702, 682.701]" word_margin="0.1">15 Takeshita M, Anai S, Mishima S, et al. Coincidence of immunotherapy- associated <LTTextBoxHorizontal y0="675.201" y1="682.701" x0="306.69" x1="538.702" width="232.012" height="7.5" bbox="[306.69, 675.201, 538.702, 682.701]" index="12">15Takeshita M, Anai S, Mishima S, et al. Coincidence of immunotherapy- associated <LTTextLineHorizontal y0="675.201" y1="682.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 675.201, 308.49, 682.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="666.201" y1="673.701" x0="42.0" x1="275.438" width="233.438" height="7.5" bbox="[42.0, 666.201, 275.438, 673.701]" word_margin="0.1"><LTTextBoxHorizontal y0="666.201" y1="673.701" x0="42.0" x1="275.438" width="233.438" height="7.5" bbox="[42.0, 666.201, 275.438, 673.701]" index="13"> 7 Hantel A, Gabster B, Cheng JX, et al. Severe hemophagocytic lymphohistiocytosis </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="666.201" y1="673.701" x0="319.29" x1="545.872" width="226.582" height="7.5" bbox="[319.29, 666.201, 545.872, 673.701]" word_margin="0.1"><LTTextBoxHorizontal y0="666.201" y1="673.701" x0="319.29" x1="545.872" width="226.582" height="7.5" bbox="[319.29, 666.201, 545.872, 673.701]" index="14">hemophagocytic syndrome and rapid tumor regression. Ann Oncol 2017;28:186&#8211;9. <Annot A="&lt;PDFObjRef:126&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[470.426, 674.968, 498.918, 666.201]" x0="470.426" x1="498.918" y0="674.968" y1="666.201" height="-8.766999999999939" width="28.49200000000002" URI="http://dx.doi.org/10.1093/annonc/mdw537"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="648.201" y1="664.701" x0="54.6" x1="282.135" width="227.535" height="16.5" bbox="[54.6, 648.201, 282.135, 664.701]" index="15"><LTTextLineHorizontal y0="657.201" y1="664.701" x0="54.6" x1="282.135" width="227.535" height="7.5" bbox="[54.6, 657.201, 282.135, 664.701]" word_margin="0.1">in a melanoma patient treated with ipilimumab + nivolumab. J Immunother Cancer <Annot A="&lt;PDFObjRef:118&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[222.582, 665.968, 280.331, 657.201]" x0="222.582" x1="280.331" y0="665.968" y1="657.201" height="-8.766999999999939" width="57.749000000000024" URI="http://dx.doi.org/10.1186/s40425-018-0384-0"/></LTTextLineHorizontal><LTTextLineHorizontal y0="648.201" y1="655.701" x0="54.6" x1="85.2" width="30.6" height="7.5" bbox="[54.6, 648.201, 85.2, 655.701]" word_margin="0.1">2018;6:73. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="621.201" y1="646.701" x0="42.0" x1="286.267" width="244.267" height="25.5" bbox="[42.0, 621.201, 286.267, 646.701]" index="16"><LTTextLineHorizontal y0="639.201" y1="646.701" x0="42.0" x1="286.267" width="244.267" height="7.5" bbox="[42.0, 639.201, 286.267, 646.701]" word_margin="0.1"> 8 Noseda R, Bertoli R, M&#252;ller L, et al. Haemophagocytic lymphohistiocytosis in patients </LTTextLineHorizontal><LTTextLineHorizontal y0="630.201" y1="637.701" x0="54.6" x1="269.602" width="215.002" height="7.5" bbox="[54.6, 630.201, 269.602, 637.701]" word_margin="0.1">treated with immune checkpoint inhibitors: analysis of who global database of </LTTextLineHorizontal><LTTextLineHorizontal y0="621.201" y1="628.701" x0="54.6" x1="230.01" width="175.41" height="7.5" bbox="[54.6, 621.201, 230.01, 628.701]" word_margin="0.1">individual case safety reports. J Immunother Cancer 2019;7:117. <Annot A="&lt;PDFObjRef:119&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[136.258, 629.968, 194.008, 621.201]" x0="136.258" x1="194.008" y0="629.968" y1="621.201" height="-8.766999999999939" width="57.75" URI="http://dx.doi.org/10.1186/s40425-019-0598-9"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="612.201" y1="619.701" x0="42.0" x1="278.054" width="236.054" height="7.5" bbox="[42.0, 612.201, 278.054, 619.701]" word_margin="0.1"><LTTextBoxHorizontal y0="612.201" y1="619.701" x0="42.0" x1="278.054" width="236.054" height="7.5" bbox="[42.0, 612.201, 278.054, 619.701]" index="17"> 9 Mizuta H, Nakano E, Takahashi A, et al. Hemophagocytic lymphohistiocytosis with </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="594.201" y1="610.701" x0="54.6" x1="282.24" width="227.64" height="16.5" bbox="[54.6, 594.201, 282.24, 610.701]" index="18"><LTTextLineHorizontal y0="603.201" y1="610.701" x0="54.6" x1="282.24" width="227.64" height="7.5" bbox="[54.6, 603.201, 282.24, 610.701]" word_margin="0.1">advanced malignant melanoma accompanied by ipilimumab and nivolumab: a case </LTTextLineHorizontal><LTTextLineHorizontal y0="594.201" y1="601.701" x0="54.6" x1="220.455" width="165.855" height="7.5" bbox="[54.6, 594.201, 220.455, 601.701]" word_margin="0.1">report and literature review. Dermatol Ther 2020;33:e13321. <Annot A="&lt;PDFObjRef:120&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[132.246, 602.968, 170.458, 594.201]" x0="132.246" x1="170.458" y0="602.968" y1="594.201" height="-8.766999999999939" width="38.21199999999999" URI="http://dx.doi.org/10.1111/dth.13321"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="585.201" y1="592.701" x0="42.0" x1="284.58" width="242.58" height="7.5" bbox="[42.0, 585.201, 284.58, 592.701]" word_margin="0.1">10 Chin CK, Hall S, Green C, et al. Secondary haemophagocytic lymphohistiocytosis due <LTTextBoxHorizontal y0="585.201" y1="592.701" x0="42.0" x1="284.58" width="242.58" height="7.5" bbox="[42.0, 585.201, 284.58, 592.701]" index="19">10Chin CK, Hall S, Green C, et al. Secondary haemophagocytic lymphohistiocytosis due <LTTextLineHorizontal y0="585.201" y1="592.701" x0="42.0" x1="43.8" width="1.8" height="7.5" bbox="[42.0, 585.201, 43.8, 592.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="576.201" y1="583.701" x0="54.6" x1="221.648" width="167.048" height="7.5" bbox="[54.6, 576.201, 221.648, 583.701]" word_margin="0.1"><LTTextBoxHorizontal y0="576.201" y1="583.701" x0="54.6" x1="221.648" width="167.048" height="7.5" bbox="[54.6, 576.201, 221.648, 583.701]" index="20">to checkpoint inhibitor therapy. Eur J Cancer 2019;115:84&#8211;7. <Annot A="&lt;PDFObjRef:121&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[141.276, 584.968, 174.696, 576.201]" x0="141.276" x1="174.696" y0="584.968" y1="576.201" height="-8.766999999999939" width="33.41999999999999" URI="http://dx.doi.org/10.1016/j.ejca.2019.04.026"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="567.201" y1="574.701" x0="42.0" x1="263.032" width="221.032" height="7.5" bbox="[42.0, 567.201, 263.032, 574.701]" word_margin="0.1">11 Kalmuk J, Puchalla J, Feng G, et al. Pembrolizumab- induced hemophagocytic <LTTextBoxHorizontal y0="567.201" y1="574.701" x0="42.0" x1="263.032" width="221.032" height="7.5" bbox="[42.0, 567.201, 263.032, 574.701]" index="21">11Kalmuk J, Puchalla J, Feng G, et al. Pembrolizumab- induced hemophagocytic <LTTextLineHorizontal y0="567.201" y1="574.701" x0="42.0" x1="43.8" width="1.8" height="7.5" bbox="[42.0, 567.201, 43.8, 574.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="558.201" y1="565.701" x0="54.6" x1="284.355" width="229.755" height="7.5" bbox="[54.6, 558.201, 284.355, 565.701]" word_margin="0.1"><LTTextBoxHorizontal y0="558.201" y1="565.701" x0="54.6" x1="284.355" width="229.755" height="7.5" bbox="[54.6, 558.201, 284.355, 565.701]" index="22">lymphohistiocytosis: an immunotherapeutic challenge. Cancers Head Neck 2020;5:3. <Annot A="&lt;PDFObjRef:122&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[202.685, 566.968, 255.552, 558.201]" x0="202.685" x1="255.552" y0="566.968" y1="558.201" height="-8.766999999999939" width="52.86699999999999" URI="http://dx.doi.org/10.1186/s41199-020-0050-3"/></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="657.201" y1="664.701" x0="306.69" x1="506.354" width="199.664" height="7.5" bbox="[306.69, 657.201, 506.354, 664.701]" word_margin="0.1">16 Satzger I, Ivanyi P, L&#228;nger F, et al. Treatment- related hemophagocytic <LTTextBoxHorizontal y0="657.201" y1="664.701" x0="306.69" x1="506.354" width="199.664" height="7.5" bbox="[306.69, 657.201, 506.354, 664.701]" index="23">16Satzger I, Ivanyi P, L&#228;nger F, et al. Treatment- related hemophagocytic <LTTextLineHorizontal y0="657.201" y1="664.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 657.201, 308.49, 664.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="639.201" y1="655.701" x0="319.29" x1="525.465" width="206.175" height="16.5" bbox="[319.29, 639.201, 525.465, 655.701]" index="24"><LTTextLineHorizontal y0="648.201" y1="655.701" x0="319.29" x1="525.465" width="206.175" height="7.5" bbox="[319.29, 648.201, 525.465, 655.701]" word_margin="0.1">lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus </LTTextLineHorizontal><LTTextLineHorizontal y0="639.201" y1="646.701" x0="319.29" x1="432.863" width="113.573" height="7.5" bbox="[319.29, 639.201, 432.863, 646.701]" word_margin="0.1">ipilimumab. Eur J Cancer 2018;93:150&#8211;3. <Annot A="&lt;PDFObjRef:127&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[352.49, 647.968, 385.91, 639.201]" x0="352.49" x1="385.91" y0="647.968" y1="639.201" height="-8.766999999999939" width="33.420000000000016" URI="http://dx.doi.org/10.1016/j.ejca.2018.01.063"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="630.201" y1="637.701" x0="306.69" x1="552.622" width="245.933" height="7.5" bbox="[306.69, 630.201, 552.622, 637.701]" word_margin="0.1">17 Lorenz G, Schul L, Bachmann Q, et al. Hemophagocytic lymphohistiocytosis secondary <LTTextBoxHorizontal y0="630.201" y1="637.701" x0="306.69" x1="552.622" width="245.933" height="7.5" bbox="[306.69, 630.201, 552.622, 637.701]" index="25">17Lorenz G, Schul L, Bachmann Q, et al. Hemophagocytic lymphohistiocytosis secondary <LTTextLineHorizontal y0="630.201" y1="637.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 630.201, 308.49, 637.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="612.201" y1="628.701" x0="319.29" x1="530.445" width="211.155" height="16.5" bbox="[319.29, 612.201, 530.445, 628.701]" index="26"><LTTextLineHorizontal y0="621.201" y1="628.701" x0="319.29" x1="530.445" width="211.155" height="7.5" bbox="[319.29, 621.201, 530.445, 628.701]" word_margin="0.1">to pembrolizumab treatment with insufficient response to high- dose steroids. </LTTextLineHorizontal><LTTextLineHorizontal y0="612.201" y1="619.701" x0="319.29" x1="409.028" width="89.738" height="7.5" bbox="[319.29, 612.201, 409.028, 619.701]" word_margin="0.1">Rheumatology 2019;58:1106&#8211;9. </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="603.201" y1="610.701" x0="306.69" x1="529.545" width="222.855" height="7.5" bbox="[306.69, 603.201, 529.545, 610.701]" word_margin="0.1">18 Okawa S, Kayatani H, Fujiwara K, et al. Pembrolizumab- induced autoimmune <LTTextBoxHorizontal y0="603.201" y1="610.701" x0="306.69" x1="529.545" width="222.855" height="7.5" bbox="[306.69, 603.201, 529.545, 610.701]" index="27">18Okawa S, Kayatani H, Fujiwara K, et al. Pembrolizumab- induced autoimmune <LTTextLineHorizontal y0="603.201" y1="610.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 603.201, 308.49, 610.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextBoxHorizontal y0="585.201" y1="601.701" x0="319.29" x1="541.553" width="222.263" height="16.5" bbox="[319.29, 585.201, 541.553, 601.701]" index="28"><LTTextLineHorizontal y0="594.201" y1="601.701" x0="319.29" x1="541.553" width="222.263" height="7.5" bbox="[319.29, 594.201, 541.553, 601.701]" word_margin="0.1">hemolytic anemia and hemophagocytic lymphohistiocytosis in non- small cell lung </LTTextLineHorizontal><LTTextLineHorizontal y0="585.201" y1="592.701" x0="319.29" x1="423.705" width="104.415" height="7.5" bbox="[319.29, 585.201, 423.705, 592.701]" word_margin="0.1">cancer. Intern Med 2019;58:699&#8211;702. <Annot A="&lt;PDFObjRef:129&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[339.561, 593.968, 369.553, 585.201]" x0="339.561" x1="369.553" y0="593.968" y1="585.201" height="-8.766999999999939" width="29.99200000000002" URI="http://dx.doi.org/10.2169/internalmedicine.1001-18"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="567.201" y1="583.701" x0="306.69" x1="525.016" width="218.326" height="16.5" bbox="[306.69, 567.201, 525.016, 583.701]" index="29">19WHO. vigiaccessorg. VigiAccess, 22. Available: http://www.vigiaccess.org/ 20 <LTTextLineHorizontal y0="576.201" y1="583.701" x0="306.69" x1="525.016" width="218.326" height="7.5" bbox="[306.69, 576.201, 525.016, 583.701]" word_margin="0.1">19WHO. vigiaccessorg. VigiAccess, 2022. Available: http://www.vigiaccess.org/ <LTTextLineHorizontal y0="576.201" y1="583.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 576.201, 308.49, 583.701]" word_margin="0.1"> </LTTextLineHorizontal><Annot A="&lt;PDFObjRef:130&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[452.517, 584.968, 525.01, 576.201]" x0="452.517" x1="525.01" y0="584.968" y1="576.201" height="-8.766999999999939" width="72.493" URI="http://www.vigiaccess.org/"/></LTTextLineHorizontal><LTTextLineHorizontal y0="567.201" y1="574.701" x0="306.69" x1="315.69" width="9.0" height="7.5" bbox="[306.69, 567.201, 315.69, 574.701]" word_margin="0.1">20<LTTextLineHorizontal y0="567.201" y1="574.701" x0="306.69" x1="308.49" width="1.8" height="7.5" bbox="[306.69, 567.201, 308.49, 574.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextLineHorizontal><LTTextLineHorizontal y0="567.201" y1="574.701" x0="319.29" x1="321.09" width="1.8" height="7.5" bbox="[319.29, 567.201, 321.09, 574.701]" word_margin="0.1"> </LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextBoxHorizontal y0="558.201" y1="574.701" x0="319.29" x1="539.685" width="220.395" height="16.5" bbox="[319.29, 558.201, 539.685, 574.701]" index="30"><LTTextLineHorizontal y0="567.201" y1="574.701" x0="319.29" x1="539.685" width="220.395" height="7.5" bbox="[319.29, 567.201, 539.685, 574.701]" word_margin="0.1">adrreports. eu E. European database of suspected adverse drug reaction reports - </LTTextLineHorizontal><LTTextLineHorizontal y0="558.201" y1="565.701" x0="319.29" x1="503.797" width="184.507" height="7.5" bbox="[319.29, 558.201, 503.797, 565.701]" word_margin="0.1">Search, 2022. Available: https://www.adrreports.eu/en/search.html# <Annot A="&lt;PDFObjRef:131&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[386.172, 566.968, 503.793, 558.201]" x0="386.172" x1="503.793" y0="566.968" y1="558.201" height="-8.766999999999939" width="117.62099999999998" URI="https://www.adrreports.eu/en/search.html#"/></LTTextLineHorizontal></LTTextBoxHorizontal>
    <LTTextLineHorizontal y0="26.93" y1="34.93" x0="42.0" x1="45.84" width="3.84" height="8.0" bbox="[42.0, 26.93, 45.84, 34.93]" word_margin="0.1"><LTTextBoxHorizontal y0="26.93" y1="34.93" x0="42.0" x1="45.84" width="3.84" height="8.0" bbox="[42.0, 26.93, 45.84, 34.93]" index="35">6 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTTextLineHorizontal y0="26.938" y1="34.938" x0="320.416" x1="553.574" width="233.158" height="8.0" bbox="[320.416, 26.938, 553.574, 34.938]" word_margin="0.1"><LTTextBoxHorizontal y0="26.938" y1="34.938" x0="320.416" x1="553.574" width="233.158" height="8.0" bbox="[320.416, 26.938, 553.574, 34.938]" index="36">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTLine y0="38.68" y1="38.68" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.68, 553.276, 38.68]" linewidth="0.5" pts="[[42.0, 38.68], [553.276, 38.68]]"/>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="45.7" x1="105.133" width="59.433" height="11.0" bbox="[45.7, 757.826, 105.133, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="45.7" x1="105.133" width="59.433" height="11.0" bbox="[45.7, 757.826, 105.133, 768.826]" index="0">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <LTRect y0="400.076" y1="542.076" x0="42.0" x1="553.276" width="511.276" height="142.0" bbox="[42.0, 400.076, 553.276, 542.076]" linewidth="0.5" pts="[[42.0, 400.076], [553.276, 400.076], [553.276, 542.076], [42.0, 542.076]]">
      <LTTextBoxHorizontal y0="503.876" y1="531.076" x0="54.6" x1="373.983" width="319.383" height="27.2" bbox="[54.6, 503.876, 373.983, 531.076]" index="31"><LTTextLineHorizontal y0="523.076" y1="531.076" x0="54.6" x1="361.254" width="306.654" height="8.0" bbox="[54.6, 523.076, 361.254, 531.076]" word_margin="0.1">Copyright 2022 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit </LTTextLineHorizontal><LTTextLineHorizontal y0="513.476" y1="521.476" x0="54.6" x1="295.096" width="240.496" height="8.0" bbox="[54.6, 513.476, 295.096, 521.476]" word_margin="0.1">https://www.bmj.com/company/products-services/rights-and-licensing/permissions/ </LTTextLineHorizontal><LTTextLineHorizontal y0="503.876" y1="511.876" x0="54.6" x1="373.983" width="319.383" height="8.0" bbox="[54.6, 503.876, 373.983, 511.876]" word_margin="0.1">BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission. </LTTextLineHorizontal></LTTextBoxHorizontal>
      <LTTextBoxHorizontal y0="449.276" y1="496.276" x0="54.0" x1="338.336" width="284.336" height="47.0" bbox="[54.0, 449.276, 338.336, 496.276]" index="32">&#9658; Submit as many cases as you like&#9658; Access all the published articles<LTTextLineHorizontal y0="488.276" y1="496.276" x0="54.6" x1="222.711" width="168.111" height="8.0" bbox="[54.6, 488.276, 222.711, 496.276]" word_margin="0.1">Become a Fellow of BMJ Case Reports today and you can: </LTTextLineHorizontal><LTTextLineHorizontal y0="478.076" y1="486.676" x0="54.0" x1="160.83" width="106.83" height="8.6" bbox="[54.0, 478.076, 160.83, 486.676]" word_margin="0.1"> &#9658; Submit as many cases as you like </LTTextLineHorizontal><LTTextLineHorizontal y0="468.476" y1="477.076" x0="54.0" x1="286.758" width="232.758" height="8.6" bbox="[54.0, 468.476, 286.758, 477.076]" word_margin="0.1"> &#9658; Enjoy fast sympathetic peer review and rapid publication of accepted articles </LTTextLineHorizontal><LTTextLineHorizontal y0="458.876" y1="467.476" x0="54.0" x1="156.696" width="102.696" height="8.6" bbox="[54.0, 458.876, 156.696, 467.476]" word_margin="0.1"> &#9658; Access all the published articles </LTTextLineHorizontal><LTTextLineHorizontal y0="449.276" y1="457.876" x0="54.0" x1="338.336" width="284.336" height="8.6" bbox="[54.0, 449.276, 338.336, 457.876]" word_margin="0.1"> &#9658; Re-use any of the published material for personal use and teaching without further permission </LTTextLineHorizontal></LTTextBoxHorizontal>
      <LTTextBoxHorizontal y0="424.676" y1="442.276" x0="54.6" x1="515.718" width="461.118" height="17.6" bbox="[54.6, 424.676, 515.718, 442.276]" index="33"><LTTextLineHorizontal y0="434.276" y1="442.276" x0="54.6" x1="112.84" width="58.24" height="8.0" bbox="[54.6, 434.276, 112.84, 442.276]" word_margin="0.1">Customer Service </LTTextLineHorizontal><LTTextLineHorizontal y0="424.676" y1="432.676" x0="54.6" x1="515.718" width="461.118" height="8.0" bbox="[54.6, 424.676, 515.718, 432.676]" word_margin="0.1">If you have any further queries about your subscription, please contact our customer services team on +44 (0) 207111 1105 or via email at support@bmj.com. </LTTextLineHorizontal></LTTextBoxHorizontal>
      <LTTextLineHorizontal y0="409.076" y1="417.076" x0="54.6" x1="272.693" width="218.093" height="8.0" bbox="[54.6, 409.076, 272.693, 417.076]" word_margin="0.1"><LTTextBoxHorizontal y0="409.076" y1="417.076" x0="54.6" x1="272.693" width="218.093" height="8.0" bbox="[54.6, 409.076, 272.693, 417.076]" index="34">Visit casereports.bmj.com for more articles like this and to become a Fellow </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
    <Annot A="&lt;PDFObjRef:128&gt;" BS="{&quot;S&quot;: &quot;/S&quot;, &quot;Type&quot;: &quot;/Border&quot;, &quot;W&quot;: 0}" Border="[0, 0, 0]" H="/N" Subtype="/Link" Type="/Annot" bbox="[319.288, 620.968, 358.475, 612.201]" x0="319.288" x1="358.475" y0="620.968" y1="612.201" height="-8.766999999999939" width="39.18700000000001" URI="http://dx.doi.org/10.1093/rheumatology/key447"/>
  </LTPage>
  <LTPage y0="0" y1="793.701" x0="0" x1="595.276" width="595.276" height="793.701" bbox="[0, 0, 595.276, 793.701]" pageid="7" rotate="0" page_index="6" page_label="">
    <LTTextLineHorizontal y0="26.93" y1="34.93" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.93, 553.276, 34.93]" word_margin="0.1"><LTTextBoxHorizontal y0="26.93" y1="34.93" x0="549.436" x1="553.276" width="3.84" height="8.0" bbox="[549.436, 26.93, 553.276, 34.93]" index="1">7 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTLine y0="38.68" y1="38.68" x0="42.0" x1="553.276" width="511.276" height="0.0" bbox="[42.0, 38.68, 553.276, 38.68]" linewidth="0.5" pts="[[42.0, 38.68], [553.276, 38.68]]"/>
    <LTTextLineHorizontal y0="26.941" y1="34.941" x0="42.0" x1="275.158" width="233.158" height="8.0" bbox="[42.0, 26.941, 275.158, 34.941]" word_margin="0.1"><LTTextBoxHorizontal y0="26.941" y1="34.941" x0="42.0" x1="275.158" width="233.158" height="8.0" bbox="[42.0, 26.941, 275.158, 34.941]" index="0">Holmes Z, et al. BMJ Case Rep 2022;0:e251052. doi:10.1136/bcr-2022-251052 </LTTextBoxHorizontal></LTTextLineHorizontal>
    <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm0" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]">
      <LTFigure y0="793.701" y1="793.701" x0="0.0" x1="595.276" width="595.276" height="0.0" bbox="[0.0, 793.701, 595.276, 793.701]" name="Fm1" matrix="[1.0, 0.0, 0.0, 1.0, 0.0, 0.0]"/>
    </LTFigure>
    <LTRect y0="756.201" y1="773.201" x0="42.0" x1="553.276" width="511.276" height="17.0" bbox="[42.0, 756.201, 553.276, 773.201]" linewidth="0.5" pts="[[42.0, 756.201], [553.276, 756.201], [553.276, 773.201], [42.0, 773.201]]">
      <LTTextLineHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" word_margin="0.1"><LTTextBoxHorizontal y0="757.826" y1="768.826" x0="490.044" x1="549.477" width="59.433" height="11.0" bbox="[490.044, 757.826, 549.477, 768.826]" index="0">Case report </LTTextBoxHorizontal></LTTextLineHorizontal>
    </LTRect>
  </LTPage>
</pdfxml>
